2018 MEETING ANNUAL - ahpba.org · 6:30pm - 9:30pm Executive Council Meeting | Poinciana 1/2...

March 7 – 11, 2018 Loews Miami Beach Hotel IN Miami Beach, Florida

2625 West 51st Terrace Westwood, KS 66205

t: 913.402.7102 [email protected]

www.ahpba.org

FINAL PROGRAM

#ahpba18

2018 ANNUAL MEETING

“Elevating Quality and Safety for our Patients”

AHPBA_2018_FinalProgram.indd 1 2/22/18 9:12 PM

AHPBA President Rebecca M. Minter, MD welcomes you to the AHPBA 2018 Annual Meeting at the Loews Miami Beach!

OTHER MEETING HIGHLIGHTS DORRY SEGEV, MD | Advancing Surgical Policy and Practice Through Big Data

First AHPBA-SAGES Joint Symposium on Lap Liver Resections

First ASTS-AHPBA Joint Symposium

Meet the Professor Rounds

PRE CONGRESS SYMPOSIUM

“HPB Across the Spectrum of Care” Moderator: Charles Vollmer, MD

AHPBA Ultrasound & Advanced Technology Course Course Director: Ellen Hagopian, MD

OVER 100 INVITED SPEAKERS 15 Countries, 4 Continents, 19 Symposia

70 ORAL PRESENTATIONS 145 Mini-Orals, 21 Videos, Over 100 ePosters


1AHPBA 2018 ANNUAL MEETING

TABLE OF CONTENTS

2 Schedule at a Glance

9 Featured Lectures

15 Leadership & Meeting Information

21 General Meeting Information

23 CME Information

25 Awards, Fellowships & Grants

41 AHPBA Chapters

42 AHPB Foundation

45 Agenda

123 Abstract Information

124 Speakers & Faculty

129 Floorplans & Exhibit Information

135 AHPBA Membership

145 In Memoriam


2 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDA

7:30am - 8:00am Ultrasound & Advanced Technology Course Registration and Breakfast | Cowrie Foyer 8:00am - 12:00pm Ultrasound & Advanced Technology Didactic Course | Cowrie 2 12Noon - 12:45pm Ultrasound & Advanced Technology Course Lunch Cowrie Foyer 12:45pm - 5:00pm Ultrasound & Advanced Technology Course Lab | Cowrie 1 12:30pm - 1:30pm Surgical Innovation Committee Meeting | Hospitality room 432 12:30pm - 1:30pm Professional Development Committee Meeting | Periwinkle 1:30pm - 2:30pm Clinical Trials Committee Meeting | Hospitality room 409 1:30pm - 2:30pm Conflict of Interest (COI) Committee Meeting Hospitality room 432 1:30pm - 2:30pm AHPBF Board Meeting | Periwinkle 2:30pm - 3:30pm Finance Committee Meeting | Hospitality room 432 2:30pm - 3:30pm Publications Committee Meeting | Periwinkle 3:00pm - 4:30pm Education & Training Committee Meeting | Poinciana 3/4 3:30pm - 4:30pm Program Committee Meeting | Poinciana 1/2 4:30pm - 6:30pm HPB Program Directors Committee Meeting | Americana 3 4:30pm - 5:30pm Research Committee Meeting | Poinciana 1/2 5:30pm - 6:30pm Membership Committee Meeting | Poinciana 3/4 5:30pm - 6:30pm International Relations Committee Meeting | Poinciana 1/2 6:00pm - 8:00pm Registration Open | Rotunda East 6:00pm - 9:00pm Ultrasound Course Fellows Practicum | Cowrie 1 6:30pm - 9:30pm Executive Council Meeting | Poinciana 1/2

WEDNESDAY, MARCH 7, 2018

S CH E D U L E AT A G L A N CE



6:00am - 9:00am Ultrasound Course Fellows Practicum | Cowrie 1 7:00am - 6:30pm Registration Open | Rotunda East

8:00am - 4:30pm Pre Congress Symposium: HPB Across the Spectrum of Care | Americana 1/2

10:15am - 10:30am Pre Congress Symposium Beverage Break | Americana Foyer

10:00am - 10:30am Industry Council & Ethicon Meeting | Cowrie 2 12:30pm - 1:30pm Pre Congress Symposium Lunch Break (on own) 12:30pm - 1:30pm AHPBA New Members Lunch with Leadership (by invitation) | Poinciana 3/4 3:00pm - 4:00pm Ultrasound Subcommittee Meeting | Cowrie 2 4:30pm - 5:30pm HPB Collaborative Meeting | Poinciana 1/2

5:30pm - 7:00pm AHPBA Welcome Reception | Americana 4

5:30pm - 7:30pm Bernard Langer Fellows Symposium | Americana 1/2

9:30pm Cocktails with AHPBA Leadership | Bar Collins

THURSDAY, MARCH 8, 2018




6:15am - 7:15am AHPBF Fund Run | Check-in at Spa Front Desk 7:00am - 6:00pm Registration Open | Rotunda East

7:00am – 7:45am IHPBA/AHPBA Joint Executive Council Meeting Sunrise Tellin 7:00am - 8:00am Continental Breakfast in Exhibit Hall | Americana 4

7:00am - 8:00am Industry Sponsored Breakfast Symposium – Thank you Aesculap! | Poinciana 3/4 8:00am - 9:30am Welcome and Presidential Plenary Session Americana 1/2 9:30am - 10:30am Presidential Address | Rebecca M. Minter, MD Americana 1/2 10:30am - 11:00am Morning Beverage Break, Exhibits & ePoster Viewing Americana 4 11:00am - 12:30pm AHPBA-SAGES Joint Symposium: Lap Liver | Americana 1/2 11:00am - 12:30pm Enhanced Recovery After HPB Surgery | Americana 3

11:00am - 12:30pm Oral Presentations 1: Hepatobiliary | Poinciana 1/2

11:00am - 12:30pm Oral Presentations 2: Pancreas | Poinciana 3/4

11:00am - 12:30pm Oral Presentations 3: Transplant | Cowrie 1/2

12:30pm - 1:00pm Lunch in Exhibit Hall | Americana 4 12:30pm - 1:30pm Advance Practice Provider Committee Meeting | Cowrie 2 1:00pm - 2:30pm Vascular Resections in HPB Cancer - When, Where, How? Americana 1/2 1:00pm - 2:30pm Does the Evidence Truly Support Aggressive Surgical or Medical Treatment in HPB Surgery? | Americana 3

FRIDAY, MARCH 9, 2018




1:00pm - 2:30pm Mini Oral Sessions Monitor 1, Pancreas Cancer Americana Foyer 1:00pm - 2:30pm Mini Oral Sessions Monitor 2, Pancreas | Americana Foyer

1:00pm - 2:30pm Mini Oral Sessions Monitor 3, Liver | Americana Foyer 1:00pm - 2:30pm Mini Oral Sessions Monitor 4, GB/Cholangiocarinoma/PNET Americana Foyer 1:30pm - 2:30pm Latin American Presidents Committee Meeting | Cowrie 2 2:30pm - 3:30pm Clinical Trials in Progress: Barriers to Prospective Trials in HPB Surgery | Americana 1/2

2:30pm - 3:30pm State of the Art Lecture: Of Math and Medicine Americana 3 2:30pm - 3:30pm Basic Translational Science | Poinciana 1/2 3:30pm - 4:00pm Afternoon Beverage Break, Exhibit & ePoster Viewing Americana 4 4:00pm - 5:00pm Leslie H. Blumgart Historical Lecture | David Adams, MD Americana 1/2 5:00pm - 6:30pm Women in Surgery: Navigating the Dual Career Waters Cowrie 1/2 5:00pm - 6:30pm Video Session: Pancreas | Americana 1/2 5:00pm - 6:30pm State of the Art Symposium - Current Management of Colorectal Liver Metastases | Americana 3 6:30pm - 7:00pm Women in Surgery Reception | Cowrie Foyer 6:30pm - 7:30pm AHPBA Cocktail Reception in Exhibit Hall Americana Foyer and Americana 4 7:30pm - 10:00pm AHPBA Congress Banquet | Americana Lawn





6:30am - 6:00pm Registration Open | Rotunda East 6:45am - 8:00am Continental Breakfast in Exhibit Hall | Americana 4 7:00am - 8:00am Professor Rounds: The Difficult Bile Duct | Cowrie 1/2 7:00am - 8:00am Professor Rounds: Assessing Marginal Livers and How to Transplant Them | Poinciana 3/4 7:00am - 8:00am Professor Rounds: Developing a Career in HPB Surgery - Chair’s Perspective | Periwinkle 7:00am - 8:00am Professor Rounds: Technical Pearls and Disasters During Whipple Procedure | Poinciana 1/2 7:30am - 9:00am Mini Oral Sessions Monitor 1, HPB Transplant Americana Foyer 7:30am - 9:00am Mini Oral Sessions Monitor 2, HCC | Americana Foyer 7:30am - 9:00am Mini Oral Sessions Monitor 3, HPB Education Cost Americana Foyer 7:30am - 9:00am Mini Oral Sessions Monitor 4, Pancreas | Americana Foyer 8:00am - 9:00am State of the Art International Symposium: ALPPS for Cancer | Americana 1/2 8:00am - 9:00am Oral Presentations 4: Pancreas II | Poinciana 1/2 8:00am - 9:00am Oral Presentations 5: Liver | Poinciana 3 9:00am - 10:00am Betty and Henry Pitt Quality Oration | Clifford Ko, MD, MS, MSHS, FACS, FASCRS | Americana 1/2 10:00am - 10:30am Morning Beverage Break, Exhibit & ePoster Viewing Americana Foyer 10:30am - 12Noon Oral Presentations 6: Large Databases | Poinciana 1/2

SATURDAY, MARCH 10, 2018




10:30am - 12Noon Video Session: Liver Biliary | Cowrie 1/2 10:30am - 12Noon ASTS/AHPBA Joint Symposium: Multidisciplinary Management of HCC | Americana 1/2 10:30am - 12Noon Locally Advanced Pancreatic Cancer | Americana 3 12:00pm - 12:30pm Industry Lunch Symposium - Thank you BTG! Poinciana 3/4 12:00pm - 12:30pm Lunch in Exhibit Hall | Americana 4 12:30pm - 2:00pm Fellows Jeopardy | Americana 1/2 12:30pm - 2:00pm Consensus Conference Symposium | Poinciana 1/2 12:30pm - 2:00pm Optimal Margins in HPB Malignancy | Americana 3 1:00pm - 5:15pm Advanced Practice Provider Symposium | Cowrie 1/2 2:00pm - 3:00pm Presidential Invited Lecture | Scott Page | Americana 1/2 3:00pm - 3:30pm Afternoon Beverage Break | Americana Foyer 3:30pm - 5:00pm Business of HPB Surgery - Why It’s Worth It | Americana 3 3:30pm - 5:00pm Changing Paradigm of Necrotizing Pancreatitis Americana 1/2 3:30pm - 5:00pm Oral Presentations 7: Basic Science | Poinciana 1/2

5:15pm - 6:00pm AHPBA Business Meeting (Members Only) Americana 1/2 6:15pm - 6:45pm Advanced Practice Provider Reception | Americana Foyer





6:30am - 7:30am AHPBA Leadership & Chapter Presidents Breakfast Meeting | Crown Conch 7:30am - 8:30am Continental Breakfast | Americana Foyer 7:30am - 11:30am Registration Open | Rotunda East 8:00am - 9:30am Oral Presentations 8: HPB/Transplant | Americana 1 8:00am - 9:30am Oral Presentations 9: Pancreas III | Americana 2 8:00am - 9:30am Oral Presentations 10: Hepatobiliary II | Americana 3 10:00am - 11:30am Video Session: Pancreas HPB | Americana 3 10:00am - 11:30am New Paradigms in Academic HPB Surgery | Americana 1 10:00am - 11:30am IRC: AHPBA Gone Global | Americana 2 11:30am - 12Noon Closing Address and Raffle | Americana 1

SUNDAY, MARCH 11, 2018




FEATURED LECTURES

Friday, March 9, 2018 9:30am - 10:30am PRESIDENTIAL ADDRESS Americana 1/2

Introduction: Charles M. Vollmer MD | University of Pennsylvania

Inclusivity and Diversity - the AHPBA’s Secret Sauce Rebecca M. Minter MD | University of Wisconsin Rebecca M. Minter, M.D., is the A.R. Curreri Professor and Chair of the Department of Surgery at the University of Wisconsin School of Medicine and Public Health. Prior to

her move to the University of Wisconsin, Dr. Minter held successive leadership roles at the University of Texas Southwestern and the University of Michigan, including serving as Chief of the Hepatopancreatobiliary Section/Division at both institutions. Dr. Minter’s clinical practice is focused in the areas of pancreatobiliary and gastrointestinal surgery. She has a particular interest in the management and treatment of benign and neoplastic diseases of the pancreas. Dr. Minter is recognized as a clinical leader in her field and presently serves as the Immediate Past-President of the Americas Hepatopancreatobiliary Association, current Chair of the International Hepatopancreatobiliary Association Education and Training Committee, and is an Associate Editor of the journal, HPB. Dr. Minter’s research efforts are primarily focused within the domain of surgical education. This work is focused on the development of training frameworks which explicitly define progressive entrustment and the development of autonomy. Dr. Minter holds national leadership positions in multiple societies in recognition of her work in the field of surgical education and academic surgery, and is the immediate past President of the Society of University Surgeons and the Fellowship Council.


10

FEATURED LECTURES CONTINUED

Friday, March 9, 2018 4:00pm - 5:00pm LESLIE H. BLUMGART HISTORICAL LECTURE Americana 1/2

Introduction: Katy Morgan MD | Medical University of South Carolina

A Pancreas Odyssey David B. Adams MD | Medical University of South Carolina David B. Adams is Professor of Surgery at the Medical University of South Carolina (MUSC). He was born in 1950 in Annapolis, Maryland. He is a 1969 Cum Laude graduate of the Hotchkiss School in Lakeville, Connecticut and was

named a Morehead Scholar at the University of North Carolina in 1969. He graduated Phi Beta Kappa from Chapel Hill in 1973. He obtained his medical degree at the Medical College of Virginia in 1977. After completing his internship and residency in surgery in 1982 at the U.S. Naval Hospital, Portsmouth, Virginia, he was named Chief of Surgery at the U.S. Naval Hospital, Guantanamo Bay, Cuba. In 1983 he returned to the continental United States to the U.S. Naval Hospital, Charleston, South Carolina where he was named Chief of Surgery prior to joining the faculty in the department of MUSC in 1986. He has served as Medical Director, One West Trauma Center, Program Director of the General Surgery Residency training program, Chief of the Division of Gastrointestinal & Laparoscopic Surgery, Interim Chair of the Department of Surgery and Co- Director of the Digestive Disease Center. He has been the Course Director of the Medical University Department of Surgery Annual Postgraduate Course in Surgery for the past two decades. He has served as President of the Waring Library Society, South Carolina Surgical Society, South Carolina ACS, Southeastern Surgical Congress, and the Halsted Society. His has been named as the Best Clinical Instructor in General Surgery, U.S. Naval Hospital Charleston, MUSC Faculty member Alpha Omega Alpha, MUSC Faculty Excellence Award, the Paul H. O’Brien Resident Teaching Award, The Leonard Tow Humanism in Medicine Award, and the MUSC Health Sciences Foundation Outstanding Clinician Award. He has been awarded the U.S. Navy Letter of Commendation from the U.S. Naval Hospital Guantanamo Bay and Charleston, South Carolina.




Saturday, March 10, 2018 9:00am - 10:00am BETTY & HENRY PITT QUALITY ORATION Americana 1/2

Introduction: Timothy Pawlik, MD, MPH, PhD | The Ohio State University

Achieving Surgical Quality: Observations from the American College of Surgeons Clifford Y. Ko MD, MS, MSHS, FACS, FASCRS | University of California-Los Angeles/American College of Surgeons Dr. Clifford Ko is the Director of the Division of Research and Optimal Patient Care at the American College of

Surgeons. Where oversees all the quality improvement programs,. He also serves as the Director of ACS NSQIP, which was recognized with the Eisenberg Award from the National Quality Forum/Joint Commission. Dr. Ko’s work focuses on surgical quality of care, including quality measurement, process improvement, value based care, and achieving high reliability in surgical care. He has served in advisory roles to national and international efforts for achieving higher quality and safety including the World Health Organization, the Institute of Medicine, the National Quality Forum, PCORI, amongst others. He has received millions of dollars in grant funding to study quality of care from sources that include the National Institutes of Health, the Centers for Disease Control and Prevention, the American Cancer Society, the Centers of Medicare and Medicaid Services, the Agency for Healthcare Research and Quality, and the Veterans Administration. He has published over 350 peer reviewed manuscripts and has written more than 20 book chapters. Clinically, Dr. Ko is a double board-certified surgeon with a practice currently focusing on patients with colorectal cancer. At UCLA, he is the Robert and Kelly Day Professor of Surgery. He is also professor of health services at the UCLA School of Public Health. Dr. Ko received his B.A (Biology), M.S. (Biological/Medical Ethics), and M.D. from the University of Chicago. He also received a Masters of Science Degree (Health Services/Outcomes Research) from the University of California, Los Angeles during his time as a Robert Wood Johnson Clinical Scholars Fellow at UCLA and RAND. Dr. Ko completed his General Surgery Residency at UCLA Medical Center, and obtained specialty training at the Lahey Clinic in Boston in Colon and Rectal Surgery.


12


Saturday, March 10, 2018 2:00pm - 3:00pm PRESIDENTIAL INVITED LECTURE Americana 1/2

Introduction: Rebecca M. Minter MD | University of Wisconsin

The Diversity Bonus: How Cognitive and Identity Diversity Improve Outcomes Scott E. Page | University of Michigan Leonid Hurwicz Collegiate Professor of Complex Systems, Political Science, and Economics, University of Michigan-Ann Arbor External Faculty, Santa Fe Institute.

Scott E. Page’s research focuses on complexity theory and diversity in social systems. His most recent book, The Diversity Bonus, was published in September 2017 as a joint project from Princeton University Press and the Mellon Foundation. His previous books include The Difference: How the Power of Diversity Creates Better Groups, Firms, Schools, and Societies, and Complex Adaptive Social Systems. The author of more than eighty research papers in fields ranging from economics, political science, sociology, psychology, philosophy, physics, public health, geography, computer science, and management, he is currently completing a book on interdisciplinary modelling. In addition to his academic writing, Scott has filmed two video series for The Great Courses, and his online course Model Thinking has attracted over three quarters of a million participants. A frequent public speaker to corporations and government agencies including NASA, Bloomberg, Google, Boeing, the IMF, Genentech, Gilead, the United States Federal Reserve, and BlackRock, Scott has been a featured speaker at The New York Times New Work Summit, Google Re:Work, The World Economic Forum – Davos, and The Aspen Ideas Festival. In addition to his teaching, Scott has consulted with Yahoo! Ford, DARPA, Procter and Gamble, and AB InBev. Professor Page has been the recipient of a Guggenheim Fellowship as well as fellowship at the Center for Advanced Studies in the Behavioral Sciences at Stanford. In 2011, he was elected a fellow of the American Academy of Arts and Sciences. A native of Yankee Springs Michigan, Scott hold degrees in mathematics from The University of Michigan and The University of Wisconsin, and a degree in managerial economics and decision sciences from Northwestern University. Scott lives in Ann Arbor, MI with political scientist Jenna Bednar, their two sons Orrie and Cooper, and their dogs Bounder and Oda.



ANNOUNCING

[email protected] or 913.402.7102

for order information


14



LEADERSHIP &

MEETING INFORMATION


16

AHPBA would like to thank the following organizations for their support of the 2018 Annual Meeting DIAMOND

Ethicon US, LLC PLATINUM

AngioDynamics GOLD

BK Ultrasound SILVER

Medtronic Novartis Pharmaceuticals Corporation BRONZE

AbbVie, Inc BTG ULTRASOUND COURSE SPONSORS BK Ultrasound - Premier

AngioDynamics Ethicon US, LLC Medtronic Stryker

MEETING SPONSOR Aesculap, Inc.


IntraOp


MEETING SPONSOR Aesculap, Inc.

AHPBA LEADERSHIP

COMMITTEE CHAIRS Latin American Chapter Presidents Oscar Guevara, MD Moises Cukier, MD | Co-Chair Clinical Trials Michael D’Angelica, MD Conflict of Interest Sean Cleary, MD CSI Chair Patricio Polanco, MD Development & Industry Council William C. Chapman, MD Education & Training Tara S. Kent, MD HPB Program Directors Maria B. Majella Doyle, MD International Relations Hosein Shokouh-Amiri, MD Membership Christopher Anderson, MD Professional Development Michael House, MD Program Shimul A. Shah, MD, MHCM Publications Roberto Hernandez Alejandro, MD Research John Mansour, MD

EXECUTIVE COUNCIL OFFICERS President Rebecca M. Minter, MD President-Elect Charles M. Vollmer, MD Secretary Felipe Jose Fernandez Coimbra, MD Treasurer Timothy M. Pawlik, MD, MPH, PhD PAST PRESIDENTS Immediate Past President Gazi B. Zibari, MD Past President Javier C. Lendoire, MD, PhD EXECUTIVE COUNCIL AT LARGE Thomas A. Aloia, MD Chad Ball, MD Quyen Chu, MD Bryan Clary, MD Moises Cukier, MD Cristina Ferrone, MD Wesley Francis, MD Mariano Gimenez, MD, PhD D. Rohan Jeyarajah, MD Nicolas Jarufe, MD Sergio Lopez, MD, MSc Shishir K. Maithel, MD Attila Nakeeb, MD Jennifer Tseng, MD, MPH Sharon Weber, MD AHPBF PRESIDENT Bruce D. Schirmer, MD FOUNDATION BOARD President | Bruce D. Schirmer, MD Vice President | C. Wright Pinson, MD, MBA Treasurer | Reid B. Adams, MD Secretary | Henry A. Pitt, MD


18

AHPBA LEADERSHIP CONTINUED

AHPBA PAST PRESIDENTS

Gazi B. Zibari, MD 2016 - 2017

Javier C. Lendoire, MD, PhD 2015 - 2016

Elijah Dixon, MD 2014 - 2015

William C. Chapman, MD 2013 - 2014

William R. Jarnagin, MD 2012 - 2013

Jean-Nicolas Vauthey, MD 2011 - 2012

Reid B. Adams, MD 2010 - -2011

W. Scott Helton, MD 2009 - 2010

Mark P. Callery, MD 2008 - 2009

Bruce D. Schirmer, MD 2007 - 2008

Sean J. Mulvihill, MD 2006 - 2007

Theodore N. Pappas, MD 2005 - 2006

C. Wright Pinson, MD, MBA 2003 - 2005

Steven M. Strasberg, MD 2001 - 2003

Henry A. Pitt, MD 1999 - 2001

William C. Meyers, MD 1997 - 1999

J. Michael Henderson, MD 1995 - 1997



AHPBA LEADERSHIP CONTINUED

PROGRAM COMMITTEE Shimul A. Shah, MD, MHCM

2018 Program Chair

David Kooby, Vice Chair

Heber Ribeiro, LA Chair

Rebecca Minter, Ex-Officio

Charles Vollmer, Ex-Officio

Shishir Maithel, Past Chair

Eddie Abdalla

Alagappan Annamalai

Stephen Behrman

Eren Berber

Kevin Billingsly

Amanda Cooper

Carlos Corvera

Kristopher Croome

Virgilio DeOliveira

Truman Earl

Sukru Emre

T. Clark Gamblin

Steven Hanish

David Iannitti

Hiromichi Ito

Michael Jacobs

Tun Jie

Michael Kendrick

Roger Kim

Stuart Knechtle

Ajay Maker

Abhishek Mathur

Eduardo Montalvo-jave

Hari Nathan

Atta Nawabi

Tri Nguyen

Susan Orloff

Mariano Palermo

Alexander Parikh

Purvi Parikh

Matthew Porembka

Henry Randall

Heber Ribeiro

Juan Sanabria

Juan Sarmiento

Luke Schoeniger

Richard Schulick

Susan Tsai

Alice Wei

Young Hong


20

AHPBA STAFF

Marjorie Malia Director, Association Management Nora Barrett Onsite Registration Tracy Brown Membership, Publications & Events Shayla Concannon Communications Deborah East Industry Relations

Americas Hepato-Pancreato-Biliary Association

2625 West 51st Terrace Westwood, KS 66205

t: 913.402.7102 [email protected]

www.ahpba.org

Jill Willhite Director, Association Management Laura Fitzgerald Finance Corinne Hornsey Meetings & Events Mary Kawulok Registration & Membership Dues

AHPBA



MEETING INFORMATION

HOTEL INFORMATION Loews Miami Beach Hotel 1601 Collins Avenue Miami Beach, Florida, 33139 t: 305.604.1601 www.loewshotels.com/miami-beach AHPBA REGISTRATION DESK HOURS Location: The Rotunda

Registration will be open throughout the meeting to provide assistance. Please let us know if there is anything we can do help make your meeting experience more valuable. HOURS OF OPERATION Wednesday 6:30pm - 8:00pm

Thursday 6:30am - 6:30pm

Friday 6:30am - 6:00pm

Saturday 7:00am - 6:00pm

Sunday 7:00am - 11:30am SPEAKER READY ROOM Location: New Yorker

Technicians will be available in the Speaker Ready Room for assistance with presentations. Please have your presentation in the room at least four hours prior to your presentation time. SAFETY & SECURITY We take every precaution to assure the safety and security of our attendees and their guests. However, we urge you to be aware and take simple steps to guard

your possessions. Therefore, we suggest the following:

• Do not leave your purse or briefcase unattended.

• Do not leave your laptop, phone or PDAs on the floor or out of your sight.

• Be aware of your surroundings.

• If you do misplace or lose something, please contact the AHPBA Registration Desk immediately.

• To connect to hotel security please pick up a house phone or dial 305-604-5435


22

MEETING INFORMATION CONTINUED

EXHIBIT HALL HOURS AND INFORMATION Location: Americana 4

Thursday 5:30pm - 7:00pm

Friday 7:00am - 7:30pm

Saturday 7:00am - 1:00pm

SOCIAL MEDIA Stay current with meeting updates, discussions and colleague networking by connecting with AHPBA Social Media. It is easy! Follow us on Twitter (www.twitter.com/ahpba) and be sure to use the HASHTAG #AHPBA18 to link your comments to the AHPBA community. We are on Facebook too, www.facebook.com/ahpba. Simply “Like” our page and you will start receiving status updates on your newsfeed. Let’s get AHPBA trending, spread the word!

MEETING APP Download the AHPBA 2018 Annual Meeting mobile app!

1. Go to https://attendify.com/ app/fmlz2j/

2. Download “Attendify – Network at Events” mobile app

3. Search “AHPBA” and select “AHPBA 2018 Annual Meeting”

4. Set up a Profile and join the virtual community!

Have questions? We are here to help, please send an email to [email protected] or visit the AHPBA registration desk.



CME INFORMATION

CME ACCREDITATION This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of PESI, Inc. and The Americas Hepato-Pancreato-Biliary Association (AHPBA). PESI, Inc. is accredited by the ACCME to provide continuing medical education for physicians. AMA PRA DESIGNATION STATEMENT The PESI, Inc. designates this live educational activity for a maximum of 41 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Of the AMA PRA Category 1 Credits™ listed above, a maximum of 24 credits meet the requirements for Self-Assessment. INTERNATIONAL CME International Physicians are formally eligible for AMA PRA Category 1 Credit™. PHYSICIAN ASSISTANTS AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.


24

CME INFORMATION CONTINUED

OVERALL EDUCATIONAL OBJECTIVES The AHPBA Annual Meeting has been structured around various tracks, representing the liver, pancreas, biliary system and transplant. At the conclusion of the Annual Meeting of the AHPBA, the Association expects its attendees to have gained knowledge and skills that will lead to changes or enhancements in their own practices and improve physician training. The AHPBA expects that the Scientific Program’s educational interventions will result in measurable improvements in patient care. The specific focus of the meeting will be on Research, Education, and Mentorship in HPB Surgery. Following the meeting attendees should have a better understanding of:

• Discuss the role for new surgical approaches to cancer involving vascular and aggressive resection and medical therapies

• Explain new roles in the management of acute pancreatitis

• Describe the role of advanced imaging, molecular testing, and new therapies for complex HPB problems

• Develop the design and implementation of clinical trials in HPB surgery

• Discuss the state of the art care for metastatic colon cancer, including the role of chemotherapy, radiation, and surgery

• Identify the role of technology and research to optimize the safety, quality, and outcomes in HPB Surgery

• Review and develop the next frontier in application and techniques of management of hepatocellular carcinoma CME AND SELF-ASSESSMENT You may claim CME and Self-Assessment credits online at www.ahpba.org. Please complete the surveys and print your certificates NO LATER THAN April 21, 2018.



AWARDS, FELLOWSHIPS

& GRANTS


26

NONIE LOWRY DISTINGUISHED SERVICE AWARD

Bernard Langer, MDToronto General Hospital

Toronto, Ontario

AHPBA 2018 Nonie Lowry Distinguished Service Award The Distinguished Service Award is named after Nora “Nonie” C. Lowry, AHPBA Director, who passed away April 9, 2016 after a long battle with breast cancer. Nonie served the association tirelessly, and her leadership, dedication, and contributions to the AHPBA will always be remembered and cherished. 2018 Honoree Bernard Langer, MD Candidates for the Distinguished Service Award should be highly distinguished physicians in the HPB field, with long-standing participation in the AHPBA. Areas of outstanding contribution may include, but are not limited to the following:

• Work in the field of HPB Surgery (clinical or basic research)

• Direct impact on education and career development

• Facilitating and fostering global outreach initiatives throughout the Americas and/or abroad

• Maintaining the highest ethical standards in the association’s fields of endeavor

• Contributions to the AHPBA organization



An Interview with Dr. Barnard Langer, as told by Dr. Paul Greig Dr. Langer is a 1st generation HPB Surgeon. He confesses that he came to HPB Surgery “by accident” and claims that “it found me”. Following Medical School & Residency in General Surgery in Toronto, Dr. Langer did a 6 month travelling Fellowship in cancer chemotherapy, followed by a 6 month Fellowship in Boston with Francis Moore where his interest and expertise in liver surgery grew from his research in the very new field of liver transplantation. Upon return to the University of Toronto, he received a grant to develop a model of auxiliary liver transplantation and clinically, he attracted the complex liver and pancreas cases. He became interested in surgery for portal hypertension and initiated an RCT

of meso-caval vs distal splenorenal shunt for bleeding esophageal varices. As the surgical management of liver, pancreas & biliary diseases evolved, he expanded the HPB focus at the Toronto General Hospital by attracting Bryce Taylor and hiring Paul Greig. In 1985 he did Toronto’s 1st liver transplant. And so the era of HPB in Toronto surgery was initiated. During his decade as Chair of the Department of Surgery at the University of Toronto, he instituted the Surgeon Scientist Program for Residents in Surgery, and income-sharing agreements in each of the divisions to facilitated sub-specialization and academic initiatives. He says that his experience in Boston “gave him insight into how to run a Department and the importance of research to the academic culture”. Following his retirement from clinical surgery, Dr. Langer served as the President of The Royal College of Physicians and Surgeons of Canada. In 2002 he was appointed Officer of the Order of Canada and in 2015 was inducted into the Canadian Medical Hall of Fame. Dr. Langer established a Fellowship in Liver Surgery which grew from one Fellow in 1982, to 3 Fellows in Transplant & HPB Surgery in 1989, and now to 7 Fellows in two separate but integrated Fellowships in HPB Surgical Oncology, accredited by the AHPBA & Fellowship Council and in Abdominal Organ Transplantation accredited by the ASTS. To date over 80 Fellows have graduated from these two Fellowships. He sites his greatest accomplishment as being the alumni of the Fellowship, currently practicing in over 25 countries, many of whom have become leaders in HPB & Transplant Surgery throughout the world. He recently met a young new Faculty HPB Surgeon who was trained by a former Langer-Fellow and who acknowledged her “Langer pedigree”. Dr Langer’s advice to new HPB Surgeons can be summed up:

1. Know yourself - your strengths & weaknesses and just what you want to do

2. Plan well - set goals and timelines and organize your life so you can accomplish them

3. Have an open mind for change or new opportunity.

4. Keep family foremost At present Dr. Langer lives in Toronto with his wife, Ryna “the essential part of my team” and enjoys his children, and grandchildren, travelling, and working in his stained-glass art studio.

NONIE LOWRY DISTINGUISHED SERVICE AWARD CONTINUED

Bernard Langer, MD


28

2016 RESEARCH AWARD UPDATE

Derek J. Erstad, MD

Derek J. Erstad, MD Massachusetts General Hospital Boston, MA Molecular MR imaging of Desmoplasia after Neoadjuvannt Treatment of Pancreatic Cancer Neoadjuvant chemoradiotherapy (CRT) can potentially downstage borderline resectable pancreatic ductal adenocarcinoma (PDAC) and improve the rate of margin clear resection. In response to CRT, PDAC undergoes a desmoplastic reaction, replacing tumor mass with dense fibrotic tissue. Standard contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI)

are unable to distinguish residual cancer from newly fibrotic tissue, thus radiographic downstaging after neoadjuvant therapy is rarely observed even when evidence of cytotoxic activity is found during pancreatic resection. Accordingly, reliable noninvasive markers of treatment response after CRT are urgently needed in order to facilitate patient selection for an operation. Type I collagen is a major component of the fibrotic response to chemotherapy and radiation in PDAC, and is used as a biomarker for measuring treatment response in standard pathologic scoring systems. Due to its extracellular nature, collagen is easily targetable with molecular probes, and our group has previously shown that collagen molecular MRI can be used to measure baseline fibrosis in pancreatic tumors. Working under the mentorship of Dr. Kenneth Tanabe and Dr. Bryan Fuchs, we developed a syngeneic, immunocompetent orthotopic murine model of PDAC with phenotypic similarity to the human disease, including a dense fibrotic response to FOLFIRINOX chemotherapy. Using this model, we compared a novel Type I collagen MRI probe, CM-101, which has been optimized for clinical translation, to the standard contrast agent, Dotarem, for their abilities to identify FOLFIRINOX-induced fibrosis as a non-invasive biomarker of treatment response. Using a specialized rodent MR scanner, we first showed that CM-101 provided superior imaging resolution of untreated PDAC tumors compared to Dotarem. PDAC tumors are inherently fibrotic, and collagen-targeted probe uptake into tumor tissue was significantly greater compared to a non-specific agent. We subsequently showed that we were able to objectively measure increases in tumor fibrosis after FOLFIRINOX chemotherapy with CM-101, which was not possible with Dotarem. In summary, we found that collagen molecular MRI with CM-101 provides a novel imaging technique that could be used to monitor the fibrotic response to neoadjuvant therapy in order to improve patient selection for an operation.

Supported in part by the AHPB Foundation



2016 RESEARCH AWARD UPDATE

Nicholas G. Berger, MD Medical College of Wisconsin Milwaukee, WI Determination of Xanthohumol inhibits Notch Signaling in vivo and Increases the Survival and Reduces Tumor Progression in HCC Liver Xenograft Primary liver cancers have few effective treatments. Survival of patients is dependent upon detection of small tumors amenable to ablation, resection,

or transplantation, and tumor response to a handful of systemic therapy options. Curcumin analogs including Xanthohumol (XN) have demonstrated hepatoprotective and antiproliferative effects in various cancers. Under the mentorship of Dr. T. Clark Gamblin and Dr. Muthusamy Kunnimalaiyaan, the AHPBA Research Grant has allowed us to examine the efficacy of curcumin analogs as novel systemic therapies for primary liver cancer. Notch signaling and the signal transducer and activator of transcription 3 (STAT3) pathway play important roles in cellular differentiation and survival and are upregulated in many cancers, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). In the work supported by the AHPBA Research Grant, we examine the effects of curcumin analogs Xanthohumol (XN) and HO-3867 (a STAT3 inhibitor) on liver cancer cell proliferation, cell cycle arrest, and apoptosis. We hypothesized that treatment of HCC and CCA with XN and HO-3867 would result in downregulation of Notch signaling and the STAT3 pathway, arrest the cell cycle, and promote apoptotic pathways in liver tumor cells. Our recent findings suggest that dose-dependent HO-3867 decreases expression of cell cycle proteins and upregulates pro-apoptotic factors in HCC. These findings are associated with reduced activated STAT3 protein expression, decreased expression of Notch, and an associated decrease in tumor cell proliferation in three HCC cell lines. Similarly, XN significantly reduced CCA growth through Notch signaling in two mice xenografts. Supported by the AHPBA Research Grant, this research has the potential to develop innovative new systemic therapies for primary liver cancer which block Notch signaling and STAT3 pathways and could lead to promising anti-cancer compounds to target primary liver cancer on a molecular level.

Nicholas G. Berger, MD



30

PAST RESEARCH AWARD RECIPIENTS

2017 Alexander Gaidarski, MD Role of p16 in Sensitivity to MEK Inhibition in Pancreatic Cancer University of Miami Miller School of Medicine 2017 Georgios Gemenetzis, MD Circulating Tumor Cells in Pancreatic Adenocarcinoma: Effect of Cancer-directed Therapy and Ex Vivo Modeling Johns Hopkins University School of Medicine 2016 Nicholas G. Berger, MD Determination of Xanthohumol Inhibits Notch Signaling in Vivo and Increases the Survival and Reduces Tumor Progression in HCC Liver Xenograft Medical College of Wisconsin 2016 Derek J. Erstad, MD Molecular MR Imaging of Desmoplasia After Neoadjuvant Treatment of Pancreatic Cancer Massachusetts General Hospital 2015 Ashton A. Connor, MD DNA Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma University of Toronto 2015 Somer Tohme, MD The Role of Neutrophil Extracellular Traps in Liver Sterile Inflammation University of Pittsburgh 2014 Oncology Research Grant Jonathan M. Hernandez, MD Characterization of Dormancy and Outgrowth for Metastatic Pancreatic Cancer in the Liver Supported by the AHPBA 2013 Physiology/Biology Research Grant Stephanie H. Greco, MD Regulation of Acute Pancreatitis by C-type Lectin Receptors New York University School of Medicine - Department of Surgery Supported by AHPBA



PAST RESEARCH AWARD RECIPIENTS CONTINUED

2012 Oncology Research Grant Kevin Soares, MD Combinatorial Immunotherapy and the Manipulation of Tumor Microenvironment in the Treatment of Pancreatic Cancer Johns Hopkins Hospital Surgery Supported by AHPBA 2011 Oncology Research Grant Michele Babicky, MD Targeting the RON Tyrosine Kinase Receptor in Pancreatic Cancer University of California, San Diego Medical Center Supported by: AHPBA 2008 Surgical Technology Assessment and Outcomes Research Grant Peter Nau, MD Development of a Novel Repair Technique for latrogenic Common Bile Duct Injuries with a Biosynthetic Absorbable Graft The Ohio State University Medical Center, Center for Minimally Invasive Surgery Supported by: Covidien and AHPBA 2008 Physiology/Biology Research Grant Kendra D. Conzen, MD The Role of HMGB1 in Steatotic Livers following Ischemia/Reperfusion Washington University Supported by: Ethicon, Inc. and AHPBA 2008 Oncology Research Grant Wigdan Al-Sukhni, MD An Analysis of Germline Genomic Copy-number Variation to Identify Disease-Associated Gene(s) in Familial PancreaticCcancer University of Toronto Supported by: Sanofi Aventis and AHPBA 2007 Covidien Surgical Technology Assessment Lia Roque Assumpcao, MD Application of Novel, High Resolution, and Freehand Ultrasound Elasticity Imaging in Liver Surgery Johns Hopkins University Hospital


32


2007 Sanofi-Anventis HPB Oncology Bedabrata Sarkar, MD Characterization of Pancreatic Cancer Stem Cells University of Michigan Medical School 2007 Ethicon HPB Physiology/Biology Lee Ocuin, MD Immune Activation of Human Liver Dendritic Cells Memorial Sloan-Kettering Cancer Center 2006 Ethicon HPB Physiology/Biology Luis Garcia, MD Targeted Inhibition of VEGF Prevents Development of Tumor Antigen-Specific T-Cell Tolerance in the Murine Liver The Milton S. Hershey Medical Center 2006 Sanofi-Aventis HPB Oncology Jon Cardinal, MD Crossroad in Cancer Signaling: Regulation of Human iNOS Expression by the WNT B-Catenin Path University of Pittsburgh 2005 Ethicon HPB Physiology/Biology Sunil K. Geevarghese, MD The Role of Mitochondrial Calcium Management in Hepatic Ischemia-Reperfusion Injury following Syngeneic Rat Liver Transplantation Vanderbilt University Medical Center 2005 Sanofi-Aventis HPB Oncology Jon Dorfman, MD Positron Emission Tomography to Monitor HSV-2 Viral Oncolysis Massachusetts General Hospital 2004 Ethicon HPB Jennifer Lynn Irani, MD The Role of CEACAM6 in Pancreatic Cancer Invasion Brigham and Women’s Hospital




2003 Ethicon HPB Shiva Sarraf-Yazdi, MD Anti-angiogenic Therapy of Murine Liver Metastases by Tie2 Inhibition Duke University Medical Center 2002 Ethicon HPB Charles M. Vollmer, MD Characterization of a Novel Translocation Breakpoint in Pancreatic Cancer University of Toronto 2001 Ethicon HPB Nicole Chandler, MD Overcoming Chemoresistance in Human Pancreatic Cancer Beth Israel Deaconess Medical Center


34

2017 NORTH & LATIN AMERICAN EXCHANGE GRANT RECIPIENTS

Mary Dillhoff, MD, MS Ohio State University Wexner Medical Center Columbus, OH Travel Destination: University of São Paulo Medical School, Brazil Host: Paulo Herman, MD Hospital das Clinicas da Faculdade de Medicine da Universidade de Sao Paulo (HCFMUSP) I am grateful to have received the AHPBA North and Latin American Exchange Grant. I spent one week with Dr. Paulo Herman and his team at both Hospital

das Clinicas and Instituto do Cancer do Estado de Sao Paulo Frias de Oliveria (Icesp) in Sao Paulo, Brazil. Dr. Herman is a leader in minimally invasive liver surgery. He has developed a robust team pioneering minimally liver operations, as well as training residents, fellows and students. His team is academically productive and are highly skilled surgeons. I spent the week observing all aspects of their practices from observing in the OR’s-a right hepatectomy with resection of the IVC to laparoscopic liver resections. Time in the clinics was enlightening as well in learning how they deliver care to their patients in both the cancer hospital and Hospital das Clinicas. In addition, most academic surgeons in the region carry robust private practices as well as their academic practices, and I also observed the delivery of care in this private setting. The multidisciplinary conference was well run and a great teaching conference for the residents and students. They even had the conference in English for me to participate! They have developed an excellent library of videos used to teach complex liver operations and minimally invasive hepatectomy to other surgeons and their students. We spent a most enjoyable morning watching videos together and discussing surgical technique. Academically the team has built a robust prospective database for all of their liver operations with over 1000 patients. This has been most useful in studying their patient outcomes and improving the care delivered to their patients. Dr. Herman is the epitome of a leader. I observed this in all interactions through the week from his interactions with his staff, to trainees and colleagues. He and his entire team were the most gracious hosts. They welcomed me into their week and spent many hours with me in the operating room and clinics to showing me how delicious Brazilian Barbeque is, to seeing a soccer game! A real treat in Brazil. A very sincere thank you to Dr. Herman and his team including Gilton Fonseca, Jaime Kruger and Danielle Cesconetto. The relationship with this team will hopefully lead to a great academic partnership! This travel award creates a unique exchange of ideas between groups from technical aspects of surgery to research collaboration and I look forward to being able to partner with this group in the future. Thank you to the AHPBA for this wonderful opportunity.

Mary Dillhoff, MD, MS



2017 NORTH & LATIN AMERICAN EXCHANGE GRANT RECIPIENTS CONTINUED

Timothy Frankel, MD Ann Arbor, MI University of Michigan Health System Travel Destination: Fundación Arturo López Pérez (FALP), Santiago, Chile Host: Jean M. Butte Barrios, MD I would like the thank the Americas Hepato-Pancreato-Biliary Association (AHPBA) Foundation for their support of my North & Latin America Annual Traveling Fellowship to Santiago, Chile in December. I was afforded the opportunity to visit the Hepatobiliary Service at Fundación Arturo López Pérez (FALP),

one of the premier cancer hospitals in South America. Graciously hosted by Surgical Oncologist Jean Michel Butte Barrios, the focus of my visit was learning techniques and practices related to the treatment of complex liver and pancreatic cancers. A secondary goal was better understanding how cancer care is delivered in a unique and different health care system. FALP is truly a world class institution which uses advanced technology and multidisciplinary care to treat the most complex malignancies. The collegiality of surgeons and willingness to share ideas and practices has made FALP a cornerstone of oncologic training and advancement in Chile and all of South America. The purpose of the AHPBA traveling fellowship is to “promote the exchange of ideas and best practices in HPB.” As a hepatobiliary surgeon who treats many patients with advanced liver disease, I chose to focus my education on the management of complex hepatic malignancies in patients not suitable for traditional resections. To accomplish this goal, Dr. Butte constructed a schedule of multidisciplinary conferences and operations which highlighted the many unique patients presenting to the institution. During my time at FALP, I was able to learn and observe the process of selection and execution of “mini-ALPPS” procedures for patients who failed to hypertrophy following standard portal vein embolization. This is a vexing subgroup of patients who I and may others struggle with in our own practices. I plan to take components of the preoperative planning, surgical technique and post-operative care back to my home institutions and integrate them in my practice. I was also able to share various aspects of my own experiences with FALP surgeons and trainees which I hope will be helpful to them as well in the future. The free exchange of ideas is paramount to our providing exemplary care to our patients. The cordial reception by Dr. Butte and the surgical staff at FALP has imparted me with knowledge, advancing my practice and ability to care for my patients. This would not have been possible without the thoughtful and generous support of the AHPBA.

Timothy Frankel, MD


36

2017 NORTH & LATIN AMERICAN EXCHANGE GRANT RECIPIENTS CONTINUED

Patricia Rebolledo, MD

Patricia Rebolledo MD Santiago, Chile Universidad de Chile Travel Destination: University of Wisconsin School of Medicine

Host: Martin J. Dib, MD In January I had the extraordinary opportunity to visit the Division of Transplantation at the University of Wisconsin, Madison, United States. The Division of Transplantation is one of the most experienced transplant programs in the nation. Their Program was created over 50 years ago, and performs an average of more than 450 organ transplants per year (125 liver transplants, over 60 pancreas and more than 300 kidneys).

The unit is under the direction of Dr. Dixon B. Kaufman, who has held a number of leadership positions in many facets in the transplant field, and is currently the President-elect of the American Society of Transplant Surgeons. My host was Dr. Martin Dib, Assistant Professor at UW and member of the Education and Training Committee at AHPBA.

Their team has been working on preservation methods for kidney and liver, including ex vivo normothermic machine perfusion for liver. This option has emerged as an alternative that tries to maintain the viability of high risk or marginal organs and even to improve its function, the safety of this technique has been demonstrated in preclinical and clinical studies. This novel approach may increase organ availability for liver transplantation. Fortunately, I had the opportunity to be present for one of their cases of normothermic liver perfusion, as part of their OrganOx multi-center clinical trial. The liver came from a marginal DCD donor and the transplant procedure was uneventful with excellent and encouraging results.

This experience was generously supported by a travelling fellowship grant from the Americas Hepato-Pancreato-Biliary Association (AHPBA). This was a remarkable experience in a variety of different ways.

I was able to attend multiple educational and clinical conferences including patient selection meetings for liver, kidney, and pancreas transplant recipients, multidisciplinary primary liver tumor conference, transplant morbidity and mortality conference, and live donor selection meetings. I was also able to share with the HPB surgical oncology team including their conferences and complex surgical cases. Furthermore, during my rotation I had the tremendous opportunity of spending time and obtaining career advice from Dr. Rebecca Minter, who was recently appointed as the new Chair of Surgery at UW-Madison, at the same time as being the current President at the AHPBA.

The hospitality of Dr. Dib and his team at UW was without equal. Despite the cold weather I had the opportunity to forge relationships with a number of the other attending surgeons and trainees. UW has an exceptional training program for residents and fellows. I was impressed by their educational quality and how the trainees were allowed to perform all steps of a liver transplant and most other complex cases. I am grateful to the AHPBA and the Department of Surgery at UW who made my visit to Madison so enriching, warm and enjoyable.

Supported in part by the AHPBA Foundation and the AHPBA



ANNUAL MEETING TRAVEL GRANT

The goal of the travel grant is to assist trainees and AHPBA members from Latin America attend the AHPBA Annual Meeting. AHPBA Candidate and Active members (within the first 5 years of their faculty appointment), who are living in Latin America, are eligible to apply for these awards.

2018 RECIPIENTS

Alfonso Bandin Musa Mexico

Fabio Vergara Suarez Columbia

Gustavo Reano Paredes Peru

Mario Interiano Tobar El Salvador

Shamir Cawich Trinidad & Tobago



38

STEVE SOTSKY PANCREATIC CANCER RESEARCH GIFT

AHPBA Member, Dr. Tara Kent and her family donated a gift to a resident who conducted outstanding work in the field of pancreatic research. The donation helped to facilitate the resident’s attendance at AHPBA, where he/she can present the research and engage in the academic community that is the AHPBA. This contribution was gifted in memory of Dr. Kent’s father, Mr. Steve Sotsky. Mr. Sotsky died of pancreatic cancer in September 2013. He was an ardent supporter of Dr. Kent and her husband during their surgical trainings. Mr. Sotsky recognized that ongoing research, and communication of its results, is the key to finding better treatment options for patients with pancreatic disease, and cancer specifically. He also understood the important role of the educational meetings, especially for young surgeons and residents, in advancing ideas and gaining momentum.

2018 STEVE SOTSKY AWARD WINNER

Alexandra G. Lopez-Aguiar

Emory University

Date and Time of Winning Presentation:

Friday, March 9, 2018

Oral Presentations 2: Pancreas

11:00am - 11:12am

Poinciana 3/4

12: THE CONUNDRUM OF <2 CM PANCREATIC

NEUROENDOCRINE TUMORS: A PREOPERATIVE

RISK SCORE TO PREDICT LYMPH NODE METASTASES

AND GUIDE SURGICAL MANAGEMENT

Alexandra G. Lopez-Aguiar



2017 HPB CERTIFICATES OF COMPLETION RECIPIENTS

Congratulations to the following members who have successfully completed their fellowship training and have fulfilled the surgical curriculum requirements, as set forth by the AHPBA and Fellowship Council. These individuals will be recognized during Friday’s opening session.

Jad Abou Khalil MD CM, MSc(Epi) | Virginia Mason Medical Center

David Al-Adra MD | Toronto General Hospital - UHN

Rachel Beard MD | University of Pittsburgh Medical Center

Nikolaos Chatzizacharias MD | Medical College of Wisconsin

Eddie Cho MD | Methodist Dallas

Jason Denbo MD | MD Anderson Cancer Center

Radhakrishnan Ganesh MD | McGill University Health Centre

Sepideh Gholami MD | Memorial Sloan-Kettering

Chad Gonczy MD | Duke University Medical Center

Nicolas Goldaracena MD | Toronto General Hospital - UHN

Jan Grendar MD | Providence Portland Medical Center

Ryan Groeschl MD | Mayo Clinic College of Medicine

Amar Gupta MD | University of Calgary/Foothills Medical Center

William Lancaster MD | Indiana University

Johannes Lauscher MD | University of Toronto (Wright)

Julie Leal MD | Stanford University

Elsa Pichardo MD | Oregon Health Science Center

J. Bart Rose MD | Washington University

Jack Rostas MD | University of Louisville

Nelson Royall MD | Cleveland Clinic

Imran Siddiqui MD | Carolinas Medical Center

Mahmoud Tabbal MD | Dalhousie University

Oz Yakir MD | McGill University Health Centre


40

AMERICAN COLLEGE OF SURGEONS/AMERICAS HEPATO-PANCREATO-BILIARY ASSOCIATION HEALTH POLICY SCHOLARSHIP

Charles B. Rosen, MD

The American College of Surgeons and the Americas Hepato-Pancreato-Biliary Association offer an annual scholarship to subsidize attendance and participation in the Executive Leadership Program in Health Policy and Management at Brandeis University.

2017 WINNER Charles B. Rosen, MD Professor of Surgery Director of the William J. von Liebig Center for Transplantation and Clinical Regeneration Medical Director for the Department of Contracting and Payer Relations Mayo Clinic, Rochester, MN I thoroughly enjoyed participating in the Heller School – American College of Surgeons Leadership Program in

Health Policy and Management. The topics covered were timely and appropriate for all surgeons and especially surgeons in leadership positions. The balance between didactic sessions, discussions, and informal conversations was superb. The setting for the course was exceptional; we were comfortable, well fed, and isolated from the daily demands on our lives such that we could concentrate on the program. I benefited from the diversity of the program participants. I thought it was important to include surgeons from small and large group private practices, academic medical centers, and large referral centers. It was nice to have a broad distribution of surgical disciplines involved with the program as well. The multitude of viewpoints, opinions, and experiences brought to the discussions by the participants was very helpful and contributed greatly to my understanding of various subjects and issues. I thoroughly enjoyed getting to know my fellow participants. Eating meals together with free flowing discussions was one of the highlights for me. I am indebted to the ACS and AHPBA for supporting my participation in this leadership program. I will look forward to working with leadership of both the ACS and AHPBA to use the knowledge and insight provided to me to help advance the practice of surgery.



AHPBA CHAPTERS

Argentina

Bolivia

Brazil

Canada

Caribbean

Chile

Colombia

Costa Rica

Ecuador

El Salvador

Guatemala

Honduras

Mexico

Nicaragua

Panama

Paraguay

Peru

Uruguay


42

AMERICAS HEPATO-PANCREATO-BILIARY

FOUNDATIONAdvancing Research, Education, Training & Philanthropic Endeavors

DONATE TODAY

ahpba.org/foundation

Research and education are the cornerstones to advancing the treatment

of hepato-pancreato-biliary diseases. The AHPB Foundation is dedicated to funding research and education

opportunities so our colleagues can directly impact HPB diseases.



MARCH 9, 2018 MIAMI BEACH, FL

FUND RUN 2018

AHPBA is dedicated to our commitment to relieve the human suffering caused by HPB disorders throughout the world by providing funding for research, education, training and humanitarian events sponsored by AHPBF. This year’s AHPBF Fund Run will take place during the 2018 AHPBA Annual Meeting in Miami Beach: 3/9/18 at 6:15am

Start a Team, Join a Team, Donate! www.ahpba.org/foundation/donate-to-your-favorite-team/ For more information on the AHPBF mission and outreach programs, please visit www.ahpba.org/foundation To view the AHPB Foundation Donor Wall, please visit www.ahpba.org/donate


44

The Americas Hepato-Pancreato-Biliary Association would like to thank the following sponsors for their support of the following meeting activities: PRE-CONGRESS SYMPOSIUM

Ethicon US, LLC BERNARD LANGER FELLOWS SYMPOSIUM

AngioDynamics ADVANCED PRACTICE PROVIDERS SYMPOSIUM & RECEPTION

AbbVie, Inc.


WELCOME RECEPTION EXHIBITOR SPOTLIGHT

Medtronic


AGENDA


46

7:30am - 5:00pm Ultrasound & Advanced Technology Course Cowrie Foyer, Cowrie 1/2

7:30am - 8:00pmUltrasound & Advanced Technology Course Registration and Breakfast

8:00am - 9:20am Welcome and Course OverviewEllen J. Hagopian MD | Hackensack Meridian

US Principles & InstrumentationEllen J. Hagopian MD | Hackensack Meridian

US Scanning Techniques: TAUS, IOUS & LAPEren Berber MD | Cleveland Clinic Foundation

9:20am - 9:30amUltrasound Course Break

9:30am - 12:00pm Liver US: Normal Anatomy and Pathologic FindingsReid Adams MD | University of Virginia School of Medicine

Pancreatobiliary US: Normal Anatomy and PathologyNicholas Zyromski MD | Indiana University School of Medicine

Introduction to Hands On SessionsEllen Hagopian | Hackensack Meridian

10:50am – 11:00am Ultrasound Course Break

HPB Anatomy and Techniques: TAUSThomas A. Aloia | The University of Texas, MD Anderson Cancer CenterReid Adams MD | University of Virginia School of MedicineEren Berber MD | Cleveland Clinic Foundation T. Clark Gamblin MD | Medical College of WisconsinChet Hammill MD | Washington UniversityD. Rohan Jeyarajah MD | Trinity Care SurgicalMartin Palavecino MD | Hospital Italiano de Buenos AiresNicholas Zyromski MD | Indiana University School of Medicine

12:00pm - 12:45pm Ultrasound & Advanced Technology Course Luncheon


AG E N DA




12:45pm - 2:15pm Techniques in Ultrasound Guidance: TAUS, IOUS & LAPDavid Iannitti MD | Carolinas HealthCare System

Methods of Tumor Ablation in HPB SurgeryRobert CG Martin MD, PhD | University of Louisville

US Coding, Billing for the HPB SurgeonD. Rohan Jeyarajah MD | Trinity Care Surgical

Getting StartedEllen Hagopian | Hackensack Meridian

2:15pm - 2:30pmUltrasound Course BreakCowrie Foyer

2:30pm - 5:00pm Scanning Methods and Ultrasound Guidance: IOUS & LAPHands On Lab Using Inanimate and Phantom ModelsThomas A. Aloia MD | The University of Texas, MD Anderson Cancer CenterReid Adams MD | University of Virginia School of MedicineEren Berber MD | Cleveland Clinic FoundationT. Clark Gamblin MD | Medical College of WisconsinChet Hammill MD | Washington UniversityW. Scott Helton MD | Virginia Mason Medical CenterDavid Iannitti MD | Carolinas HealthCare SystemD. Rohan Jeyarajah MD | Trinity Care SurgicalMartin Palavecino MD | Hospital Italiano de Buenos AiresDennis Vrochides MD | Carolinas HealthCare SystemNicholas Zyromski MD | Indiana University School of Medicine

12:30pm - 1:30pmSurgical Innovation Committee MeetingHospitality room 432

12:30pm - 1:30pmProfessional Development Committee MeetingPeriwinkle

1:30pm - 2:30pmClinical Trials Committee MeetingHospitality room 409

AG E N DA


48

1:30pm - 2:30pmConflict of Interest (COI) Committee MeetingHospitality room 432

1:30pm - 2:30pmAHPBF Board MeetingPeriwinkle

2:30pm - 3:30pmFinance Committee MeetingHospitality room 432

2:30pm - 3:30pmPublications Committee MeetingPeriwinkle

3:00pm - 4:30pmEducation & Training Committee MeetingPoinciana 3/4

3:30pm - 4:30pmProgram Committee MeetingPoinciana 1/2

4:30pm - 6:30pmHPB Program Directors Committee MeetingAmericana 3

4:30pm - 5:30pmResearch Committee MeetingPoinciana 1/2

5:30pm - 6:30pmMembership Committee MeetingPoinciana 3/4

5:30pm - 6:30pmInternational Relations Committee MeetingPoinciana 1/2


AG E N DA



6:00pm - 8:00pmRegistration OpenRotunda East

6:00pm - 9:00pmUltrasound Course Fellows PracticumCowrie 1

6:30pm - 9:30pmExecutive Council MeetingPoinciana 1/2


AG E N DA


50

6:00am - 9:00amUltrasound Course Fellows PracticumCowrie 1

7:00am - 6:30pmRegistration OpenRotunda East

8:00am - 4:30pmPre Congress Symposium | HPB Across the Spectrum of CareAmericana 1/2Moderator: Charles M. Vollmer MD | University of Pennsylvania

8:00am-10:15amHPB Across the Spectrum of Care | Selecting the Right PatientModerators: Herbert J. Zeh MD | University of Pittsburgh Medical Center; Javier C. Lendoire MD, PhD | Hospital Dr C Argerich

KEYNOTE SPEAKER: PrehabRichard M. Charnley MD | Freeman Hospital

Bilobar Colorectal Mets: When to Operate?Rene Adam MD | Paul Brousse Hospital

Cirrhosis and SurgeryJuan Francisco Guerra MD | Pontificia Universidad Católica de Chile

Role of Laparoscopy with HPB Cancers TodayRebekah R. White MD | University of California San Diego

MIS or Open Whipple?Horacio J. Asbun MD | Mayo Clinic

Salvage or Sucker: Transplanting the High MELD PatientJulie K. Heimbach MD | Mayo Clinic

10:15am – 10:30amMorning Beverage BreakAmericana Foyer


AG E N DA



10:30am-12:30pmHPB Across the Spectrum of Care | Intraop Approaches for SuccessModerators: Carlos Chan MD | National Institute of Medical Sciences; Sharon Weber, MD | University of Wisconsin

KEYNOTE SPEAKER: Coaching in the OR - Wait A Minute, Slow DownCarol-anne Moulton MD | University Health Network, University of Toronto

Averting Biliary LeaksThomas Aloia MD | MD Anderson Cancer Center

Preventing Pancreatic LeaksCharles M. Vollmer MD | University of Pennsylvania

Avoiding Blood LossElijah Dixon MD | University of Calgary

Handing Over the ReignsPaul D. Greig MD | University of Toronto

12:30pm – 1:30pmLunch Break (on own)

12:30pm - 1:30pmAHPBA New Members Lunch with Leadership (by invite only)Poinciana 3/4

1:30pm-4:30pmHPB Across the Spectrum of Care | HPB Surgery: It’s ComplicatedModerators: Mariano Gimenez MD | University of Buenos Aires; Mark P. Callery MD | Harvard Medical School

KEYNOTE SPEAKER: Classification of Complications and BenchmarkingPierre-Alain Clavien MD PhD | University Hospital Zurich

Dealing with a Bile Duct InjuryMiguel Angel Mercado MD | Instituto Nacional de Ciencias Medicas

Y Nutricion Salvador Zubiran

Post-Op HemorrhageMajor Lee MD PhD | Univeresity of Pennsylvania

Vascular Complications After a Liver TransplantSatish N. Nadig MD, PhD | Medical University of South Carolina

Managing Pancreatic LeaksGiuseppe Malleo MD, PhD | The Pancreas Institute, University of Verona

Dealing with Living Donor DeathCharles Miller MD | Cleveland Clinic


AG E N DA


52

3:00pm - 4:00pmUltrasound Subcommittee MeetingCowrie 2

4:30pm – 5:30pmHPB Collaborative MeetingPoinciana 1/2

5:30pm - 7:00pmAHPBA Welcome ReceptionAmericana 4

5:30pm - 7:30pmBernard Langer Fellows SymposiumAmericana 1/2Moderators: M.B. Majella Doyle, MD, MBA | Washington University School of Medicine; Blaire Anderson, MD | Washington University School of Medicine; Robert Simon, MD | Cleveland Clinic Foundation

Honorary WelcomeBernard Langer, MD | Toronto General Hospital

Best Practices for Securing a Job and Transitioning into PracticeThomas Aloia MD | MD Anderson Cancer Center

How to Position Yourself for LeadershipElijah Dixon MD | University of Calgary

Training in MIS HPBErin H. Baker MD | Carolinas Medical Center

How to Become a Surgical ScientistRyan C. Fields MD | Washington University School of Medicine

How to Assure Patients You are CapableSean P. Cleary MD | Mayo Clinic

Panelists: HPB Training – A Tripartite Perspective Houssam G. Osman MD | Methodist Richardson Medical CenterJulie H. Hallet MD, MSc | Sunnybrook Health Sciences Centre,

University of TorontoKendra D. Conzen, MD | University of Colorado School of Medicine

9:30pmCocktails with AHPBA LeadershipBar Collins


AG E N DA



6:15am - 7:15amAHPBF Fund RunCheck-in at Spa Front Desk


7:00am - 8:00amContinental Breakfast in Exhibit HallAmericana 4

7:00am - 8:00amIndustry Sponsored Breakfast Symposium - Thank you Aesculap!Poinciana 1/2

8:00am – 8:30am Welcome & Opening Session AHPBA President, Rebecca Minter MD | University of Wisconsin

8:30am - 9:30amPresidential PlenaryAmericana 1/2Moderator: Rebecca Minter MD | University of Wisconsin

8:30am - 8:45am1. MINIMALLY INVASIVE VERSUS OPEN DISTAL PANCREATECTOMY (LEOPARD): MULTICENTER PATIENT-BLINDED RANDOMIZED CONTROLLED TRIALPresenter: Thijs de Rooij MSc | Academic Medical Center Invited Discussant: Elijah Dixon MD | University of Calgary

8:45am - 9:00am2. REGIONAL DIFFERENCES IN GALLBLADDER CANCER PATHOGENESIS: INSIGHTS FROM A COMPARISON OF TUMOR MUTATIONSPresenter: Raja Narayan MD, MPH | Memorial Sloan Kettering Cancer Center Invited Discussant: Henry Pitt MD | Lewis Katz School of Medicine at Temple University


AG E N DA


54

9:00am - 9:15am3. EVALUATION OF HEPATOCELLULAR CARCINOMA CIRCULATING TUMOR CELLS EXPRESSING PROGRAMMED DEATH-LIGAND 1Presenter: Paul Winograd MD | David Geffen School of Medicine at UCLA Invited Discussant: William Jarnagin MD | Memorial Sloan Kettering Cancer Center

9:15am - 9:30am4. SURGICAL COMPLICATIONS AFTER RIGHT HEPATECTOMY FOR LIVE LIVER DONATION. A SINGLE CENTER EXPERIENCE AFTER >500 CASESPresenter: Andre Gorgen MD | University Health Network, Toronto General Hospital Invited Discussant: Will Chapman MD | Washington University

9:30am - 10:30amPresidential AddressAmericana 1/2

Introduction: Charles M. Vollmer MD | University of Pennsylvania

Inclusivity and Diversity - the AHPBA’s Secret SauceRebecca M. Minter MD | University of Wisconsin

10:30am - 11:00amMorning Beverage Break, Exhibits & ePoster ViewingAmericana 4

11:00am - 12:30pmAHPBA-SAGES Joint Symposium: Lap Liver ResectionsAmericana 1/2Moderators: Nicholas A. O’Rourke MBBS | Royal Brisbane Hospital; D. Rohan Jeyarajah MD | Methodist Richardson Medical Center

The State of MIS Liver SurgeryDavid Geller MD | University of Pittsburgh

Review of ILLS Paris ExperienceDaniel Cherqui MD, PhD | Paul Brousse Hospital

Updates from EGMLLS 2017 ExperienceHoracio J. Asbun MD | Mayo Clinic

MIS Training for Practicing HPB Surgeons and FellowsAdnan Alseidi MD, EdM | Virginia Mason Medical Center

South American and Western ExperiencePaulo Herman MD | University of São Paulo


AG E N DA



11:00am - 12:30pmEnhanced Recovery After HPB SurgeryAmericana 3Moderators: Sharon Weber MD | University of Wisconsin – Madison; Dionisios Vrochides, MD, PhD | Carolinas Medical Center

Relationship Between Enhanced Recovery and Value Based HealthcareThomas Aloia MD | MD Anderson Cancer Center

Database Management and ComplianceErin H. Baker MD | Carolinas Medical Center

Lessons Learned on the Way to a Liver PathwayAlice C. Wei MD | University Health Network, University of Toronto

Predictive Analytics for Pancreas Pathway DevelopmentJason W. Denbo MD | University of Minnesota

Anesthesia Perspective: GDFT and Regional BlocksVijaya Gottumukkala MD | MD Anderson Cancer Center

11:00am - 12:30pmOral Presentations 1: HepatobiliaryPoinciana 1/2Moderators: Eddie Abdalla MD | Northside Hospital Cancer Institute; Cassio Virgilio de Oliveira MD | Universidade Federal da Paraíba

11:00am - 11:12am5. GROWTH SUPPRESSION BY ALTERATION IN KEAP1/NRF2-NOTCH-STAT3 SIGNALING IN CHOLANGIOCARCINOMAPresenter: Muthusamy Kunnimalaiyaan PhD | Medical College of Wisconsin Invited Discussant: Steve Hughes MD | University of Florida

11:12am - 11:24am6. LONG-TERM OUTCOMES OF PATIENTS WITH INTRADUCTAL GROWTH SUB-TYPE OF INTRAHEPATIC CHOLANGIOCARCINOMAPresenter: Fabio Bagante MD | The Ohio State University Invited Discussant:

11:24am - 11:36am7. DOES ADDITIONAL RE-RESECTION OF A POSITIVE PROXIMAL MARGIN IN HILAR CHOLANGIOCARCINOMA AFFECT SURVIVAL? MAYO EXPERIENCEPresenter: Lavanya Yohanathan MD | Mayo Clinic Invited Discussant: Mike D’Angelica MD | Memorial Sloan Kettering Cancer Center


AG E N DA


56

11:36am - 11:48am8. IS HEPATECTOMY SAFE FOLLOWING YTTRIUM-90 THERAPY? A MULTI-INSTITUTIONAL INTERNATIONAL EXPERIENCEPresenter: Laleh Melstrom MD, MS | City of Hope Cancer Center Invited Discussant: Parsia Vagefi MD | University of Texas, Southwestern

11:48am - 12:00pm9. LAPAROSCOPIC PARENCHYMA-SPARING LIVER RESECTION FOR COLORECTAL METASTASESPresenter: Davit Aghayan MD | Oslo University Hospital Invited Discussant: Ching-Wei Tzeng MD | University of Texas, MD Anderson Cancer Center

12:00pm - 12:12pm10. CHEMORADIOTHERAPY FOR POSITIVE HEPATIC MARGIN ON CHOLANGIOCARCINOMAPresenter: Teiichi Sugiura MD | Shizuoka Cancer Center Invited Discussant: Chandrakanth Are MBBS, MBA | University of Nebraska Medical Center

12:12pm - 12:24pm11. SURVIVAL AFTER RESECTION OF MULTIPLE TUMOR FOCI OF INTRAHEPATIC CHOLANGIOCARCINOMAPresenter: Stefan Buettner BSc | The Ohio State University Invited Discussant: Kimberly Bertens MD, MPH | The Ottawa Hospital

11:00am - 12:30pmOral Presentations 2: PancreasPoinciana 3/4Moderators: Michael Kendrick MD | Mayo Clinic Rochester; Rebecca Snyder MD, MPH | University of South Carolina School of Medicine- Greenville

11:00am - 11:12am12. THE CONUNDRUM OF <2 CM PANCREATIC NEUROENDOCRINE TUMORS: A PREOPERATIVE RISK SCORE TO PREDICT LYMPH NODE METASTASES AND GUIDE SURGICAL MANAGEMENTPresenter: Alexandra Lopez-Aguiar MD | Emory University Invited Discussant: Yumon Fong MD | City of Hope

11:12am - 11:24am13. EVALUATION OF THE SAFETY AND EFFICACY OF STING AGONISTS FOR DOWNSTAGING AND MARGIN ACCENTUATION STRATEGIES IN A MURINE MODEL OF LOCALLY ADVANCED PANCREATIC CANCERPresenter: Ephraim Tang MD, MSc | Providence Cancer Center Invited Discussant: Rebecca Snyder MD, MPH | University of South Carolina School of Medicine-Greenville


AG E N DA



11:24am - 11:36am14. MONITORING GASTRIC MYOELECTRIC AFTER PANCREATICODUODENECTOMY FOR DIET “READINESS”Presenter: Brendan Visser MD | Stanford University Invited Discussant: Jin He MD, PhD | Johns Hopkins University School of Medicine

11:36am - 11:48am15. DECODING GRADE B PANCREATIC FISTULA: A CLINICAL AND ECONOMICAL ANALYSIS AND SUB-CLASSIFICATION PROPOSALPresenter: Giuseppe Malleo MD | University of Pennsylvania Invited Discussant: Kamran Idrees MD, MSCI, MMHC | Vanderbilt University Medical Center

11:48am - 12:00pm16. ENHANCEMENT OF ANTI-TUMOR IMMUNITY AND SURVIVAL PROLONGATION BY NEOADJUVANT FOLINIC ACID 5-FU, OXALIPLATIN AND IRINOTECAN (FOLFIRINOX) IN PANCREATIC DUCTAL ADENOCARCINOMA PATIENTSPresenter: Lei Cai MD, PhD | Massachusetts General Hospital, Harvard Medical School Invited Discussant: George Poultsides MD | Stanford University

12:00pm - 12:12pm17. QUALITY IMPROVEMENT FOR PANCREATODUODENECTOMY THROUGH THE DEVELOPMENT AND INTEGRATION OF PROCEDURE-SPECIFIC RISK ASSESSMENTPresenter: Brett Ecker MD | University of Pennsylvania Invited Discussant: Stephen Behrman MD | University of Tennessee Health Science Center 12:12pm - 12:24pm18. RADIOLOGICAL FACTORS ASSOCIATED WITH MISSTAGING OF PANCREATIC DUCTAL ADENOCARCINOMAPresenter: Ammar Javed MD | Johns Hopkins University School of Medicine Invited Discussant: Courtney Scaife MD | Huntsman Cancer Institute, University of Utah


AG E N DA


58

11:00am - 12:30pmOral Presentations 3: TransplantCowrie 1/2Moderators: Anand Annamalai MD | St.Vincents Medical Center; Steven Hanish MD | University of Maryland

11:00am - 11:12am19. RISK OF TRANSPLANT WAITLIST PROGRESSION IN HEPATOCELLULAR CARCINOMA USING BIOMARKERS OF TUMOR IMMUNE TOLERANCE PRIOR TO TRANSARTERIAL CHEMOEMBOLIZATIONPresenter: Paul Thevenot PhD | Ochsner Health System Invited Discussant: Stephen Gray MD | University of Alabama at Birmingham

11:12am - 11:24am20. HALTHCC AS A NOVEL TUMOR RESPONSE METRIC IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LOCOREGIONAL THERAPY WHILE AWAITING LIVER TRANSPLANTATIONPresenter: Kazunari Sasaki MD | Cleveland Clinic Foundation Invited Discussant: Karim Halazun MD | Weill Cornell Medicine

11:24am - 11:36am21. OUTCOMES OF TRANSPLANTATION FOR BIPHENOTYPIC LIVER TUMORS ARE SIMILAR TO OUTCOMES OF TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMAPresenter: Leigh Anne Dageforde MD, MPH | Washington University Invited Discussant: Vijay Vij MBBS,MS, MRCS | Fortis Hospitals

11:36am - 11:48am22. IMPACT OF SIDE-TO-SIDE CAVOCAVOSTOMY VERSUS TRADITIONAL PIGGYBACK IMPLANTATION IN LIVER TRANSPLANTPresenter: Vikrom Dhar MD | University of Cincinnati Invited Discussant: John Renz MD, PhD | University of Chicago

11:48am - 12:00pm23. REDUCING READMISSIONS AFTER LIVER TRANSPLANTATIONPresenter: David Levi MD | Carolinas HealthCare System Invited Discussant: Chris Sonnenday MD, MHS | University of Michigan


AG E N DA



12:00pm - 12:12pm24. UNDERSTANDING FIBRINOLYSIS SHUTDOWN IN LIVER TRANSPLANTATIONPresenter: Vikrom Dhar MD | University of Cincinnati Invited Discussant: Kristopher Croome MD | Mayo Clinic Florida

12:12pm - 12:24pm25. EFFECTS OF SEVOFLURANE METABOLITE HEXAFLUORO-2-PROPANOL PRECONDITIONING IN EXPERIMENTAL LIVER ISCHEMIA REPERFUSION INJURYPresenter: Joel Rocha Filho MD, PhD | Hospital das Clinicas of University of Sao Paulo Invited Discussant: Charles Rosen MD | Mayo Clinic

12:30pm - 1:00pmLunch in Exhibit HallAmericana 4

12:30pm - 1:30pmAdvance Practice Provider Committee MeetingCowrie 2

1:00pm - 2:30pmVascular Resections in HPB Cancer - When, Where, How?Americana 1/2Moderators: Carlos U. Corvera MD | UCSF; Oscar C. Imventarza MD | Hospital Argerich- Hospital Garrahan

Extended Resections in Pancreatic CancerJeffrey E. Lee MD | UTMD Anderson Cancer Center

IVC Resection with HepatectomyGabriel E. Gondolesi MD | Fundacion Favaloro

Aggressive HCC Resections with Portal Vein ThrombosisJean C. Emond MD | Columbia Univeristy and The New York Presbyterian

Hospital

Hilar Cholangiocarcinoma with Vascular ResectionsChristopher J. Sonnenday MD, MHS | University of Michigan


AG E N DA


60

1:00pm - 2:30pmDoes the Evidence Truly Support Aggressive Surgical or Medical Treatment in HPB Surgery?Americana 3Moderators: Jeffrey B. Matthews MD | University of Chicago; Jose P. Garbanzo MD | Centro de Enfermedades del Higado

Pancreatic AdenocarcinomaSteven Gallinger MD | University Health Network, University of Toronto

PNETsEmily R. Winslow MD, MS | University of Wisconsin

Hilar CholangiocarcinomaWilliam R. Jarnagin MD | Memorial Sloan Kettering Cancer Center

HCCSean P. Cleary MD | Mayo Clinic

Incidental Gall Bladder Cancer: Radical Resection?Jean M. Butte MD | Instituto Oncologico Fundacion Arturo Lopez Perez

1:00pm - 2:30pmMini Oral Sessions | Monitor 1 Pancreas CancerAmericana FoyerModerator: Kevin Billingsley MD | Oregon Health and Science University

1:00pm - 1:05pmMO 1. OPERATIVE MANAGEMENT OF LOCALLY ADVANCED PANCREATIC CANCER: ANALYSIS OF THE NATIONAL CANCER DATABASEPresenter: Chad Barnes MD | Medical College of Wisconsin

1:05pm - 1:10pmMO 2. ALL TALK AND NO ACTION: A REVIEW OF THE USE OF NEOADJUVANT CHEMOTHERAPY FOR PANCREATIC CANCER IN THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAMPresenter: Erin Gilbert MD | Oregon Health and Sciences University

1:10pm - 1:15pmMO 3. BILIARY MICROBIOME IN PANCREATIC CANCER: ALTERATIONS WITH NEOADJUVANT THERAPYPresenter: Neha Goel MD | Fox Chase Cancer Center


AG E N DA



1:15pm - 1:20pmMO 4. EXPLORATION OF IRREVERSIBLE ELECTROPORATION INDUCED APOPTOTIC PATHWAYS AND MECHANISMS IN PANCREATIC ADENOCARCINOMA CELLSPresenter: Christopher McNicoll MD, MPH, MS | University of Las Vegas Nevada School of Medicine

1:20pm - 1:25pmMO 5. PREDICTORS OF RECURRENCE IN PATIENTS WITH SOLID PSEUDOPAPILLARY NEOPLASMS OF THE PANCREAS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 2579 PATIENTSPresenter: NATESH YEPURI MBBS | Suny Upstate Medical University

1:25pm - 1:30pmMO 6. HIGH VOLUME PANCREATICODUODENECTOMY PERFORMED AT A COMMUNITY CANCER CENTERPresenter: Arvind Sabesan MD | Helen F Graham Cancer Center & Research Institute

1:30pm - 1:35pmMO 7. IMPROVED OVERALL SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER UNDERGOING NEOADJUVANT THERAPY AND IRREVERSIBLE ELECTROPORATIONPresenter: M. Farzan Rashid BS | Columbia University

1:35pm - 1:40pmMO 8. RECURRENT OR METACHRONOUS ADENOCARCINOMA OF THE PANCREATIC REMNANT: LONG-TERM SURVIVAL AFTER COMPLETION PANCREATECTOMYPresenter: Thuy Tran MD | Stanford University

1:40pm - 1:45pmMO 9. THE ROLE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO IN PREDICTING SURVIVAL IN PANCREATIC CANCER PATIENTS BASED ON NEOADJUVANT CHEMOTHERAPY PATHOLOGICAL RESPONSE.Presenter: Basem Azab MD | University of Miami Miller School of Medicine


AG E N DA


62

1:45pm - 1:50pmMO 10. EVALUATING A SINGLE NEEDLE HIGH-FREQUENCY IRREVERSIBLE ELECTROPORATION (H-FIRE) PROBE FOR PANCREATIC ABLATION IN VIVO.Presenter: Iain McKillop PhD | Carolinas HealthCare System

1:50pm - 1:55pmMO 11. A MULTI-INSTITUTIONAL ANALYSIS OF FACTORS AFFECTING SURVIVAL FOR LEFT-SIDED PANCREATIC ADENOCARCINOMAPresenter: Farzad Alemi MD | Virginia Mason Medical Center

1:55pm - 2:00pmMO 12. IMPACT OF TUMOR LOCATION ON RESECTABILITY AND SURVIVAL FOR PANCREATIC DUCTAL ADENOCARCINOMAPresenter: Vikrom Dhar MD | University of Cincinnati 2:00pm - 2:05pmMO 13. THE CLINICAL IMPACT OF LEFT GASTRIC ARTERY RECONSTRUCTION/PRESERVATION DURING DISTAL PANCREATECTOMY WITH CELIAC AXIS RESECTION FOR PANCREATIC BODY CANCERPresenter: Atsushi Oba MD, PhD | Cancer Institute Hospital, Japanese Foundation for Cancer Research

2:05pm - 2:10pmMO 14. CHEMOTHERAPY VS CHEMORADIATION AS PREOPERATIVE THERAPY FOR RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA: A PROPENSITY SCORE ADJUSTED ANALYSISPresenter: Jordan Cloyd MD | The University of Texas MD Anderson Cancer Center

2:10pm - 2:15pmMO 15. DOES NEOADJUVANT THERAPY AFFECT PERIOPERATIVE OUTCOMES IN SARCOPENIC PATIENTS WITH PANCREATIC ADENOCARCINOMA?Presenter: Dylan Kahler BA | University of Pittsburgh Medical Center

2:15pm - 2:20pmMO 16. PREDICTING RE-ADMISSION IN SUBTOTAL PANCREATECTOMY PATIENTSPresenter: Michelle Huyser MD | Kaiser Permanente, Oakland Medical Center


AG E N DA



2:20pm - 2:25pmMO 17. PANCREATICODUODENECTOMY AND VEIN RESECTION WITHOUT RECONSTRUCTION FOR LOCALLY ADVANCED PANCREATIC CANCER: A CASE SERIESPresenter: Bradley Reames MD, MS | Johns Hopkins University School of Medicine

2:25pm - 2:30pmMO 18. IMPACT OF PERIOPERATIVE BLOOD TRANSFUSIONS ON SURVIVAL IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA AFTER NEOADJUVANT THERAPYPresenter: Rebecca Snyder MD, MPH | The University of Texas MD Anderson Cancer Center

1:00pm - 2:30pmMini Oral Sessions | Monitor 2 PancreasAmericana FoyerModerator: Attila Nakeeb MD | Indiana University

1:00pm - 1:05pmMO 19. INTERNATIONAL VALIDATION OF THE UPDATED INTERNATIONAL STUDY GROUP OF PANCREATIC SURGERY DEFINITION OF POSTOPERATIVE PANCREATIC FISTULA AFTER DISTAL PANCREATECTOMYPresenter: Jony van Hilst MD | Academic Medical Center

1:05pm - 1:10pmMO 20. PANCREATIC AND BILIARY LEAKS IN FRAIL. SAME INCIDENCE, GRAVE IMPACTPresenter: Ioannis Konstantinidis MD | City of Hope Cancer Center

1:10pm - 1:15pmMO 21. LONG TERM EXOCRINE AND ENDOCRINE FUNCTION AFTER PANCREATECTOMYPresenter: Blaire Anderson MD | Washington University

1:15pm - 1:20pmMO 22. THE TRUE COST OF HIGH VOLUME WHIPPLE PROCEDURESPresenter: Michael Lopez DO | University of Miami- Palm Beach


AG E N DA


64

1:20pm - 1:25pmMO 23. DISTAL SPLENORENAL AND MESOCAVAL SHUNTING AT THE TIME OF PANCREATECTOMY: AN IMPORTANT ADJUNCT TO THE OPERATIVE MANAGEMENT OF SELECTED PATIENTS.Presenter: Mariana Chavez MD | Medical College of Wisconsin

1:25pm - 1:30pmMO 24. PREOPERATIVE CYTOKINE EXPRESSION IS ASSOCIATED WITH PERIOPERATIVE OUTCOMES AFTER PANCREATECTOMYPresenter: Malcolm Hart Squires MD | The Ohio State University

1:30pm - 1:35pmMO 25. DEFINING THE PRACTICE OF DISTAL PANCREATECTOMY AROUND THE WORLDPresenter: Giuseppe Malleo MD | University of Pennsylvania

1:35pm - 1:40pmMO 26. TRENDS AND SEASONALITY IN BILIARY AND ALCOHOLIC ACUTE PANCREATITIS INCIDENCE IN THE UNITED STATESPresenter: Steven Clark Cunningham MD | Saint Agnes Hospital Center

1:40pm - 1:45pmMO 27. TRANSMEMBRANE MUCIN MUC13 DISTINGUISHES INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS FROM NON-MUCINOUS CYSTS AND IS ASSOCIATED WITH HIGH-RISK LESIONSPresenter: Zachary Stiles DO | University of Tennessee Health Science Center

1:45pm - 1:50pmMO 28. WEEKEND EFFECT IS ASSOCIATED WITH ADVERSE OUTCOMES IN POSTOPERATIVE READMISSIONS FOLLOWING PANCREATIC RESECTIONPresenter: Anai Kothari MD, MS | Loyola University Medical Center

1:50pm - 1:55pmMO 29. BILIARY ANASTOMOTIC STRICTURES AFTER PANCREATICODUODENECTOMY: AN UNDERAPPRECIATED COMPLICATIONPresenter: Ammar Javed MD | Johns Hopkins University School of Medicine


AG E N DA



1:55pm - 2:00pmMO 30. COMPLICATIONS FROM RADICAL ANTEGRADE MODULAR PANCREATICOSPLENECTOMY MAY BE UNDER-REPORTED IN ACS-NSQIPPresenter: Tarin Worrest MD | Oregon Health and Sciences University

2:00pm - 2:05pmMO 31. ANALYSIS OF 90-DAY READMISSION RATES AND HEALTHCARE COST IN PANCREATIC SURGERY: WHAT IF BUNDLED PAYMENT SYSTEMS WERE APPLIED TO PANCREATIC SURGERY?Presenter: Michael LeCompte MD | Vanderbilt University Medical Center

2:05pm - 2:10pmMO 32. EVALUATING THE ACS-NSQIP RISK CALCULATOR IN PRIMARY PANCREATIC NEUROENDOCRINE TUMOR: RESULTS FROM THE UNITED STATES NEUROENDOCRINE TUMOR STUDY GROUPPresenter: Eliza Beal MD | The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center

2:10pm - 2:15pmMO 33. PRESENCE OF ADDICTION DOES NOT PREDICT WORSE OUTCOMES WITH RESPECT TO PAIN AFTER TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATIONPresenter: Robert Simon MD | Cleveland Clinic Foundation

2:15pm - 2:20pmMO 34. THE BENEFICIAL EFFECTS OF MINIMIZING BLOOD LOSS IN PANCREATODUODENECTOMYPresenter: Thomas Seykora BA | University of Pennsylvania

2:20pm - 2:25pmMO 35. AN ANALYSIS OF 6,125 PANCREATICOJEJUNAL ANASTOMOSES: DOES TECHNIQUE MATTER?Presenter: Lyonell Kone MD, MHS | University of Illinois at Chicago

2:25pm - 2:30pmMO 36. MACHINE LEARNING AND PREDICTIVE ANALYTICS PROVIDE INDIVIDUALIZED RISK PROFILES FOR PATIENTS UNDERGOING MINIMALLY INVASIVE LEFT PANCREATECTOMYPresenter: Michael Passeri MD | Carolinas HealthCare System


AG E N DA


66

1:00pm - 2:30pmMini Oral Sessions | Monitor 3 LiverAmericana FoyerModerator: David Iannitti MD | Carolinas HealthCare System

1:00pm - 1:05pmMO 37. WHO NEEDS A DRAIN AFTER MAJOR HEPATECTOMY?Presenter: Konstantinos Zorbas MD | Lewis Katz School of Medicine at Temple University Hospital

1:05pm - 1:10pmMO 38. CTLA-4 BLOCKADE INDUCES INDOLEAMINE 2,3-DIOXYGENASE WHERE TREATMENT WITH 1-METHYL-D-TRYPTOPHAN DISPLAYS GREATER TREATMENT EFFECT IN TUMORS WITH HIGH IDO EXPRESSION.Presenter: Zachary Brown DO | National Institutes of Health

1:10pm - 1:15pmMO 39. INCREMENTAL COSTS AND OUTCOMES OF HEPATECTOMY WITH VS WITHOUT RESECTION FOR METASTATIC CANCERPresenter: Jay Idrees MD | The Ohio State University

1:15pm - 1:20pmMO 40. SUPERUSERS OF POSTOPERATIVE HEPATOBILIARY CARE: IDENTIFYING DRIVERS OF EXTREME HEALTHCARE COSTS USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAMPresenter: Sarah Brownlee BA | Loyola University Medical Center

1:20pm - 1:25pmMO 41. DOES METABOLIC SYNDROME AFFECT THE SHORT- AND LONG-TERM OUTCOMES OF PATIENTS UNDERGOING HEPATIC RESECTION? ANALYSIS OF A SINGLE TERTIARY CENTER DATABASEPresenter: Mohammed Al-Temimi MD, MPH | Kaiser Permanente, Los Angeles Medical Center

1:25pm - 1:30pmMO 42. QUANTITATIVE CT IMAGING FEATURES CORRELATE WITH COLORECTAL CANCER LIVER METASTASES (CLM) MUTATIONAL STATUSPresenter: Rebecca Marcus MD | The University of Texas MD Anderson Cancer Center


AG E N DA



1:30pm - 1:35pmMO 43. PRINGLE MANEUVER DURING LIVER RESECTIONS IN THE UNITED STATES: PATTERNS OF USE AND IMPACT IN OUTCOMESPresenter: Ali Mokdad MD, MS | University of Texas Southwestern

1:35pm - 1:40pmMO 44. QUANTINTATIVE RISK ASSESSMENT FOR POST-HEPATECTOMY LIVER FAILURE: ANALYSIS OF THE 2015 ACS-NSQIP PROCEDURE-TARGETED HEPATECTOMY DATABASEPresenter: Yana Puckett MD | Texas Tech University Health Sciences Center

1:40pm - 1:45pmMO 45. THE LIVER HANGING MANEUVER REVISITED: A CADERVERIC STUDY OF THE WIDTH OF THE RETRO-HEPATIC AVASCULAR SPACEPresenter: Atsushi Shimizu MD, PhD | Jichi Medical University

1:45pm - 1:50pmMO 46. THE USE OF INDOCYANINE GREEN FLUORESCENCE FOR INTRAOPERATIVE VISUALIZATION OF LIVER TUMORSPresenter: Eren Berber MD | Cleveland Clinic Foundation

1:50pm - 1:55pmMO 47. KRAS MUTATIONAL STATUS SURPASSES THE TREATMENT MODALITY IN PATIENTS WITH COLORECTAL LIVER METASTASESPresenter: Hideo Takahashi MD | Cleveland Clinic Foundation

1:55pm - 2:00pmMO 48. LONG TERM ONCOLOGIC OUTCOMES OF ROBOTIC LIVER RESECTION FOR PRIMARY LIVER CANCERSPresenter: Sidrah Khan MD | University of Pittsburgh Medical Center

2:00pm - 2:05pmMO 49. YOUNGER PATIENTS WITH RESECTABLE COLORECTAL LIVER METASTASES HAVE COMPARABLE SURVIVAL TO OLDER PATIENTS DESPITE WORSE HISTOPATHOLOGIC FEATURES AND INCREASED RAS MUTATIONSPresenter: Claire Goumard MD | The University of Texas MD Anderson Cancer Center


AG E N DA


68

2:05pm - 2:10pmMO 50. BENEFITS OF HAND-ASSISTED LAPAROSCOPIC HEPATECTOMYPresenter: Luis Mercado MD | Hospital Universitario Fundación Favaloro

2:10pm - 2:15pmMO 51. UNIQUE TECHNICAL COMPLEXITIES AND EFFICACY OF ERCP AFTER IRREVERSIBLE ELECTROPORATION FOR LOCALLY ADVANCED PANCREATIC CANCERPresenter: Neal Bhutiani MD | University of Louisville School of Medicine

2:15pm - 2:20pmMO 53. PROGNOSTIC SIGNIFICANCE OF PRIMARY TUMOR SIDEDNESS IN PATIENTS UNDERGOING LIVER RESECTION FOR METASTATIC COLORECTAL CANCERPresenter: Jenny Lim MD, MHSc | Duke University Medical Center

2:20pm - 2:25pmMO 54. TUMOR GRADE SHOULD INFLUENCE THE UTILIZATION OF PORTAL LYMPHADENECTOMY FOR EARLY STAGE INTRAHEPATIC CHOLANGIOCARCINOMAPresenter: Sean Martin DO | National Institutes of Health

1:00pm - 2:45pmMini Oral Sessions | Monitor 4 GB/Cholangiocarcinoma/PNETAmericana FoyerModerator: T. Clark Gamblin MD, MS, MBA | Medical College of Wisconsin

1:00pm - 1:05pmMO 55. STAGING GALLBLADDER CANCER WITH LYMPHADENECTOMY: THE PRACTICAL APPLICATION OF 6 LYMPH NODESPresenter: Natasha Leigh MD | Icahn School of Medicine at Mount Sinai

1:05pm - 1:10pmMO 56. IMPROVING OUTCOMES OF CHOLANGIOCARCINOMA: AN ANALYSIS OF THE SEER DATABASEPresenter: Aitua Salami MD, MPH | Einstein Healthcare Network

1:10pm - 1:15pmMO 57. REVISION OF NATIONWIDE PRACTICE PATTERNS IN THE MANAGEMENT OF T2 GALLBLADDER CARCINOMAPresenter: Francisco Igor Macedo MD | University of Miami Miller School of Medicine


AG E N DA



1:15pm - 1:20pmMO 58. PREOPERATIVE BILIARY STENTING IS ASSOCIATED WITH INCREASED COMPLICATIONS AFTER LIVER RESECTION FOR CHOLANGIOCARCINOMAPresenter: Rajesh Ramanathan MD | University of Pittsburgh Medical Center

1:20pm - 1:25pmMO 59. SURGERY MAY NOT IMPROVE SURVIVAL FOR LYMPH NODE POSITIVE INTRAHEPATIC CHOLANGIOCARCINOMA COMPARED TO CHEMOTHERAPY ALONEPresenter: Scott Kizy MD | University of Minnesota

1:25pm - 1:30pmMO 60. R1 RESECTION IN HILAR CHOLANGIOCARCINOMA MIGHT NOT TRANSLATE TO INFERIOR PATIENT SURVIVAL; AN INTENTION TO TREAT ANALYSISPresenter: Michael Passeri MD | Carolinas HealthCare System

1:30pm - 1:35pmMO 61. NEOADJUVANT SYSTEMIC THERAPY FOR CHOLANGIOCARCINOMA : A NSQIP DATABASE ANALYSISPresenter: Dominic Sanford MD | Mayo Clinic, Florida

1:35pm - 1:40pmMO 62. MAJOR COMPLICATIONS FOLLOWING PANCREATECTOMY FOR SMALL PANCREATIC NEUROENDOCRINE AND CYSTIC NEOPLASMS LESS THAN 2-CM: AN ARGUMENT FOR SELECTIVE OBSERVATION OR RESECTIONPresenter: Thuy Tran MD | University of Illinois at Chicago

1:40pm - 1:45pmMO 63. SAFETY AND EFFICACY OF IRREVERSIBLE ELECTROPORATION IN THE TREATMENT OF OBSTRUCTIVE JAUNDICE IN LOCALLY ADVANCED HILAR CHOLANGIOCARCINOMAPresenter: Emily Martin MEng | University of Louisville School of Medicine

1:45pm - 1:50pmMO 64. EFFECT OF BLOOD TRANSFUSION ON SURVIVAL FOR RESECTED PANCREATIC NEUROENDOCRINE TUMORS: ANALYSIS OF THE U.S. NEUROENDOCRINE STUDY GROUPPresenter: Paula Marincola Smith MD | Vanderbilt University Medical Center


AG E N DA


70

1:50pm - 1:55pmMO 65. ONCOLOGIC OUTCOMES OF PREOPERATIVE THERAPY FOR DISTAL CHOLANGIOCARCINOMAPresenter: Jordan Cloyd MD | The University of Texas MD Anderson Cancer Center

2:00pm - 2:05pmMO 67. IS PRIMARY SCLEROSING CHOLANGITIS-RELATED GALLBLADDER CANCER ASSOCIATED WITH WORSE SURVIVAL? RESULTS FROM THE U.S. EXTRAHEPATIC BILIARY MALIGNANCY CONSORTIUMPresenter: Victoria Rendell MD | University of Wisconsin School of Medicine and Public Health

2:05pm - 2:10pmMO 68. INCIDENCE OF GALLBLADDER CANCER AND OVERALL SURVIVAL IN DIFFERENT RACIAL POPULATIONS IN NORTHERN CALIFORNIAPresenter: Michelle Huyser MD | Kaiser Permanente, Oakland Medical Center

2:10pm - 2:15pmMO 69. IS CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY INDICATED IN HEPATOBILIARY MALIGNANCIES?Presenter: Natasha Leigh MD | Icahn School of Medicine at Mount Sinai

2:15pm - 2:20pmMO 70. A LITERATURE-BASED TREATMENT ALGORITHM FOR LOW-GRADE NEUROENDOCRINE LIVER METASTASESPresenter: Neal Bhutiani MD | University of Louisville School of Medicine

2:20pm - 2:25pmMO 71. RE-RESECTION IN INCIDENTAL GALLBLADDER CANCER: LYMPH NODES RETRIEVED IN OPEN VS LAPAROSCOPIC APPROACHPresenter: Oscar Guevara MD, MSc | Universidad Nacional de Colombia


AG E N DA



2:25pm - 2:30pmMO 72. THE INTERSECTION OF SURGERY AND BIOENGINEERING: INNOVATIVE SOLUTIONS FOR CLINICAL PROBLEMS IN PANCREATIC AND OTHER CANCERS.Presenter: Matthew Ware PhD | Baylor College of Medicine

2:30pm - 2:35pmMO 73. REPEAT CHOLECYSTECTOMY FOR THE RETAINED GALLBLADDER REMNANT: PRESENTATION AND MANAGEMENTPresenter: Seth Concors MD | University of Pennsylvania

2:40pm - 2:45pmMO 75. MELD SCORE IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH NORMAL LIVER PARENCHYMA AFTER LIVER RESECTIONPresenter: Victor Zaydfudim MD, MPH | University of Virginia

1:30pm - 2:30pmLatin American Presidents Committee MeetingCowrie 2

2:30pm - 3:30pmClinical Trials in Progress: Barriers to Prospective Trials in HPB SurgeryAmericana 1/2Moderators: Daniel E. Abbott MD | University of Wisconsin; Natalie Coburn MD, MPH | The Odette Cancer Centre

Collaborative Multicenter Trials in HBP SurgeryMichael D’Angelica MD | Memorial Sloan Kettering Cancer Center

Oslo COMET Randomized Trial: Lessons LearnedAsmund A. Fretland MD | Oslo University Hospital

Single Center Prospective Trials: Are They Worth It?Peter J. Allen MD | Memorial Sloan Kettering Cancer Center

Where Should the Funding Come From and How to Get It?Charles A. Staley MD | Emory University


AG E N DA


72

2:30pm - 3:30pmState of the Art Lecture | Of Math and MedicineAmericana 3Moderator: Hari Nathan, MD, PhD | University of Michigan

Advancing Surgical Policy and Practice Through Big DataDorry Segev MD PhD | Johns Hopkins University

2:30pm - 3:30pmBasic Translational SciencePoinciana 1/2Moderators: Ryan C. Fields MD | Washington University School of Medicine; Vikas Dudeja MD | University of Miami

Personalized Medicine in Biliary Tract CancersJason K. Sicklick MD | University of California, San Diego Moores Cancer Center

Role of CMV in Allograft Chronic RejectionSusan L. Orloff MD | Oregon Health & Science University

Hypothermic Ex Vivo Liver PerfusionJames V. Guarrera MD | Rutgers New Jersey Medical School

Novel Targets in Pancreas CancerWilliam G. Hawkins MD | Washington University in St. Louis

3:30pm - 4:00pmAfternoon Beverage Break, Exhibit & ePoster ViewingAmericana 4

4:00pm - 5:00pmLeslie H. Blumgart Historical LectureAmericana 1/2

IntroductionKaty Morgan MD | Medical University of South Carolina

A Pancreas OdysseyDavid B. Adams MD | Medical University of South Carolina


AG E N DA



5:00pm - 6:30pmWomen in Surgery | Navigating the Dual Career WatersCowrie 1/2Moderators: Rebecca M. Minter, MD | University of Wisconsin; Cristina Ferrone MD | Massachusetts General Hospital

Navigating the Tale of Two CitiesSusan L. Orloff MD | Oregon Health & Science University

The Nonportable SpouseRebekah R. White MD | University of California San Diego

HPB Training: A South American Marriage PerspectivePatricia A. Rebolledo MD | Hospital San Borja Arriaran

5:00pm - 6:30pmState of the Art Symposium | Current Management of Colorectal Liver MetastasesAmericana 3Moderators: Michael G. House MD | Indiana University School of Medicine; Felipe J. Coimbra MD | AC Camargo Cancer Center

Resectable Liver Mets - Resect or Chemo First?Rene Adam MD | Paul Brousse Hospital

Synchronous Rectal Metastasis: AlgorithmMoises Cukier MD | National Cancer Institute - Panama

Understanding Steatohepatitis and How to Tackle ItYuman Fong MD | City of Hope

Gene Sequencing, Mutations and Prediction ModelsNicholas Vauthey MD | MD Anderson Cancer Center

Current Role of HIPEC with Colorectal CancerKaitlyn J. Kelly MD | UC San Diego


AG E N DA


74

5:00pm - 5:12pmV 1. PANCREATICODUODENECTOMY WITH MESOCAVAL SHUNT FOR LOCALLY ADVANCED PANCREATIC ADENOCARCINOMAPresenter: Eve Simoneau MD, PhD | The University of Texas MD Anderson Cancer Center

5:12pm - 5:24pmV 2. LAPAROSCOPIC PUESTOW PROCEDURE AFTER OPEN WHIPPLE FOR PRIMARY PANCREATIC DUCT STONEPresenter: Armando Rosales MD | Cleveland Clinic Florida

5:24pm - 5:36pmV 3. ROBOTIC TRANSDUODENAL APPROACH TO A LARGE PERIAMPULLARY SESSILE TUBULOVILLOUS ADENOMAPresenter: Robert Simon MD | Cleveland Clinic Foundation

5:36pm - 5:48pmV 4. LAPAROSCOPIC ROUX-EN-Y LONGITUDINAL PANCREATICO-JEJUNOSTOMY FOR CHRONIC OBSTRUCTION OF THE MAIN PANCREATIC DUCTPresenter: Fabio Makdissi MD | University of Sao Paulo

5:48pm - 6:00pmV 5. PANCREATO-ENTERIC RECONSTRUCTION FOLLOWING ROBOTIC PANCREATO-DUODENECTOMY. IS ONE TYPE OF RECONSTRUCTION BETTER THAN THE OTHER?Presenter: Eduardo Fernandes MD, PhD | University of Illinois at Chicago

6:00pm - 6:12pmV 6. SUTURE-LESS BINDING PANCREATICOGASTROSTOMY : A VIDEO DEMOSTRATIONPresenter: Phani Krishna Ravula MS, MRCS, MCh | Pace hospitals

6:12pm - 6:24pmV 7. COMPLETE ENDOSCOPIC DIAGNOSIS, STAGING, AND PALLIATION OF PERIAMPULLARY MALIGNANCYPresenter: Angelena Crown MD | Virginia Mason Medical Center

6:24pm - 6:36pmInvited Video: Extended hepatectomy with IVC Replacement using Venous Bypass Presenter: Daniel Cherqui MD | Paul Brousse Hospital - Université Paris Sud

AG E N DA


5:00pm - 6:36pmVideo Session - PancreasAmericana 1/2Moderators: Matthew Weiss MD | Johns Hopkins Hospital; Sergio Lopez Torrez MD, MSc | Hospital Roberto Calderon



6:30pm - 7:00pmWomen in Surgery ReceptionCowrie Foyer

6:30pm - 7:30pmAHPBA Cocktail Reception in Exhibit HallAmericana Foyer and Americana 4

7:30pm - 10:00pmAHPBA Congress BanquetAmericana Lawn


AG E N DA


76


6:45am - 8:00amContinental Breakfast in Exhibit HallAmericana 4

7:00am - 8:00amProfessor Rounds | The Difficult Bile DuctCowrie 1/2Moderators/Speakers:

Jeffrey S. Barkun MD | McGill University Health Centre Jean C. Emond MD | Columbia University and The New York

Presbyterian Hospital

7:00am - 8:00amProfessor Rounds | Developing a Career in HPB Surgery? Chair’s PerspectivePeriwinkleModerators/Speakers:

Lynt B. Johnson MD | Medstar Georgetown University HospitalDavid C. Linehan MD | University of Rochester Medical Center Jennifer F. Tseng MD, MPH | Boston University School of Medicine

7:00am - 8:00amProfessor Rounds | Technical Pearls and Disasters During Whipple ProcedurePoinciana 1/2Moderators/Speakers:

Syed A. Ahmad MD | University of CincinnatiDouglas B. Evans MD | Medical College of Wisconsin Juan M. Sarmiento MD | Emory University

7:00am - 8:00amProfessor Rounds | Assessing Marginal Livers and How to Transplant ThemPoinciana 3/4Moderators/Speakers:

Benjamin Samstein MD | Weill Cornell Medicine Joe Tector MD, PhD | University of Alabama at BirminghamMario Vilatoba MD | Instituto Nacional de Ciencias Medicas y Nutricion


AG E N DA



7:30am - 9:00amMini Oral Sessions | Monitor 1 HPB TransplantAmericana FoyerModerator: Juan Rocca MD | Montefiore Medical Center

7:30am - 7:35amMO 76. IMPLEMENTATION OF CLINICALLY MEANINGFUL LAB PROTOCOL: UTILIZING PREDICTIVE ANALYTICS TO GUIDE QUALITY IMPROVEMENT INITIATIVES FOR PANCREATICODUODENECTOMY AND HEPATECTOMY PATIENTSPresenter: Kendra Tezber BSN, RN | Carolinas HealthCare System

7:35am - 7:40amMO 77. SAFETY OF INTRAOPERATIVE BLOOD SALVAGE DURING LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA; SYSTEMATIC REVIEW AND META-ANALYSISPresenter: Vera Rutten MBBS | Erasmus MC

7:40am - 7:45amMO 78. HIGHEST OVERALL NEUTROPHIL TO LYMPHOCYTE RATIO ON WAITING LIST PREDICTS RECURRENCE-FREE SURVIVAL IN LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMAPresenter: John McVey BA | Cleveland Clinic Foundation

7:45am - 7:50amMO 79. RECOMMENDATIONS OF AN INTERNATIONAL MULTIDISCIPLINARY COMMITTEE ON STANDARDS FOR REPORTING OUTCOMES OF TREATING BILIARY INJURIESPresenter: Steven Strasberg MD, PhD | Washington University

7:50am - 7:55amMO 80. LONG-TERM OUTCOMES OF CHANGE IN INSURANCE COVERAGE AFTER LIVER TRANSPLANTATIONPresenter: Clifford Akateh MD | The Ohio State University and Nationwide Children’s Hospital

7:55am - 8:00amMO 81. SLEEVE GASTRECTOMY DECREASES THE INCIDENCE OF METABOLIC SYNDROME IN OBESE POST-LIVER TRANSPLANT PATIENTSPresenter: Andrew Jung MD | University of Cincinnati


AG E N DA


78

8:00am - 8:05amMO 82. LIVER TRANSPLANTATION BY REFRACTORY’S ASCITES AND ITS CORRELATION WITH THE PRESENCE OF HEPATOCELLULAR CARCINOMAPresenter: Andre Gorgen MD | University of Campinas

8:05am - 8:10amMO 83. ELEVATED RED CELL DISTRIBUTION WIDTH AND OUTCOMES IN ADVANCED STAGE HCC AT LIVER TRANSPLANTPresenter: Jacentha Buggs MD | Tampa General Hospital

8:10am - 8:15amMO 84. LIVER SIZE MISMATCH IN DECEASED DONOR LIVER TRANSPLANTATIONPresenter: Jacentha Buggs MD | Tampa General Hospital

8:15am - 8:20amMO 85. WHEN OBSERVED DOES NOT GO AS EXPECTED: DEVASTATING TRAJECTORIES IN HEPATOBILIARY SURGERYPresenter: Lindsay Gil BS, BA | Loyola University Medical Center

8:20am - 8:25amMO 86. BILIARY COMPLICATIONS AFTER PEDIATRIC LIVER TRANSPLANTATIONPresenter: Adeel Khan MD, MPH | Washington University

8:30am - 8:35amMO 88. ASSOCIATION BETWEEN DONOR HYPERNATREMIA AND LIVER TRANSPLANT GRAFT FUNCTIONPresenter: Carlos Florez-Zorrilla MD | Centro Medico Nacional

8:35am - 8:40amMO 89. THE EFFECT OF DONOR RACE-MATCHING ON OVERALL SURVIVAL FOR AFRICAN AMERICAN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMAPresenter: Jack Silva BS | Medical College of Wisconsin


AG E N DA



8:40am - 8:45amMO 90. SURVIVAL AND HCC RECURRENCE AFTER LIVER TRANSPLANT DUE TO NASH RELATED HCC VS. NON-NASH RELATED HCCPresenter: Julio Sokolich M.D. | Tampa General Hospital

8:45am - 8:50amMO 91. INCISIONAL HERNIA AFTER LIVER TRANSPLANTATIONPresenter: Heidy Cos MD | Washington University

8:50am - 8:55amMO 92. LAPAROSCOPIC FREY PROCEDURE. WHAT ARE THE POTENTIAL CONTRAINDICATIONS ?Presenter: Roman Izrailov MD | Moscow Clinical Scientific Centre

8:55am - 9:00amMO 93. DISTAL PANCREATECTOMY FOR PANCREATITIS: DIVERSE DISEASE WITH DISMAL OUTCOMESPresenter: William Lancaster MD | Medical University of South Carolina

7:30am - 9:00amMini Oral Sessions | Monitor 2 HCCAmericana FoyerModerator: Shawn Pelletier MD | University Of Virginia Health System

7:30am - 7:35amMO 94. OUTCOMES FOLLOWING TRANSARTERIAL EMBOLIZATION FOR HEPATOCELLULAR CARCINOMA WITH COMPLETE RADIOLOGIC RESPONSEPresenter: Michele Babicky MD | Memorial Sloan Kettering Cancer Center

7:35am - 7:40amMO 95. A COMPARISON OF PRESENTATION AND OUTCOME IN PATIENTS WITH HEPATOCELLULAR CANCER FROM NONALCOHOLIC STEATOHEPATITIS AND VIRAL HEPATITIS ETIOLOGIESPresenter: Caitlin Hester MD | University of Texas Southwestern

7:40am - 7:45amMO 96. CONDITIONAL PROBABILITY OF SURVIVAL IN PATIENTS WITH SPONTANEOUS TUMOR RUPTURE ON HEPATOCELLULAR CARCINOMA AFTER PARTIAL HEPATECTOMY: A PROPENSITY SCORE MATCHING ANALYSISPresenter: Qian Zhu MD, PhD | Zhongda Hospital


AG E N DA


80

7:45am - 7:50amMO 97. OPTIMIZING CANCER CARE FOR HEPATOCELLULAR CARCINOMA AT A SAFETY-NET HOSPITAL: THE VALUE OF A MULTIDISCIPLINARY DISEASE MANAGEMENT TEAMPresenter: Grace Duininck BA | Emory University

7:50am - 7:55amMO 99. GENDER DIFFERENCES IN HEPATOCELLULAR CANCER: SHOULD FEMALES WITH NONALCOHOLIC FATTY LIVER DISEASE AND STEATOHEPATITIS UNDERGO SURVEILLANCE FOR HEPATOCELLULAR CANCER?Presenter: Eric Wu BS | John A. Burns School of Medicine, University of Hawaii at Manoa

7:55am - 8:00amMO 100. INVESTIGATING THE BREATH METABOLOME AS A DIAGNOSTIC TOOL FOR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTSPresenter: Lou-Anne Acevedo-Moreno MD | Cleveland Clinic Foundation

8:00am - 8:05amMO 101. RISK FACTORS FOR VERY EARLY RECURRENCE OF HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE REVIEWPresenter: Robert Simon MD | Cleveland Clinic Foundation

8:05am - 8:10amMO 102. UNRAVELLING THE COMPLEXITY MYTH FOR LAPAROSCOPIC RIGHT HEPATECTOMYPresenter: Salila Hashmi MD | Emory University

8:10am - 8:15amMO 103. SELECTIVE LYMPH NODE SAMPLING IN RESECTABLE HEPATOCELLULAR CARCINOMA: NATIONAL PRACTICE PATTERNS AND NODE POSITIVITY RATESPresenter: Andrew Lee MD, PhD | The University of Texas MD Anderson Cancer Center

8:15am - 8:20amMO 104. SOCIOECONOMIC FACTORS INCLUDING RACE INCREASE ODDS OF LATE STAGE DIAGNOSIS OF HCCPresenter: Marco Aru MS | University of Mississippi Medical Center


AG E N DA



8:20am - 8:25amMO 105. OUTCOMES AND PREDICTORS OF MORTALITY AFTER LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA WITH MACROVASCULAR INVASION: A COHORT STUDYPresenter: Andre Gorgen MD | University Health Network, Toronto General Hospital

8:25am - 8:30amMO 106. A REAL-WORLD APPLICATION OF YTTRIUM90 TRANSARTERIAL RADIOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMAPresenter: Kliment Bozhilov MD | John A. Burns School of Medicine, University of Hawaii at Manoa

8:30am - 8:35amMO 107. IMPLICATIONS OF UNPLANNED CONVERSION TO AN OPEN PROCEDURE DURING LAPAROSCOPIC LIVER RESECTION FOR HEPATOCELLULAR CARCINOMAPresenter: Zachary Stiles DO | University of Tennessee Health Science Center

8:35am - 8:40amMO 109. REGIONAL UTILIZATION OF SURGERY AND SURVIVAL IN PATIENTS WITH EARLY STAGE HEPATOCELLULAR CARCINOMAPresenter: Grace Lee MD | Massachusetts General Hospital

8:40am - 8:45amMO 110. PREDICTION OF MICROVASCULAR INVASION OF HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANTATION USING QUANTITATIVE PARAMETERS IN DYNAMIC COMPUTED TOMOGRAPHY.Presenter: Elaine Ataide PhD | University of Campinas

8:45am - 8:50amMO 111. SURGICAL RESECTION OF HEPATOCELLULAR CARCINOMA IN THE CIRRHOTIC PATIENT: ANATOMIC VERSUS NON-ANATOMIC RESECTION?Presenter: Anthony Scholer MD, MBS | Rutgers University


AG E N DA


82

7:30am - 9:00amMini Oral Sessions | Monitor 3 HPB Education CostAmericana FoyerModerator: M.B. Majella Doyle MD, MBA | Washington University

7:30am - 7:35amMO 112. THE LATIN AMERICAN HPB CONSORTIUM OF EDUCATION AND RESEARCH (LAHCER): A PILOT SURVEY OF HEPATOPANCREATOBILIARY TRAINING IN LATIN AMERICAPresenter: Ismael Dominguez Rosado MD, MSc | Instituto Nacional de Ciencias Médicas y Nutrición, Hospital Italiano de Buenos Aires, Hospital General de México, Corporación Médica Monte Sinai, Hospital Das Clnicas FMUSP, Hospital A Beneficiencia Portugues

7:35am - 7:40amMO 113. WHAT DO HPB FELLOWS EXPECT OF THEIR TRAINING: A SURVEY OF INCOMING HPB FELOWS AT THE BEGINNING OF THEIR FELLOWSHIP.Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center

7:40am - 7:45amMO 114. IMPLEMENTING QUALITY ASSURANCE FOR PANCREATIC CANCER WITHIN AN INTEGRATED HEALTH SYSTEMPresenter: Daniel Solomon MD | Icahn School of Medicine at Mount Sinai

7:45am - 7:50amMO 115. THE ADHERENCE TO CHOLECYSTECTOMY TIMING GUIDELINES AND ITS EFFECT ON HEALTHCARE AND PATIENT CENTERED OUTCOMESPresenter: Nourah Al-Beeshi | King Saud University

7:50am - 7:55amMO 116. PATIENT-SPECIFIC PREDICTORS OF FAILURE TO RESCUE AFTER MAJOR HEPATECTOMYPresenter: Elizabeth Gleeson MD, MPH | Lewis Katz School of Medicine at Temple University


AG E N DA



7:55am - 8:00amMO 117. TAILORED MULTISTAGE MINIMALLY INVASIVE MANAGEMENT OF RESECTABLE STAGE IV COLORECTAL CANCER OFFERS OPTIMAL POSTOPERATIVE OUTCOMES AND LONG-TERM SURVIVAL: A PROPENSITY-SCORE WEIGHTING ANALYSISPresenter: Claire Goumard MD | The University of Texas MD Anderson Cancer Center

8:00am - 8:05amMO 118. EFFICACY AND LIMITATIONS OF 68-GALLIUM DOTATATE PET/CT FOR NEUROENDOCRINE TUMORS: CLINICAL EXPERIENCE FOLLOWING FDA APPROVALPresenter: Ryan Griffith MD | Saint Joseph Hospital

8:05am - 8:10amMO 119. THE BENEFIT OF MINIMALLY INVASIVE PANCREATICODUODENECTOMY ON ENHANCED RECOVERY IS RESTRICTED TO PATIENTS WHO AVOID POSTOPERATIVE COMPLICATIONS: A NSQIP ANALYSISPresenter: Dominic Sanford MD, MPHS | Washington University

8:10am - 8:15amMO 120. DISTAL PANCREATECTOMY WITHOUT INTRAPERITONEAL DRAINAGE: A COST-EFFECTIVE ALTERNATIVE TO ROUTINE DRAINAGE.Presenter: Felipe Maegawa MD, MS | Southern Arizona VA Health Care System/ University of Arizona

8:15am - 8:20amMO 121. ELDERLY DISPARITIES IN UTILIZATION AND ACCESS TO TECHNOLOGY IN AN URBAN HEPATOPANCREATOBILIARY SURGICAL PRACTICEPresenter: John Hardaway MD, PhD | Roger Williams Medical Center

8:20am - 8:25amMO 122. COMPARATIVE OUTCOMES OF EARLY AND STANDARD DISCHARGE IN PATIENTS UNDERGOING PANCREATODUODENECTOMYPresenter: Gautam Sharma MD | Cleveland Clinic Foundation


AG E N DA


84

8:25am - 8:30amMO 123. ACADEMIC RANK IN HEPATOPANCREATICOBILIARY SURGEONS: IDENTIFYING BENCHMARKSPresenter: Amit Khithani MD | City of Hope Cancer Center

8:30am - 8:35amMO 124. RISK FACTORS FOR 30 DAY READMISSION RATES AFTER HEPATECTOMY AND PANCREATECTOMY FOR BENIGN DISEASE, AN ACS NSQIP DATABASE REVIEW.Presenter: Cara Lyle MD | West Virginia University

8:35am - 8:40amMO 125. INTEREST IN CAREER IN HEPATOPANCREATOBILIARY SURGERY AND DIFFERENCES BY GENDER IN CHILEAN GENERAL SURGERY RESIDENTS -RESULTS OF A NATIONAL SURVEYPresenter: Diego Garcia MD | Hospital San Borja Arriaran

8:40am - 8:45amMO 126. POST-HOC VIDEO REVIEW OF ROBOTIC PANCREATICODUODENECTOMY TO PREDICT CIRCUMFERENTIAL MARGIN POSITIVITY IN PANCREATIC ADENOCARCINOMAPresenter: Brian Boone MD | University of Pittsburgh

8:45am - 8:50amMO 127. PREDICTION ON SURGICAL OUTCOMES OF VIDEOLAPAROSCOPIC CHOLECYSTECTOMY IN ELDERLY PATIENTS USING COMORBIDITY COMBINED SCOREPresenter: Vitor Carminatti Romano MS | Hospital das Clinicas of University of Sao Paulo

8:50am - 8:55amMO 128. OUTCOME OF 164 PATIENTS WITH IATROGENIC BILIARY STRICTURE SUBMITTED TO SURGICAL REPAIR IN A SPECIALIZED CENTERPresenter: Estela Figueira MD, PhD | Hospital das Clinicas of University of Sao Paulo

8:55am - 9:00amMO 129. DOES FELLOW LEVEL OF TRAINING IMPACT OUTCOMES AFTER DECEASED DONOR LIVER TRANSPLANTATION?Presenter: Sandra Garcia-Aroz MD | Washington University


AG E N DA



7:30am - 9:15amMini Oral Sessions | Monitor 4 PancreasAmericana FoyerModerator: Alexander Parikh MD, MPH | University of South Carolina, Greenville

7:30am - 7:35amMO 130. LAPAROSCOPIC TRANSGASTRIC NECROSECTOMY REDUCES RE-INTERVENTION AND MORBIDITY COMPARED TO OPEN NECROSECTOMYPresenter: Patrick Worth MD | Stanford University

7:35am - 7:40amMO 131. A SINGLE INSTITUTION’S FIRST 100 ROBOTIC PANCREATICODUODENECTOMIES: A PRODUCT OF THE INEVITABLE SHIFT TOWARDS MINIMALLY INVASIVE SURGERYPresenter: Alexander Rosemurgy MD | Florida Hospital, Tampa

7:40am - 7:45amMO 132. PANCREATODUODENECTOMY IN THE CIRRHOTIC PATIENT: PREDICTORS OF OUTCOME.Presenter: James Butler MD, PhD | Indiana University

7:45am - 7:50amMO 133. RISK FACTORS FOR DEVELOPING DEEP VENOUS THROMBOSIS & PULMONARY EMBOLISM IN PATIENTS UNDERGOING PANCREATICODUODENECTOMYPresenter: Casey Allen MD | University of Miami Miller School of Medicine

7:50am - 7:55amMO 134. EXPERIENCE OF 215 TOTALLY LAPAROSCOPIC PANCREATODUODENECTOMIESPresenter: Magomet Baychorov MD | Moscow Clinical Scientific Centre

7:55am - 8:00amMO 135. INITIAL REPORTING OF OVERALL SURVIVAL OF THE AHPBA PANCREATIC REGISTRYPresenter: Robert CG Martin MD, PhD | University of Louisville School of Medicine


AG E N DA


86

8:00am - 8:05amMO 136. DOES DRAIN SUCTION INFLUENCE THE INCIDENCE OF CLINICALLY RELEVANT POSTOPERATIVE PANCREATIC FISTULAPresenter: Jason Liu MD, MS | Lewis Katz School of Medicine at Temple University

8:05am - 8:10amMO 137. LAPAROSCOPIC VERSUS ROBOTIC-ASSISTED LEFT PANCREATECTOMY FOR ADENOCARCINOMA AT A HIGH VOLUME, MINIMALLY INVASIVE CENTERPresenter: William Lyman MD | Carolinas HealthCare System

8:10am - 8:15amMO 138. OPEN PANCREATIC DÉBRIDEMENT: CONTEMPORARY OUTCOMES IN CHANGING TIMESPresenter: Thomas Maatman MD | Indiana University

8:15am - 8:20amMO 139. COMPLIANCE WITH ERAS PROTOCOLS IMPROVES OVERALL AND DISEASE FREE SURVIVAL AFTER PANCREATICODUODENECTOMYPresenter: Michael Passeri MD | Carolinas HealthCare System

8:20am - 8:25amMO 140. ANTIPLATELET THERAPY AFTER PANCREATICODUODENECTOMY WITH PORTAL VEIN RESECTION MAY BE THE OPTIMAL ANTICOAGULANTPresenter: Amit Sastry MD | Carolinas HealthCare System

8:25am - 8:30amMO 141. IMPROVED MORTALITY AFTER PANCREATECTOMY IN THE MODERN ERAPresenter: Michael Lidsky MD | Memorial Sloan Kettering Cancer Center

8:30am - 8:35amMO 142. PREOPERATIVE PANCREATIC GLAND RADIODENSITY PREDICTS LEAKS IN DISTAL PANCREATECTOMY, BUT NOT PANCREATICODUODENECTOMY.Presenter: Patrick Worth MD | Oregon Health and Sciences University


AG E N DA



8:35am - 8:40amMO 143. EARLY VERSUS LATE DRAIN REMOVAL AFTER WHIPPLE PROCEDUREPresenter: Konstantinos Zorbas MD | Lewis Katz School of Medicine at Temple University Hospital

8:40am - 8:45amMO 144. DIFFERENCES IN THE PATTERN AND TIMING OF RECURRENCE IN PATIENTS AFTER UPFRONT OR POST-NEOADJUVANT PANCREATECTOMY FOR PANCREATIC DUCTAL ADENOCARCINOMAPresenter: Vincent P. Groot MD | Johns Hopkins University School of Medicine

8:45am - 8:50amMO 145. PATIENTS OVER AGE 70 AT HIGHER RISK FOR PERIOPERATIVE COMPLICATIONS AFTER DISTAL PANCREATECTOMY FOR NEUROENDOCRINE AND CYSTIC NEOPLASMSPresenter: Rajesh Ramanathan MD | Virginia Commonwealth University Medical Center

8:50am - 8:55amMO 146. TRAVEL DISTANCE AFFECTS RATES AND REASONS FOR READMISSION AFTER PANCREATECTOMYPresenter: Rachel Simpson MD | Indiana University

8:55am - 9:00amMO 147. THE LONG-TERM OUTCOMES OF RADICAL PANCREATOSPLENECTOMY FOR PATIENTS WITH DISTAL PANCREATIC ADENOCARCINOMAPresenter: Genki Watanabe MD | Cancer Institute Hospital, Japanese Foundation for Cancer Research

9:00am - 9:05amMO 148. DABIGATRAN (PRADAXA) IS SAFE FOR EXTENDED VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER PANCREATIC ONCOLOGIC SURGERYPresenter: M. Farzan Rashid BS | Columbia University


AG E N DA


88

9:05am - 9:10amMO 149. THE IMPACT OF TUMOR DIFFERENTIATION ON PERIOPERATIVE OUTCOMES AND PATTERNS OF RECURRENCE FOLLOWING PREOPERATIVE THERAPY FOR RESECTABLE PANCREATIC ADENOCARCINOMAPresenter: James Lindberg MD | The University of Texas MD Anderson Cancer Center

9:10am - 9:15amMO 150. PREOPERATIVE IMAGING CHARACTERISTICS PREDICT POOR SURVIVAL AND INADEQUATE RESECTION FOR LEFT-SIDED PANCREATIC ADENOCARCINOMA: A MULTI-INSTITUTIONAL ANALYSISPresenter: Farzad Alemi MD | Virginia Mason Medical Center

8:00am - 9:00amState of the Art International Symposium | ALPPS for CancerAmericana 1/2Moderators: William C. Chapman MD | Washington University School of Medicine; Javier C. Lendoire MD, PhD | Hospital Dr C Argerich

Colorectal MetastasesRoberto Hernandez-Alejandro MD | University of Rochester

Transplantation After “Failed” ALPPSPierre-Alain Clavien MD PhD | University Hospital Zurich

Laparoscopic VersionMarcel Machado MD | University of Sao Paulo

8:00am - 9:00amOral Presentations 4: Pancreas IIPoinciana 1/2Moderators: Claudemiro Quireze Jr MD, PhD | Federal University of Goiás; Stephen Behrman MD | University of Tennessee Heath Science Center

8:00am - 8:12am26. CALCIFICATIONS AND CYSTIC MORPHOLOGY ON PREOPERATIVE IMAGING PREDICT SURVIVAL AFTER RESECTION OF PANCREATIC NEUROENDOCRINE TUMORSPresenter: Eleftherios Makris MD, PhD | Stanford University Invited Discussant: Sameer Patel MD | University of Cincinnati Medical Center


AG E N DA



8:12am - 8:24am27. CAN HIGH-VOLUME ANESTHESIOLOGISTS DECREASE PERIOPERATIVE COSTS FOR PANCREATIC SURGERY?Presenter: Abhineet Uppal MD | John Wayne Cancer Institute Invited Discussant: Federico Aucejo MD | Cleveland Clinic

8:24am - 8:36am28. TUMOR LOCATION PREDICTS PRESENCE OF HIGH GRADE DYSPLASIA AND INVASIVE CARCINOMA IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREASPresenter: Stephanie Kerlakian BS | University of Cincinnati Invited Discussant: Melissa Hogg MD, MS | UPMC

8:36am - 8:48am29. ROBOTIC PANCREATODUODENECTOMY WITH VASCULAR RESECTION: HOW STEEP IS THE LEARNING CURVE?Presenter: Joal Beane MD | University of Pittsburgh Medical Center Invited Discussant: Mike Kendrick MD | Mayo Clinic Rochester

8:48am - 9:00am30. SELECTIVE PANCREATIC STENTING AND RECTAL INDOMETHACIN IN HIGH-RISK ERCP PATIENTS RESULTS IN SIGNIFICANT DECREASE IN POST-ERCP PANCREATITISPresenter: Wesley Jones MD | University of South Carolina School of Medicine, Greenville Invited Discussant: Alex Rosemurgy MD | University of Central Florida, Florida Hospital Tampa

8:00am - 9:00amOral Presentations 5: LiverPoinciana 3Moderators: Sukru H. Emre MD | Yale School of Medicine; Abhishek Mathur MD | Ochsner Clinic

8:00am - 8:12am31. IN PATIENTS UNDERGOING HEPATIC RESECTION, IS THE LIVER SURGERY COMPLEXITY SCORE A BETTER PREDICTOR OF CASE COMPLEXITY AND POSTOPERATIVE MORBIDITY THAN THE CONVENTIONAL MAJOR/MINOR CLASSIFICATION?Presenter: Mohammed Al-Temimi MD, MPH | Kaiser Permanente, Los Angeles Medical Center Invited Discussant: David Levi MD | Carolinas Medical Center


AG E N DA


90

8:12am - 8:24am32. IMPROVED PERFORMANCE WITH MINIMALLY INVASIVE LIVER RESECTION: A SINGLE CENTER WESTERN EXPERIENCE WITH 1,062 CASESPresenter: Forat Swaid MD | University of Pittsburgh Medical Center Invited Discussant: Joseph Buell MD, MBA | Tulane University

8:24am - 8:36am33. A MULTI-INSTITUTIONAL ANALYSIS OF MINIMALLY INVASIVE LIVER RESECTIONSPresenter: Alison Smith MD, PhD | Tulane University School of Medicine; Carolinas Medical Center; City of Hope Invited Discussant: Sean Cleary MD, MSC, MPH | Mayo Clinic

8:36am - 8:48am34. STANDARDIZATION OF OPERATIVE TECHNIQUE IN LAPAROSCOPIC RIGHT HEPATECTOMY: IMPROVING COST-VALUE RELATIONSHIP THROUGH VALUE STREAM MAPPINGPresenter: Mohammad Raheel Jajja MD | Emory University Invited Discussant: Clancy Clark MD | Wake Forest Baptist Health

8:48am - 9:00am35. MULTIDISCIPLINARY, PERIOPERATIVE CARE BUNDLE DECREASES SURGICAL SITE INFECTION IN PATIENTS UNDERGOING SYNCHRONOUS COLORECTAL/LIVER RESECTIONPresenter: Lauren Tufts BA | Memorial Sloan Kettering Cancer Center Invited Discussant: Susanne Warner MD | City of Hope Comprehensive Cancer Center

9:00am - 10:00amBetty & Henry Pitt Quality OrationAmericana 1/2

IntroductionTimothy Pawlik, MD, MPH, PhD | The Ohio State University

Achieving Surgical Quality: Observations from the American College of SurgeonsClifford Y. Ko MD, MS, MSHS, FACS, FASCRS | University of California-Los Angeles/American College of Surgeons

10:00am - 10:30amMorning Beverage Break, Exhibit & ePoster ViewingAmericana Foyer


AG E N DA



10:30am - 12NoonASTS/AHPBA Joint Symposium: Multidisciplinary Management of HCCAmericana 1/2Moderators: Christopher J. Sonnenday MD, MHS | University of Michigan; Wellington Andraus MD, PhD | Sao Paulo University School of Medicine

Resect When You CanCristina Ferrone MD | Massachusetts General Hospital

Why Resect When You Can Ablate?David A. Iannitti MD | Carolinas HealthCare System

Effectiveness of Liver Directed TherapyRiad Salem MD, MBA | Northwestern University

Downstage and Then TransplantMaria B. Doyle MD, MBA | Washington University School of Medicine

Case Presentations

10:30am - 12:00pmLocally Advanced Pancreatic CancerAmericana 3Moderators: Syed A. Ahmad MD | University of Cincinnati Medical Center; Andre Montagnini MD | Universidade de Sao Paulo, Brazil

Treatment Sequencing for Borderline and Locally Advanced DiseaseMatthew Katz MD | UT MD Anderson Cancer Center

Novel Vascular Reconstruction TechniquesMark J. Truty MD, MS | Mayo Clinic

Can Systematic Therapy Downstage Patients?Davendra Sohal, MD | Cleveland Clinic

Role of Radiation for Borderline and Locally Advanced DiseaseJoseph M. Herman MD | University of Texas MD Anderson Cancer Center

Role for IRERobert Martin MD, PhD | University of Louisville


AG E N DA


92

10:30am - 12:00pmVideo Session HPBCowrie 1/2Moderators: Karim Halazun MD | Weill Cornell Medicine; Eduardo Montalvo-Jave MD, PhD | Hospital General de Mexico

10:30am - 10:42amV 8. LAPAROSCOPIC RESECTION OF CAUDATE LOBE. TECHNICAL STRATEGIES FOR A DIFFICULT LIVER SEGMENTPresenter: Marcel Autran Machado MD | University of Sao Paulo

10:42am - 10:54amV 9. FULLY ROBOTIC LEFT HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA IN A PATIENT WITH HEPTAITIS B CIRRHOSISPresenter: Karim Halazun MD | Weill Cornell Medicine

10:54am - 11:06amV 10. LAPAROSCOPIC RIGHT HEPATECTOMY FOR COMPLEX BILIARY INJURY AFTER LAPAROSCOPIC CHOLECYSTECTOMYPresenter: Marcel Autran Machado MD | University of Sao Paulo

11:06am - 11:18amV 11. LEFT HEMIHEPATECTOMY WITH THROMBECTOMY FROM INFERIOR VENA CAVA AND RIGHT ATRIUM UNDER CARDIOPULMONARY BYPASS IN PATIENT WITH HEPATOCELLULAR CARCINOMAPresenter: Ruslan Alikhanov MD, PhD | Moscow Clinical Scientific Center

11:18am - 11:30amV 12. LAPAROSCOPIC RIGHT CAUDATE LOBE MASS RESECTIONPresenter: Benjamin Farber MD | Montefiore Medical Center/Albert Einstein College of Medicine

11:30am - 11:42amV 13. LAPAROSCOPIC EXTENDED POSTERIOR SECTORECTOMY FOR METASTATIC ADRENOCORTICAL CARCINOMA: A MINIMALLY INVASIVE APPROACH TO PARENCHYMAL PRESERVATIONPresenter: Michael Lidsky MD | Memorial Sloan Kettering Cancer Center

11:42am - 11:54amV 14. INTERCOSTAL AND GLISSONIAN PEDICLE APPROACH IN LAPAROSCOPIC LIVER RESECTION FOR BILOBAR TUMORSPresenter: Tadahiro Uemura MD, PhD | Alleghey Health Network


AG E N DA



10:30am - 12:00pmOral Presentations 6: Large DatabasesPoinciana 1/2Moderators: Flavio Paterno MD, MPH | University of Cincinnati; Tun Jie MD | University of Arizona

10:30am - 10:42am36. ANATOMICAL HEPATIC RESECTION VERSUS WEDGE RESECTION FOR GALLBLADDER CANCER: ANALYSIS OF MULTI-CENTER DATABASEPresenter: Mohammed Al-Temimi MD, MPH | Kaiser Permanente, Los Angeles Medical Center Invited Discussant: Mariano Gimenez MD, PhD | University of Buenos Aires

10:42am - 10:54am37. WOUND PROTECTORS MITIGATE SUPERFICIAL SURGICAL SITE INFECTIONS AFTER PANCREATODUODENECTOMYPresenter: Jason Liu MD, MS | Lewis Katz School of Medicine at Temple University Invited Discussant: Chad Ball MD, MSC | University of Calgary

10:54am - 11:06am38. DEFINING A LIVER TRANSPLANT BENEFIT THRESHOLD FOR MODEL FOR END STAGE LIVER DISEASEPresenter: Eliza W. Beal MD | The Ohio State University Invited Discussant: Peter Kim MD | University of British Columbia

11:06am - 11:18am39. LIFE EXPECTANCY AFTER PANCREATIC CANCER RESECTION, ACCORDING TO HOSPITAL OPERATIVE MORTALITYPresenter: Mustafa Raoof MD, MS | City of Hope Cancer Center Invited Discussant: Shishir Maithel MD | Emory University

11:18am - 11:30am40. ANALYSIS OF OUTCOME OF OPEN AND MINIMAL INVASIVE PANCREATICODUODENECTOMY USING NSQIP.Presenter: Hassan Aziz MD | Banner University Medical Center Invited Discussant: Sharona Ross MD | Florida Hospital, Tampa

11:30am - 11:42am41. PANCREATECTOMY AND BODY MASS INDEX: AN INTERNATIONAL EVALUATION OF CUMULATIVE POSTOPERATIVE COMPLICATIONS USING THE COMPREHENSIVE COMPLICATIONS INDEXPresenter: Brendan Lovasik MD | Emory University Invited Discussant: Margo Shoup, MD | Northwestern Medicine


AG E N DA


94

11:42am - 11:54am42. LOCAL REFERRAL OF PANCREATECTOMY PATIENTS TO IMPROVE SURGICAL QUALITYPresenter: Margaret Smith MD | University of Michigan Invited Discussant: Matthew Katz MD | University of Texas, MD Anderson Cancer Center

12:00pm - 12:30pmIndustry Lunch Symposium - Thank you BTGPoinciana 3/4

12:00pm - 12:30pmLunch in Exhibit HallAmericana 4

12:30pm - 2:00pmFellows JeopardyAmericana 1/2

12:30pm - 2:00pmOptimal Margins in HPB MalignancyAmericana 3Moderators: David Kooby MD | Emory University; Carlos Chan MD | National Institute of Medical Sciences

Pancreas Cancer: Margin is CriticalChristopher L. Wolfgang MD, PhD | Johns Hopkins

Pancreas Cancer: Margin Doesn’t MatterDavid Kooby MD | Emory University

IPMN: Need a Negative MarginGiuseppe Malleo MD, PhD | Unit of General and Pancreatic Surgery,

University of Verona Hospital Trust

IPMN: Less is MoreNipun B. Merchant MD | University of Miami Hospital

Colorectal Liver Mets: 1cm is mandatoryFlavio G. Rocha MD | Virginia Mason Medical Center

Colorectal Liver Mets: 1mm is FineJuan C. Sabogal MD, MSc | Mederi Hospital and San Ignacio Hospital


AG E N DA



12:30pm - 2:00pmFellows JeopardyAmericana 1/2Moderator: Shishir K. Maithel MD | Emory University

12:30pm – 2:00pmConsensus Conference | The Role of Somatostatin Analogues in Pancreas SurgeryPoinciana 1/2Moderator: John Mansour MD | University of Texas Southwestern Medical Center

Audience ParticipationAjay Maker MD | University of Illinois at Chicago

IntroductionJohn Mansour MD | University of Texas Southwestern Medical Center

Delphi Process MethodsNatalie Coburn MD | The Odette Cancer Centre

State of the LiteratureCharles St. Hill MD | UNLV School of Medicine

Initial Survey DesignSusanne Warner MD | City of Hope

The Consensus ProcessQuan Ly MD | University of Nebraska Medical Center

Final Survey Results and Consensus StatementsClifford Cho MD | University of Michigan Medical School

Audience ParticipationAjay Maker MD | University of Illinois at Chicago

Discussion

Lessons Learned and Future Plans for AHPBA Consensus Conference John Mansour MD | University of Texas Southwestern Medical Center


AG E N DA


96

1:00pm - 5:15pmAPP SymposiumCowrie 1/2Moderator: Jenna L. Jeganathan PA-C | Cleveland Clinic; Mary Beth Henry RN, MS, CS, APNP | University of Wisconsin

1:00pm – 3:00pm Pancreas Cyst RegistryLan P. Vu PA-C | UT Southwestern Medical Center

Radiology for the HPB APPJennifer A. Flood ANP-NC | Memorial Sloan Kettering Cancer Center

Choledochal CystsTanya Kintz DNP, FNP-BC, HNB-BC, AOCNP | Henry Ford Hospital

The Role of the APP in the Care of Liver Transplant PatientsLacey Bittel PA-C | University of Cincinnati Medical Center

3:00pm - 3:30pmAfternoon Beverage BreakAmericana Foyer

3:30pm – 5:15pmDVT ProphylaxisCaitlin Brown NP | University of Pennsylvania

Quick Shot: GDA Bleeding after IRE Treatment of Locally-Advanced Pancreatic CancerNathan Ogilvie PA-C | Wake Forest Baptist Medical Center

Quick Shot: Pancreatitis…What Lies Beneath?Veronica L. Coleman MPAS, PA-C | UT Southwestern Medical Center

Quick Shot: Reducing Cost in HealthcareMorgan L. Bruno ACNP-BC | UT MD Anderson Cancer Center

Quick Shot: Locally Advanced Pancreatic Cancer and (IRE) Irreversible ElectroporationSarah Reed MHS, PA-C | Duke University

Quick Shot: Nurse Navigation: An Important Aspect of Multidisciplinary Care for Hepatopancreaticobiliary Cancer PatientsAlyssa J. Chapates BSN, RN, OCN | Methodist Richardson Cancer Center

Keynote Address: Improving the Patient ExperienceEmily R. Winslow MD, MS | University of Wisconsin


AG E N DA



Panel Discussion: Role of Co-Management of Patients with APP and Surgeon - Which Model Works Best?

HCAHPs Scores/Patient’s Experience Scores - Do They Correlate with Better Outcomes?

Patient Coordination/Negotiating Multidisciplinary Care

Interesting Cases to Underscore Collaborative Practice

Panelists: Ashley H. Seawright DNP, ACNP-BC | University of Mississippi Medical Center; Cherese Lofton, RN | Cleveland ClinicLindsey Manos DHSc, PA-C | Johns Hopkins Hospital; Ann Parker CRNP | George Washington University Hospital

2:00pm - 3:00pmPresidential Invited LectureAmericana 1/2

IntroductionRebecca M. Minter MD | University of Wisconsin

The Diversity Bonus: How Cognitive and Identity Diversity Improve OutcomesScott E. Page | University of Michigan

3:00pm - 3:30pmAfternoon Beverage BreakAmericana Foyer

3:30pm - 5:00pmBusiness of HPB Surgery: Why It’s Worth ItAmericana 3Moderators: Bryan M. Clary MD, MBA | UC San Diego; Mark S. Talamonti MD | NorthShore University HealthSystem

Creation and Revenue of an HPB UnitMelissa Hogg MD MS | University of Pittsburgh Medical Center

Assessing Value and Compensation for HPB SurgeonsCharles R. Scoggins MD, MBA | University of Louisville

Benefits of a Liver Transplant ProgramChristopher D. Anderson MD | University of Mississippi of Medical Center

Building Volume, Growth, and Revenue Through Multidisciplinary ClinicsRichard Schulick MD, MBA | University of Colorado School of Medicine

Is It Worth It? Chair’s PerspectiveKeith D. Lillemoe MD | Massachusetts General Hospital


AG E N DA


98

3:30pm - 5:00pmChanging Paradigm of Necrotizing PancreatitisAmericana 1/2Moderators: Nicholas J. Zyromski MD | Indiana University School of Medicine; Richard M. Charnley MD | Freeman Hospital

Frame the IssueNicholas J. Zyromski MD | Indiana University School of Medicine

GI PerspectiveGregory A. Cote MD, MS | Medical University of South Carolina

Percutaneous Approach / Step UpRajesh Gupta MD | Postgraduate Institute of Medical Education and Research

Surgical Approach: Open NecrosectomyJessica L. Cioffi MD | University of Florida

Surgical Approach: Minimally Invasive ApproachesChad G. Ball MD, MSC | University of Calgary

3:30pm - 5:00pmOral Presentations 7: Basic SciencePoinciana 1/2Moderators: Allan Tsung MD | University of Pittsburgh Medical Center; Juan Sanabria MD, MSc | Marhsall University

3:30pm - 3:42pm43. CD73 AS A NOVEL IMMUNE TARGET AND BIOMARKER IN PANCREATIC ADENOCARCINOMAPresenter: Nouredin Messaoudi MD | Centre hospitalier de l’Université de Montréal Invited Discussant: Jordan Cloyd MD | The Ohio State University

3:42pm - 3:54pm44. COLLAGEN TARGETED MRI ACCURATELY MEASURES THE DESMOPLASTIC RESPONSE TO FOLFIRINOX TREATMENT IN A MURINE MODEL OF PANCREATIC CANCERPresenter: Derek Erstad MD | Massachusetts General Hospital, Harvard Medical School Invited Discussant: Williams Hawkins MD | Washington University


AG E N DA



3:54pm - 4:06pm45. INDUCTION OF PD-L1 EXPRESSION IN PANCREATIC TUMOR MICROENVIRONMENT BY IFN-Y: RATIONALE FOR PD-L1 THERAPY COMBINATION WITH IRREVERSIBLE ELECTROPORATION THERAPYPresenter: Young Hong MD | University of Louisville School of Medicine Invited Discussant: Ryan Fields MD | Washington University

4:06pm - 4:18pm46. LOCAL VERSUS CIRCULATING IMMUNE CELL POPULATIONS IN PANCREATIC DUCTAL ADENOCARCINOMA PATIENTSPresenter: Michael Gerber MD | University of Florida Invited Discussant: Motaz Qadan MD, PhD | Massachusetts General Hospital

4:18pm - 4:30pm47. CHANGE IN CIRCULATING TUMOR DNA AFTER HEPATIC RESECTION FOR METASTATIC COLORECTAL CANCERPresenter: Raja Narayan MD, MPH | Memorial Sloan Kettering Cancer Center Invited Discussant: Ted Welling MD | NYU Langone Health

4:30pm - 4:42pm48. NOVEL CELL MEMBRANE CATION TRANSPORTER ASSOCIATED WITH PLATINUM THERAPY RESISTANCE IN PANCREATIC ADENOCARCINOMA IDENTIFIED THROUGH CRISPR/CAS9 LOSS-OF-FUNCTION SCREENPresenter: Epameinondas Dogeas MD | University of Texas Southwestern Invited Discussant: Ajay Maker MD | University of Illinois at Chicago

4:42pm - 4:54pm49. THE EFFECTS OF P-NAK-TIDE AND SW033299 ON NASH ASSOCIATED CIRRHOSIS IN THE RODENT.Presenter: Matthew Schade MSc | Marshall University School of Medicine & Case Western Reserve University School of Medicine Invited Discussant: Martin Dib MD | University of Wisconsin, Madison

5:15pm - 6:00pmAHPBA Business Meeting (Members Only)Americana 1/2

6:15pm - 6:45pmAdvanced Practice Provider ReceptionAmericana Foyer


AG E N DA


100

6:30am - 7:30amAHPBA Leadership & Chapter Presidents Breakfast MeetingCrown Conch 7:30am - 8:30amContinental BreakfastAmericana Foyer - The Rotunda

7:30am - 11:30amRegistration OpenRotunda East

8:00am - 9:30amOral Presentations 8: HPB/TransplantAmericana 1Moderators: Vinay Kapoor MD | SGPGIMS; T. Mark Earl MD | University of Mississippi Medical Center

8:00am - 8:12am50. PERIOPERATIVE BLOOD TRANSFUSIONS FOLLOWING HEPATIC LOBECTOMY: A NATIONAL ANALYSIS OF ACADEMIC MEDICAL CENTERS IN THE MODERN ERAPresenter: Vikrom Dhar MD | University of Cincinnati Invited Discussant: Tim Pawlik MD, MPH, PhD | The Ohio State University Wexner Medical Center

8:12am - 8:24am51. A GENETIC RISK NOMOGRAM FOR PATIENTS WITH COLORECTAL LIVER METASTASES: THE CENTRAL ROLE OF BRAF MUTATIONAL STATUS IN STRATIFYING OUTCOMESPresenter: Georgios Antonios Margonis MD, PhD | Johns Hopkins University School of Medicine

8:24am - 8:36am52. DOUBLE LIGATION OF PORTAL AND HEPATIC VEINS ACHIEVES HYPERTROPHY COMPARABLE TO ALPPS - A STUDY IN PIGSPresenter: Erik Schadde MD | Rush University Medical Center Invited Discussant: Asmund Fretland MD | Oslo University Hospital


AG E N DA


Invited Discussant: Matthew Porembka MD | University of TexasSouthwestern Medical School


8:36am - 8:48am53. OPEN VERSUS LAPAROSCOPIC LIVER RESECTION FOR COLORECTAL LIVER METASTASES LOCATED IN THE POSTERO-SUPERIOR SEGMENTS: A SUB-GROUP ALAYSIS FROM THE OSLO-COMET TRIALPresenter: Davit Aghayan MD | Oslo University Hospital Invited Discussant: Emily Winslow MD | University of Wisconsin 8:48am - 9:00am54. SERUM FACTOR V AS A PREDICTOR OF GRAFT DYSFUNCTION AND MORTALITY AFTER LIVER TRANSPLANTATIONPresenter: Andre Gorgen MD | Hospital de Clinicas de Porto Alegre Invited Discussant: Lucio Pereira MD | Hospital Brasilia

9:00am - 9:12am55. POSITIVE CYSTIC DUCT STUMP AT INDEX CHOLECYSTECTOMY IN INCIDENTAL GALLBLADDER CANCER IS A STRONG NEGATIVE PROGNOSTICATOR EVEN IN PATIENTS WITHOUT RESIDUAL DISEASE AT ONCOLOGIC RE-RESECTIONPresenter: Eduardo Vega MD | The University of Texas MD Anderson Cancer Center and Hospital Sotero del Rio Invited Discussant: Allan Tsung MD | University of Pittsburgh Medical Center65.

9:12am - 9:24am56. EVALUATION OF LIVER TRANSPLANT RESULTS WITH “LIVERS THAT NOBODY WANTS”Presenter: Emilio Quiñonez MD | Hospital el Cruce Invited Discussant: Ashish Singhal MD | Fortis Hospital

8:00am - 9:30amOral Presentations 9: Pancreas IIIAmericana 2Moderators: Susanne Warner MD | City of Hope Comprehensive Cancer Center; Purvi Parikh MD | Kaiser Permanente

8:00am - 8:12am57. IMPACT OF RECENT GUIDELINES ON OVERTREATMENT OF ASYMPTOMATIC PANCREATIC CYSTIC LESIONSPresenter: Katherine Baugh MD | Baylor College of Medicine Invited Discussant: Kimberly Dalal MD |Palo Alto Medical Foundation


AG E N DA


102

8:12am - 8:24am58. EFFECT OF VESSEL PRESERVATION ON SPLENIC VOLUME AND FUNCTION IN PATIENTS WITH SPLEEN PERSERVING DISTAL PANCREATECTOMIES.Presenter: Lavanya Yohanathan MD | University of Toronto Invited Discussant: Marcus Tan MBBS | Vanderbilt University Medical Center

8:24am - 8:36am59. OUTCOMES AFTER PANCREATECTOMY WITH ROUTINE USAGE OF PASIREOTIDEPresenter: John Kunstman MD, MHS | Memorial Sloan Kettering Cancer Center Invited Discussant: Luke Schoeniger MD, PhD | University of Rochester

8:36am - 8:48am60. PATHOLOGICAL COMPLETE RESPONSE TO CHEMOTHERAPY IN PANCREATIC CANCER: FREQUENCY, PREDICTORS AND IMPACT ON OVERALL SURVIVAL.Presenter: Basem Azab MD | University of Miami Miller School of Medicine Invited Discussant: Adam Yopp MD | University of Texas Southwestern Medical School

8:48am - 9:00am61. A PROSPECTIVE STUDY OF PASIREOTIDE IN PATIENTS UNDERGOING PANCREATICODUODENECTOMY: A PROPENSITY SCORE MATCHED ANALYSISPresenter: Dominic Sanford MD MPHS | Washington University Invited Discussant: Dan Abbott MD | University of Wisconsin

9:00am - 9:12am62. DOES PERIOPERATIVE FLUID RESUSCITATION IMPACT PANCREATIC FISTULA RATES AFTER PANCREATICODUODENECTOMY?Presenter: Leah Winer MD | University of Cincinnati Invited Discussant: Charles Vollmer MD | University of Pennsylvania

9:12am - 9:24am63. THE IMPACT OF FAILURE TO ACHIEVE SYMPTOM CONTROL AFTER RESECTION OF FUNCTIONAL NEUROENDOCRINE TUMORS: AN 8-INSTITUTION STUDY FROM THE US NEUROENDOCRINE TUMOR STUDY GROUPPresenter: Mohammad Zaidi MD, MS | Emory University Invited Discussant: Heber Salvador de Castro Ribeiro MD | AC Camargo Cancer Hospital


AG E N DA



8:00am - 9:30amOral Presentations 10: Hepatobiliary IIAmericana 3Moderators: Patricio Polanco MD | University of Texas Southwestern Medical Center; Henry Randall MD | SSM/Saint Louis University Hospital

8:00am - 8:12am64. COMPLETION, AND NOT JUST INITIATION, OF INTENDED ONCOLOGIC THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL AFTER PANCREATIC RESECTION FOR CANCERPresenter: Danielle DePeralta MD | Moffitt Cancer Center Invited Discussant: Eduardo Montalvo-Jave MD, PhD | Hospital General de Mexico.

8:12am - 8:24am65. CLINICAL CRITERIA FOR INTEGRATED MOLECULAR PATHOLOGY IN IPMN: LESS IS MOREPresenter: Rachel Simpson MD | Indiana University Invited Discussant: Danny Yakoub MD, PhD | University of Miami

8:24am - 8:36am66. NORMAL AND FIBROTIC LIVER PARENCHYMA RESPOND DIFFERENTLY TO IRREVERSIBLE ELECTROPORATION ABLATIONPresenter: Tammy T. Chang MD, PhD | University of California, San Francisco Invited Discussant: Tri Nguyen MD, PhD | Piedmont Atlanta Hospital

8:36am - 8:48am67. A COMPARISON OF MICROWAVE THERMOSPHERE VERSUS RADIOFREQUENCY THERMAL ABLATION IN THE TREATMENT OF COLORECTAL LIVER METASTASESPresenter: Kazunari Sasaki MD | Cleveland Clinic Foundation Invited Discussant: Rob Martin MD, PhD | University of Louisville

8:48am - 9:00am68. LOSS OF MUSCLE MASS DURING PREOPERATIVE CHEMOTHERAPY PREDICTS WORSE RECURRENCE-FREE SURVIVIAL IN PATIENTS WITH RESECTABLE COLORECTAL LIVER METASTASESPresenter: Masayuki Okuno MD, PhD | The University of Texas MD Anderson Cancer Center Invited Discussant: Julie Hallet MD MSc | Sunnybrook Health Sciences Centre, University of Toronto


AG E N DA


104

9:00am - 9:12am69. ONCOLOGICAL BENEFIT OF COMPLETE METASTASECTOMY FOR SIMULTANEOUS COLORECTAL LIVER AND LUNG METASTASESPresenter: Masaru Matsumura MD | University of Tokyo Invited Discussant: Hiromichi Ito MD | Cancer Institute Hospital, Japanese Foundation for Cancer Research

9:12am - 9:28am70. DISPARITIES IN HEPATOPANCREATOBILIARY OPERATIVE EXPERIENCE AMONG GENERAL SURGERY RESIDENTS: A 27-YEAR ANALYSIS OF ACGME CASE LOGSPresenter: R. Cutler Quillin, III MD | Columbia University Invited Discussant: C. Max Schmidt MD, PhD, MBA | Indiana University School of Medicine

10:00am - 11:30amVideo Session Pancreas HPBAmericana 3Moderators: Heber Ribeiro MD | AC Camargo Cancer Hospital; Roger Kim MD | SIU School of Medicine

10:00am – 10:12amV 15. LAPAROSCOPIC CENTRAL HEPATECTOMY FOR METASTATIC COLORECTAL CANCERPresenter: Ephraim Tang MD, MSc | Providence Cancer Center

10:12am - 10:24amV 16. LAPAROSCOPIC LEFT EXTENDED HEPATECTOMY FOR HEPATOCELLULAR CARCINOMAPresenter: Katherine MacCallum MD | Montefiore Medical Center

10:24am - 10:36amV 17. MULTIVISCERAL ROBOTIC LIVER RESECTIONS. FEASIBLE AND SAFEPresenter: Ioannis Konstantinidis MD | City of Hope National Cancer Center

10:36am - 10:48amV 18. LAPAROSCOPIC RIGHT HEPATECTOMY FOLLOWING RIGHT PORTAL VEIN EMBOLIZATION FOR HEPATOCELLULAR CARCINOMAPresenter: Katherine MacCallum MD | Montefiore Medical Center


AG E N DA



10:48am - 11:00amV 19. ROBOTIC CHOLEDOCODUODENOSTOMYPresenter: Iswanto Sucandy MD | Florida Hospital Tampa

11:00am - 11:12amV 20. ROBOT-ASSISTED INTRA/EXTRA/BILE DUCT EXPLORATION IN A SICKLE CELL DISEASE PATIENT WITH BILIARY OBSTRUCTIONPresenter: Gregory Grimberg MD | Rutgers University

11:12am - 11:24amV 21. LAPAROSCOPIC BEGER PROCEDUREPresenter: Izrailov Roman MD | Moscow Clinical Scientific Center

10:00am - 11:30amNew Paradigms in Academic HPB SurgeryAmericana 1Moderator: Tara S. Kent MD | Beth Israel Deaconess Medical Center, Harvard Medical School; Courtney L. Scaife MD | University of Utah

Health Services / OutcomesJennifer F. Tseng MD, MPH | Boston University School of Medicine

Multi-Institutional DatabasesTimothy M. Pawlik MD, MPH, PhD | The Ohio State University Medical Center

Clinical TrialsWilliam E. Fisher MD | Baylor College of Medicine

InnovationMariano Gimenez MD | University of Buenos Aires

International OutreachT. Peter Kingham MD | Memorial Sloan Kettering Cancer Center

AdministrativeCharles Wright Pinson MD, MBA | Vanderbilt University Medical Center


AG E N DA


106

10:00am - 11:30amInternational Relations Committee | AHPBA Gone GlobalAmericana 2Moderators: Alagappan Anand Annamalai MD | St. Vincent Medical Center; Frans I. Serpa MD | Hospital Carlos Andrade Marin

Access to HPB Disease Care WorldwideGazi B. Zibari MD | Willis-Knighton Health System

Development of International AHPBA ChaptersHoover Henriquez Cooper MD | Military Hospital Honduras

How to Improve HPB Education Through the ChaptersOscar A. Guevara MD, MSc | Universidad Nacional de Colombia /

Instituto Nacional de Cancerologia

Challenges in the Interaction Between AHPBA and the ChaptersJavier C. Lendoire MD, PhD | Hospital Dr C Argeric


AG E N DA



ePoster Displays | Monitor 5 P 2. A PREDICTIVE SCORING SYSTEM FOR INSUFFICIENT LIVER HYPERTROPHY AFTER PREOPERATIVE PORTAL VEIN EMBOLIZATIONPresenter: Nobuyuki Watanabe MD | Shizuoka Cancer Center

P 5. SINGLE INCISION VERSUS THREE PORT LAPAROSCOPIC CHOLECYSTECTOMY IN SYMPTOMATIC GALLSTONES: A PROSPECTIVE RANDOMIZED STUDYPresenter: Mohammed Omar MD | South Valley University, Qena Faculty of Medicine

P 7. MALNUTRITION ASSOCIATED WITH POSTOPERATIVE COMPLICATIONS IN PATIENTS UNDERGONE HEPATECTOMY FOR HEPATOCELLULAR CARCINOMAPresenter: Tzu Hao Huang MD | Chiayi Chang Gung Memorial Hospital

P 9. CIRRHOTIC CARDIOMYOPATHY AND DIASTOLIC DYSFUNCTION IN LIVER TRANSPLANTATIONPresenter: Nyingi Kemmer MD | Tampa General Hospital

P 12. VIDEO CASE PRESENTATION: UTILITY OF ROBOTICS IN PARTIAL HEPATECTOMY FOR ISOLATED LIVER METASTASISPresenter: Ashraf Elzanie MD | Saint Vincents Medical Center

P 13. VIDEO PRESENTATION: HAND-ASSISTED LAPAROSCOPIC DISTAL PANCREATECTOMY AND SPLENECTOMY FOR DISCONNECTED PANCREATIC DUCT SYNDROMEPresenter: Joseph Kim MD | Icahn School of Medicine at Mount Sinai

P 14. PANCREATICODUODENECTOMY WITH COMMON HEPATIC ARTERY AND PORTAL VEIN RESECTION FOR LOCALLY ADVANCED PANCREATIC CANCERPresenter: Hiromichi Ito MD | Cancer Institution Hospital, Japanese Foundation for Cancer Research

P 15. LAPAROSCOPIC RESECTION OF A COMPLEX SEGMENT III/IVB LIVER CYST USING ULTRASONIC SURGICAL ASPIRATORPresenter: Eren Berber MD | Cleveland Clinic Foundation

ePOSTER DISPLAYS BY MONITOR

AG E N DA


108

P 16. LAPAROSCOPIC RESECTION OF A SEGMENT VIII COLORECTAL LIVER METASTASIS USING AN ULTRASONIC SURGICAL ASPIRATORPresenter: Eren Berber MD | Cleveland Clinic Foundation

P 17. RIGHT POSTERIOR SECTIONECTOMY WITH GLISSONIAN APPROACH: ADVANTAGES OF HAND-ASSISTED LAPAROSCOPIC TECHNIQUEPresenter: Fabio Makdissi MD | University of Sao Paulo

P 19. PERI-OPERATIVE RISK FACTORS FOR POST OPERATIVE LIVER FAILURE AFTER HEPATECTOMY: AN ACS-NSQIP ANALYSISPresenter: Travis Mason MD | Virginia Commonwealth University Medical Center

P 21. ROBOTIC RESECTION OF EXTRAHEPATIC BILE DUCTS WITH LEFT HEPATECTOMY AND CAUDATE LOBE RESECTION FOR BISMUTH TYPE II PERI-HILAR CHOLANGIOCARCINOMAPresenter: Sarah Corn MD | University of Kansas School of Medicine, Wichita

P 23. LAPAROSCOPIC COMPLETION CHOLECYSTECTOMY: AN AUDIT FROM THE CARIBBEAN CHAPTER OF THE AHPBAPresenter: Shamir Cawich MD | University of the West Indies

P 25. LAPAROSCOPIC CHOLEDOCHAL CYST EXCISION WITH CHOLEDOCHODUODENOSTOMY USING NOVEL ARTICULATING NEEDLE DRIVERPresenter: Kellie Helin MD | West Virginia University Charleston

P 26. DUCT-PENETRATING METHOD FOR PANCREATICOJEJUNOSTOMY USING A SUTURE-ASSISTANCE DEVICE: OUTCOMES OF EARLY CLINICAL STUDYPresenter: Tomio Ueno MD, PhD | Kawasaki Medical School

P 27. RESIDENT EXPERIENCE IN HEPATOPANCREATOBILIARY SURGERY AT HIGH-VOLUME CENTERS: SHOULD IT COUNT?Presenter: Manuel Castillo-Angeles MD, MPH | Beth Israel Deaconess Medical Center

P 30. ROBOTIC APPROACH TO PANCREATIC RESECTION RE-VISITEDPresenter: Caitlin Takahashi MS | Florida State University, Sarasota Memorial Hospital


AG E N DA



P 32. OUTCOMES AFTER PANCREATICODUODENECTOMY IN PATIENTS WITH SARCOPENIA AND/OR OBESITYPresenter: William Lyman MD | Carolinas HealthCare System

P 33. FACTORS ASSOCIATED WITH RETURN TO OPERATING ROOM FOLLOWING PANCREATIC RESECTION FOR MALIGNANCYPresenter: Bradley Hall MD | University of Nebraska Medical Center

P 34. COMPARISON OF NEOADJUVANT GEMCITABINE VERSUS 5-FLUOROURACIL OR CAPECITABINE CHEMORADIATION FOR BORDERLINE RESECTABLE PANCREATIC CANCERPresenter: June Peng MD | Cleveland Clinic Foundation

P 36. LONG-TERM OUTCOMES OF PERIAMPULLARY ADENOCARCINOMAS AFTER PANCREATICODUODENECTOMY – A PERUVIAN MULTI-INSTITUTIONAL STUDYPresenter: David Callacondo MD | Hospital Nacional Guillermo Almenara Irigoyen

P 37. DOES SURGICAL VOLUME TRUMP DISPARITIES IN PREDICTING OUTCOMES FOLLOWING HEPATOPANCREATICOBILIARY (HPB) SURGERY?Presenter: Britney Harris | West Virginia University

P 38. CLINICAL OUTCOMES AFTER MAJOR LIVER RESECTION IN A LOW VOLUME CENTRE IN THE CARIBBEANPresenter: Shamir Cawich MD | University of the West Indies

P 39. LAPAROSCOPIC EXTENDED LYMPHADENECTOMY FOR INCIDENTAL GALLBLADDER CANCER.Presenter: Patricia Rebolledo MD | Hospital San Borja Arriaran

P 40. CRITICAL VIEW OF SAFETY IN CHOLECYSTECTOMY IS NOT A WELL DISSEMINATED CONCEPT. A WEB BASED ANALYSISPresenter: Ismael Dominguez Rosado MD, MSc | Instituto Nacional de Ciencias Médicas y Nutrición

P 41. SUBCUTANEOUS DRAINAGE TO PREVENT WOUND MORBIDITY IN PATIENTS UNDERGOING PANCREATICODUODENECTOMIES: A RETROSPECTIVE STUDYPresenter: Emilio Alonso MD | Kaiser Permanente, Riverside Medical Center


AG E N DA


110

P 42. RACIAL DISPARITIES IN SURVIVAL AMONG PATIENTS WITH RESECTED PANCREATIC ADENOCARCINOMA AND PANCREATIC NEUROENDOCRINE TUMOR. MIAMI-BASED POPULATION STUDY.Presenter: Basem Azab MD | University of Miami Miller School of Medicine

P 44. ARTERIO-VENOUS FISTULA AS A LATE COMPLICATION AFTER DISTAL PANCREATECTOMY WITH EN BLOC SPLENIC VESSELS LIGATION: MYTH OR REALITY?Presenter: John Stauffer MD | Mayo Clinic, Florida

P 46. RESECTION VERSUS OBSERVATION OF SMALL NONFUNCTIONING PANCREATIC NEUROENODCRINE TUMORSPresenter: Nir Lubezky MD | Tel-Aviv Medical Center

P 47. THE ANTERIOR SECTOR VENOUS DRAINAGE USING SUPERFICIAL FEMORAL VEIN GRAFT IN RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATIONPresenter: Shigeyuki Kawachi MD, PhD | Tokyo Medical University Hachioji Medical Center

P 48. A SINGLE CENTER EXPERIENCE WITH DIAGNOSTIC LAPAROSCOPY PRIOR TO PLANNED PANCREATIC RESECTIONPresenter: Jack Silva BS | UC Irvine

P 49. SURGICAL OUTCOMES IN PATIENTS WITH RESECTED INSULINOMAPresenter: Georgios Gemenetzis MD | Johns Hopkins University School of Medicine

P 50. DOES SURGEON VOLUME MITIGATE PREDICTED RISK FOR PATIENTS UNDERGOING PANCREATODUODENECTOMY?Presenter: Zachary Stiles DO | University of Tennessee Health Science Center

P 51. IS INTEGER-BASED RISK SCORE TO PREDICT IN-HOSPITAL MORTALITY FOLLOWING PANCREATECTOMY RELIABLE?Presenter: SANA BADAR MD | Louisiana State University Health Shreveport


AG E N DA



ePoster Displays | Monitor 6 P 52. TRIGGERS FOR BLOOD TRANSFUSION DURING PANCREATICODUODENECTOMY: ARE WE FOLLOWING INSTITUTIONAL GUIDELINES?Presenter: Daniel Rice BS | University of Cincinnati

P 53. PERIOPERATIVE OUTCOMES OF COMBINED SURGERY OF PRIMARY COLORECTAL CANCER AND SYNCHRONOUS LIVER METASTASESPresenter: Jorge A Gajardo MD | Fundacion Arturo Lopez Perez

P 54. HEPATO-PANCREATO-BILIARY MALIGNANCIES IN PATIENTS WITH CROHN’S DISEASE: A UNITED STATES POPULATION BASED STUDY FROM NATIONAL INPATIENT SAMPLE DATABASE (1998-2010)Presenter: Sachin Patil MD | South Central Regional Medical Cent

P 55. HEPATO-PANCREATO-BILIARY MALIGNANCIES IN PATIENTS WITH CONNECTIVE TISSUE DISORDERS: A UNITED STATES POPULATION BASED STUDY FROM NATIONAL INPATIENT SAMPLE DATABASE (1998-2010)Presenter: Apostolos Kandilis MD, PhD | Providence Park Hospital/Michigan State University College of Human Medicine

P 56. IMPLEMENTATION AND EARLY OUTCOMES FOR A SURGEON-DIRECTED HEPATIC ARTERIAL INFUSION PUMP PROGRAM FOR COLORECTAL LIVER METASTASESPresenter: Jeffery Chakedis MD | The Ohio State University

P 57. HEPATIC NEUROENDOCRINE TUMORS WITHOUT AN IDENTIFIABLE EXTRAHEPATIC PRIMARYPresenter: Lavanya Yohanathan MD | Mayo Clinic

P 58. TOTAL LAPAROSCOPIC PANCREATODUODENECTOMY WITH EXTERNALIZED STENT IN A HIGH FISTULA RISK SCENARIOPresenter: Ismael Dominguez Rosado MD, MSc | Instituto Nacional de Ciencias Médicas y Nutrición

P 59. R0 RESECTION IMPROVES DISEASE-FREE SURVIVAL IN PATIENTS WITH PANCREATIC NEUROENDOCRINE TUMORS INDEPENDENT OF STAGE AND GRADE OF TUMORPresenter: Mazhar Khalil MD | Icahn School of Medicine at Mount Sinai


AG E N DA


112

P 60. NEO-ADJUVANT CHEOMORADIATION THERAPY FOR PANCREATIC CANCER IS ASSOCIATED WITH ADVERSE OUTCOME AFTER PANCREATICODUODECTOMY.Presenter: Hassan Aziz MD | Banner University Medical Center

P 61. SARCOMATOUS TRANSFORMATION OF HEPATOCELLULAR CARCINOMA FOLLOWING TREATMENT WITH Y-90 RADIOEMBOLIZATIONPresenter: Connor Wiles BS | Providence Portland Medical Center

P 62. ROBOTIC DUODENAL SURGERY IS A SAFE ALTERNATE TO LAPAROSCOPIC AND OPEN RESECTION FOR BENIGN AND LOW GRADE MALIGNANT CONDITIONS NOT AMENABLE TO ENDOSCOPIC INTERVENTIONPresenter: Adeel Khan MD, MPH | Carolinas HealthCare System

P 63. SURVIVAL ANALYSIS IN PATIENTS WITH GALLBLADER CANCER IN MEDELLIN-COLOMBIAPresenter: jaime ramirez MD | IPS Universidad de Antioquia, Clinica Leon XIII

P 64. A MULTI-ORGAN STUDY USING COMPARING MICROWAVE ABLATION 2450 MHZ SYSTEMS- EQUIVALENCE OR SUPERIORITYPresenter: Megan Stevenson MD | University of Louisville School of Medicine

P 65. IS ENDOSCOPIC RETROGRADE CHOLANGIO PANCREATOGRAPHY (ERCP) A RISK FACTOR FOR CONVERSION OF LAPAROSCOPIC CHOLECYSTECTOMY? - EXPERIENCE OF A TERTIARY CARE HEPATOBILIARY REFERRAL CENTREPresenter: Malith Nandasena MBBS, MD, MRCS | National Hospital of Sri Lanka

P 66. CHOLEDOCHOPLASTY WITH GALLBLADDER WALL FREE FLAP: A NOVEL TECHNIQUE FOR MIRIZZI’S SYNDROME AND BILE DUCT INJURIES IN HIGH RISK PATIENTSPresenter: Louis Chai MD | Drexel University College of Medicine

P 67. INDOCYANINE GREEN FLUORESCENCE COUNTERSTAINING FOR ANATOMIC LAPAROSCOPIC PARTIAL SPLENECTOMYPresenter: Takashi Mizuno MD, PhD | The University of Texas MD Anderson Cancer Center


AG E N DA



P 68. BMI AND PANCREATIC NECROSIS...DO OBESE PATIENTS DO WORSE?Presenter: Stephen Quigley MD | Indiana University

P 69. LONG TERM FOLLOW-UP RESULTS OF SURGICAL MANAGEMENT OF CHRONIC PANCREATITISPresenter: Thiago Costa MD, PhD | Hospital das Clinicas of University of Sao Paulo

P 71. DO SOLID ORGAN TRANSPLANT RECIPIENTS HAVE A HIGHER RISK OF HEPATO-PANCREATO-BILIARY MALIGNANCIES? A UNITED STATES POPULATION BASED STUDY FROM NATIONAL INPATIENT SAMPLE DATABASE (1998-2010)Presenter: Apostolos Kandilis MD, PhD | Providence Park Hospital/Michigan State University College of Human Medicine

P 72. CONVENTIONAL PANCRETICOJEJUNOSTOMY VERSUS SUTURE-LESS BINDING PANCREATICOGASTROSTOMY- A SINGLE INSTITUTION SINGLE SURGEON COMPARITIVE STUDYPresenter: Phani krishna Ravula MS, MRCS, MCh | Pace hospitals

P 73. SURGICAL RESULTS OF MAJOR AND MINOR LAPAROSCOPIC HEPATECTOMIESPresenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile

P 74. FEASIBILITY OF LAPAROSCOPIC PARENCHYMAL SPARING HEPATECTOMIES: A SYSTEMATIC REVIEWPresenter: Jennifer Kalil MD | Rush University Medical Center

P 75. EFFECT OF INTENSIVE LIFESTYLE INTERVENTIONS ON LIVER TRANSAMINASESPresenter: Francisco Ramirez MD | Weimar Institute

P 76. PANCREATICODUODENECTOMY IN PATIENTS WITH ROUX-EN-Y GASTRIC BYPASS: A MATCHED CASE-CONTROL STUDYPresenter: John Stauffer MD | Mayo Clinic, Florida

P 77. PATTERNS OF RECURRENCE AND PERI-OPERATIVE PREDICTORS OF LIVER METASTASIS AFTER PANCREATIC CANCER RESECTIONPresenter: Constantinos Zambirinis MR, MRes | Memorial Sloan Kettering Cancer Center


AG E N DA


114

P 79. LAPAROSCOPIC LIVER RESECTION FOR METASTATIC MELANOMAPresenter: Davit Aghayan MD | Oslo University Hospital

P 80. LIVER ABSCESS PATHOLOGY AND MANAGEMENT IN WESTERN SYDNEYPresenter: Yi Liang MBBS | Westmead Hospital

P 81. MAJOR PANCREAS RESECTION FOR ADENOCARCINOMA IN THE ELDERLY PATIENTS; DOES AGE IMPACT THE OUTCOME?Presenter: Alireza Hamidian Jahromi MD, MRCS | John C. McDonald Regional Transplant Center

P 82. PANCREATICODUODENECTOMY WITH IRREVERSIBLE ELECTROPORATION MARGIN ENHANCEMENT FOR BORDERLINE RESECTABLE PANCREATIC CARCINOMAPresenter: Amit Sastry MD | Carolinas HealthCare System

P 83. OUTCOMES OF PANCREATICODUODENECTOMY IN PATIENTS WITH SUPERIOR MESENTERIC ARTERY CALCIFICATIONPresenter: Kelvin Wang BMBS, MRCS | St James’s University Hospital

P 85. PYOGENIC LIVER ABSCESS: EPIDEMIOLOGY, CLINICAL FEATURES AND MANAGEMENTPresenter: Helmut Alfredo Segovia Lohse MD | Hospital de Clínicas

P 86. CHOLECYSTECTOMY AFTER WALLED-OFF PANCREATIC NECROSISPresenter: Joseph A Reza MD | Florida Hospital

P 87. STABILITY OF COUNTY RANKINGS IN LIVER TRANSPLANT OUTCOMESPresenter: Clifford Akateh MD | The Ohio State University and Nationwide Children’s Hospital


AG E N DA



P 88. PANCREATIC CYSTGASTROSTOMY: DEFINITIVE OR TEMPORIZING PROCEDURE?Presenter: Edward Cho MD | Methodist Richardson Medical Center

P 89. CONGENITAL COMMON BILE DUCT AGENESIS: AN EXTREMELY RARE ANOMALY. TWO CASE REPORTS AND REVIEW OF LITERATURE.Presenter: Louis Chai MD | Drexel University College of Medicine

ePoster Displays | Monitor 7 P 90. MAJOR HEPATECTOMY IN OCTOGENARIAN PATIENTSPresenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile

P 91. HEPATIC ADENOMAS: PHENOTYPIC EXPRESSION, CASE DESCRIPTION AND LITERATURE REVIEW.Presenter: Elaine Ataide PhD | University of Campinas

P 92. POSTOPERATIVE COMPLICATIONS IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY; VALIDATION OF THE RISK CALCULATOR OF THE AMERICAN COLLEGE OF SURGEONS AT A PRIVATE HOSPITAL IN MEXICO CITY.Presenter: Victor José Visag-Castillo MD | Medica Sur Clinic Foundation

P 93. INCIDENCE OF SPLANCHNIC VEIN THROMBOSIS FOLLOWING ABDOMINAL SURGERY, A SYSTEMATIC REVIEW AND META-ANALYSIS.Presenter: Minji Kim MD | McMaster University

P 94. WBC COUNT AS A SURROGATE OF SIRS IN THE EARLY POST-OPERATIVE PERIOD. CAN IT PREDICT OUTCOMES AFTER PANCREATICODUODENECTOMY?Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center

P 95. MODIFIED HEIDELBERG TECHNIQUE FOR PANCREATIC ANASTOMOSISPresenter: Orlando Torres MD, PhD | Federal University of Maranhao

P 96. LAPAROSCOPIC RESECTION OF SEGMENT IVB/V COLORECTAL LIVER METASTASIS USING A NEW MULTIFUNCTIONAL ARTICULATING VESSEL SEALERPresenter: Eren Berber MD | Cleveland Clinic Foundation


AG E N DA


116

P 97. BARBED SUTURE FOR PANCREATIC ANASTOMOSIS DURING PANCREATICODUODENECTOMY DECREASES INCIDENCE OF CLINICALLY SIGNIFICANT PANCREATIC FISTULAPresenter: Andrew Guzowski MD | Cleveland Clinic, Akron General

P 99. MINIMALLY INVASIVE PANCREATECTOMY FOR ADENOCARCINOMA; A SINGLE CENTER EXPERIENCE WITH 100 RESECTIONSPresenter: Michael Passeri MD | Carolinas HealthCare System

P 101. THE PERSUIT OF SAFETY IN LAPAROSCOPIC HEPATECTOMYPresenter: Naokazu Chiba MD, PhD | Tokyo Medical University Hachioji Medical Center

P 102. PERCUTANEOUS CHOLECYSTOSTOMY FOR ACUTE CALCULOUS CHOLECYSTITIS: OUTCOMES FROM A SINGLE CENTRE EXPERIENCEPresenter: Francois Rouleau Fournier MD | CHU de Quebec - Laval University

P 103. TRANSVERSUS ABDOMINUS MUSCLE RELEASE WITH MESH REINFORCEMENT IS SAFE AND EFFECTIVE FOR REPAIRING INCISIONAL HERNIAS IN LIVER TRANSPLANT PATIENTSPresenter: Dominic Sanford MD, MPHS | Washington University

P 104. PERCUTANEOUS TRANS-HEPATIC APPROACH TO ADDRESS COMMON BILE DUCT STONE (CBDS) IN PATIENTS WHO HAD LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS (LRYGB)Presenter: Gazi B. Zibari MD | John C. McDonald Regional Transplant Center

P 105. ROBOTIC-ASSISTED COMPLETION CHOLECYSTECTOMY FOLLOWING PREVIOUS SUBTOTAL CHOLECYSTECTOMY -- A CASE SERIESPresenter: William Lyman MD | Carolinas HealthCare System

P 106. POST-FELLOWSHIP COMMUNITY PRACTICE FACILITATES EARLY ADOPTION OF ROBOTIC SURGERY AS ALGORITHM FOR APPROPRIATE PATIENT SELECTION.Presenter: Shanel Bhagwandin DO, MPH | Jupiter Medical Center

P 107. MANAGEMENT OF A DUODENOBRONCHIAL FISTULA AFTER YTTRIUM 90 TRANSARTERIAL RADIOEMBOLIZATION IN A PATIENT WITH RECURRENT HEPATOCELLULAR CARCINOMAPresenter: Kliment Bozhilov MD | Johns Hopkins University School of Medicine


AG E N DA



P 108. HEPATOCELLULAR CARCINOMA INVADING BILE DUCTS PRESENTING AS A KLATSKIN TUMORPresenter: Jorge Uribe MD | Drexel University College of Medicine

P 109. DUCT PENETRATING METHOD (DPM) FOR PANCREATOJEJUNOSTOMY WITH AN INTERNAL STENT PLACEMENT BY “PUSH & PULL TECHNIQUE”Presenter: Mio Nakatani MD | Kawasaki Medical School

P 110. PANCREATIC PSEUDOCYST DILEMMA; CUMULATIVE MULTI-CENTERS EXPERIENCE IN MANAGEMENT USING ENDOSCOPY, LAPAROSCOPY, AND OPEN SURGERYPresenter: Mohammed Omar MD | South Valley University, Qena Faculty of Medicine

P 111. VIDEO-ASSISTED RETROPERITONEAL DEBRIDEMENT IN A PATIENT WITH INFECTED NECROTIZING PANCREATITISPresenter: Helmut Alfredo Segovia Lohse MD | Hospital de Clínicas

P 112. HSP70, GLUTAMINE SYNTHETASE, GLIPICAN3, PD1, PDL1 AND BETACATENIN: IMMUNOHISTOCHEMICAL STUDY IN PATIENTS UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA. REVIEW OF RECURRENCE AND SURVIVAL.Presenter: Simone Perales PhD | University of Campinas

P 113. MAJOR HEPATIC RESECTIONS IN A NEW HOSPITAL. HOW AN EXPERIENCED SURGICAL GROUP CAN POSITIVELY AFFECT OUTCOMES.Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center

P 114. BENEFITS OF AN EIGHT-TEEN DAY PROGRAM ON CHRONIC HEPATITISPresenter: Francisco Ramirez MD | Weimar Institute

P 115. LAPAROSCOPIC COMMON BILE DUCT EXPLORATION USING FLUOROSCOPY GUIDED STONE BASKET EXTRACTION IN THE MANAGEMENT OF EXTRAHEPATIC BILE DUCT STONES: A JOSE R. REYES MEMORIAL MEDICAL CENTER EXPERIENCEPresenter: Alain Neil Ancheta MD | Jose R. Reyes Memorial Medical Center

P 117. PANCREATODUODENECTOMY: BRAZILIAN PRACTICE PATTERNSPresenter: Orlando Torres MD, PhD | Federal University of Maranhao


AG E N DA


118

P 118. PANCREAS TRANSECTION WITH LINEAR STAPLER AND BIPOLAR CAUTERY FORCEPS IN DISTAL PANCREATECTOMYPresenter: Toshimasa Okada MD, PhD | Kawasaki Medical School

P 119. COMPLEX DISTAL PANCREATECTOMY PERFORMED AT A COMMUNITY CANCER CENTERPresenter: Benjamin Gough DO | Helen F Graham Cancer Center & Research Institute

P 121. RADIO-EMBOLIZATION WITH YTTRIUM-90 MICROSPHERES FOR UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA. WHO GETS IT?Presenter: Spyridon Pagkratis MD | Methodist Richardson Medical Center

P 122. ROLE OF FAT AND FIBROSIS IN POST-OPERATIVE PANCREATIC FISTULAPresenter: Suman Bhushan Koganti MD | Nizams institute of medical sciences

P 124. THE FIRST US REPORT OF MRI EOVIST AS A BILIARY AGENT. 2 CASE REPORTS.Presenter: Edward Cho MD | Methodist Richardson Medical Center

P 125. URGENCY SURGICAL TREATMENT FOR RUPTURED HEPATIC ADENOMA: EXPERIENCE OF 23 YEARS.Presenter: Elaine Ataide PhD | University of Campinas

P 126. THE ROLE OF BILIARY T-TUBES IN CONTEMPORARY HEPATOBILIARY AND EMERGENCY SURGERY: HAS THEIR TIME PASSED?Presenter: Sushant Chaudhary MD | University of Calgary

P 127. CENTRAL HEPATECTOMY FOR RARE PURE SQUAMOUS CELL CARCINOMA OF THE GALLBLADDER WITH LOCAL EXTENSION INTO LIVERPresenter: Jayne McCauley MD | Texas Tech University Health Sciences Center

P 128. EPIDEMIOLOGY OF PANCREATIC SOLID PSEUDOPAPILLARY NEOPLASMS IN A CARIBBEAN POPULATIONPresenter: Shamir Cawich MD | University of the West Indies


AG E N DA



P 129. ACUTE LIVER FAILURE AS INITIAL PRESENTATION OF MULTIPLE MYELOMAPresenter: Amit Reddy MBBS | University of Mississippi Medical Center

P 130. HEPATIC ARTERY-PORTAL VEIN FISTULAS (APFS) FOLLOWING A THORACO-ABDOMINAL STAB WOUND: CASE REPORT AND LITERATURE REVIEWPresenter: Amandeep Juneja MD | Staten Island University Hospital

ePoster Displays | Monitor 8 P 131. A CASE SERIES OF CENTRAL HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA - A USEFUL PARENCHYMA PRESERVING TECHNIQUE TO PREVENT POST-HEPATECTOMY LIVER FAILURE.Presenter: Phani krishna Ravula MS, MRCS, MCh | Pace Hospital

P 132. DOES COMPLIANCE WITH AN ERAS PROTOCOL FOR PANCREATICODUODENECTOMY LEAD TO A DIFFUSION EFFECT ON COMPLIANCE FOR LEFT PANCREATECTOMY?Presenter: Michael Passeri MD | Carolinas HealthCare System

P 133. MORBID THOUGHTS DECREASE ON INDIVIDUALS WITH CONCUSSION HISTORY AFTER AN 8-WEEK EDUCATIONAL PROGRAMPresenter: Francisco Ramirez MD | Nedley Clinic

P 135. PANCREATIC SURGERY IN OCTOGENARIAN PATIENTSPresenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile

P 136. THE PANCREAS AS A TARGET FOR METASTASES OF ABDOMINAL TUMORSPresenter: Gabriel E. Gondolesi MD | Hospital Universitario Fundación Favaloro (HUFF)

P 137. CASE SERIES TYPE 2 AUTOIMMUNE PANCREATITIS (OR IDCP): AN AUSTRALIAN CASE SERIES AND ANALYSIS OF DIAGNOSTIC APPROACHPresenter: Krishna Pattabathula MBBS | Wesley Hospital

P 138. MANAGEMENT OF PATIENTS WITH ADENOCARCINOMAPresenter: Sean Willis MS | Holy Cross Hospital


AG E N DA


120

P 139. FACTORS ASSOCIATED WITH BETTER SURVIVAL IN PATIENTS UNDERGOING PANCREATICODUODENECTOMY FOR PANCREATIC ADENOCARCINOMAPresenter: Andres Troncoso MD | Pontificia Universidad Católica de Chile

P 141. SURGICAL IMPORTANCE OF DUCT OF LUSCHKA ON BILE DUCT LEAK : EMPIRICAL REVIEW OF LITERATURE.Presenter: Natalia Cortes MD | Hospital Universitaria San Ignacio

P 142. IGG4-RELATED CHOLECYSTITIS PRESENTING AS MIRIZZI SYNDROME.Presenter: Nuria Ortega MD | Vall D’Hebron Universitary Hospital

P 143. SUPERIOR INTRAOPERATIVE PERFORMANCE OF HARMONIC HD 1000I SHEARS FOR PANCREATICODUODENECTOMIESPresenter: Edward Cho MD | Methodist Richardson Medical Center

P 144. D4 OPENS A DOOR: ENDOSCOPIC ULTRASOUND GUIDED TRANSDUODENAL DRAINAGE OF PERIPANCREATIC ABSCESS:A CASE REPORT AND LITERATURE REVIEW.Presenter: Essa Aleassa MD, MSc | Cleveland Clinic Foundation

P 145. SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PANCREATIC CYSTIC NEOPLASMS IN A REFERRAL CENTRE ON HPB IN COLOMBIA.Presenter: Camilo Ramirez MD | Mederi Hospital

P 146. TRAUMATIC HEMOBILIAPresenter: Timothy Sahawneh MD | East Tennessee State University

P 147. IRREVERSIBLE ELECTROPORATION FOR POST-PANCREATICODUODENECTOMY LOCALLY RECURRENT PANCREATIC ADENOCARCINOMA: A CASE PRESENTATIONPresenter: Kiara Tulla MD | University of Illinois at Chicago

P 148. PANCREATIC NEUROENDOCRINE TUMOR: A DIAGNOSTIC CHALLENGE IN FINE NEEDLE ASPIRATION CYTOLOGYPresenter: Amit Reddy MBBS | University of Mississippi Medical Center

P 149. HILAR BILE DUCT NEUROENDOCRINE TUMOR: AN INCIDENTAL FINDINGPresenter: Amit Reddy MBBS | University of Mississippi Medical Center


AG E N DA



P 150. DOUBLE CYSTIC MUCINOUS CYSTIC NEOPLASM AT THE BODY AND THE TAIL OF THE PANCREAS.Presenter: Natalia Lozano MD | Mederi Hospital

P 151. NEUROENDOCRIN TUMOR DE PANCREAS. PRESENTACION DE AMPULOMAS CON HISTOLOGIA POCO FRECUENTE.Presenter: Alejandro Fabian Rabellino MD | Hospital J. B. Iturraspe

P 152. EVERY OTHER DAY TREATMENT MAY REDUCE FATIGUE IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH STEREOTACTIC BODY RADIOTHERAPYPresenter: Shaakir Hasan DO | Allegheny Health Network

P 153. IMPROVED PREDICTION OF HEPATIC FAILURE WITH THE ALBUMIN-BILIRUBIN MODEL FOR HEPATOCELLULAR CARCINOMA PATIENTS FOLLOWING STEREOTACTIC BODY RADIOTHERAPY WITH AND WITHOUT TRANSPLANTPresenter: Shaakir Hasan DO | Allegheny Health Network

HPB Fellowship Program ePosters


AG E N DA


122



ABSTRACTS

AHPBA 2018 Annual Meeting abstracts are published online

via an HPB Abstract Supplement.

Abstracts may be accessed online at www.ahpba.org/annual-meeting/

or on the Meeting App


124

SPEAKERS AND FACULTY

Daniel E. Abbott, MD | University of Wisconsin

Rene Adam, MD | Paul Brousse Hospital

David B. Adams, MD | Medical University of South Carolina

Reid Adams, MD | University of Virginia School of Medicine

Syed A. Ahmad, MD | University of Cincinnati Medical Center

Peter J. Allen, MD | Memorial Sloan Kettering Cancer Center

Thomas A. Aloia, MD | University of Texas, MD Anderson Cancer Center

Adnan Alseidi, MD, EdM | Virginia Mason Medical Center

Blaire Anderson, MD | Washington University School of Medicine

Christopher D. Anderson, MD | University of Mississippi of Medical Center

Wellington Andraus, MD, PhD | Sao Paulo University School of Medicine

Alagappan Anand Annamalai, MD | St. Vincent Medical Center

Horacio J. Asbun, MD | Mayo Clinic

Erin H. Baker, MD | Carolinas Medical Center

Chad G. Ball, MD, MSC | University of Calgary

Jeffrey S. Barkun, MD | McGill University Health Centre

Eren Berber, MD | Cleveland Clinic Foundation

Lacey Bittel, PA-C | University of Cincinnati Medical Center

Caitlin Brown, NP | University of Pennsylvania

Morgan L. Bruno, ACNP-BC | UT MD Anderson Cancer Center

Jean M. Butte, MD | Instituto Oncologico Fundacion Arturo Lopez Perez

Mark P. Callery, MD | Harvard Medical School

Carlos Chan, MD | National Institute of Medical Sciences

Alyssa J. Chapates, BSN, RN, OCN | Methodist Richardson Cancer Center

William C. Chapman, MD | Washington University School of Medicine

Richard M. Charnley, MD | Freeman Hospital

Daniel Cherqui, MD, PhD | Paul Brousse Hospital

Clifford Cho, MD | University of Michigan Medical School

Jessica L. Cioffi, MD | University of Florida

Bryan M. Clary, MD, MBA | University of California San Diego

Pierre-Alain Clavien, MD PhD | University Hospital Zurich

Sean P. Cleary, MD | Mayo Clinic

Natalie Coburn, MD, MPH | The Odette Cancer Centre

Felipe J. Coimbra, MD | AC Camargo Cancer Center

Veronica L. Coleman, MPAS, PA-C | UT Southwestern Medical Center

Kendra D. Conzen, MD | University of Colorado School of Medicine

Hoover Henriquez Cooper, MD | Military Hospital Honduras



SPEAKERS AND FACULTY CONTINUED

Carlos U. Corvera, MD | UCSF

Gregory A. Cote, MD, MS | Medical University of South Carolina

Moises Cukier, MD | National Cancer Institute - Panama

Michael D’Angelica, MD | Memorial Sloan Kettering Cancer Center

Jason W. Denbo, MD | University of Minnesota

Elijah Dixon, MD | University of Calgary

Maria B. Doyle, MD, MBA | Washington University School of Medicine

Vikas Dudeja, MD | University of Miami

Jean C. Emond, MD | Columbia University and The New York Presbyterian Hospital

Douglas B. Evans, MD | Medical College of Wisconsin

Cristina Ferrone, MD | Massachusetts General Hospital

Ryan C. Fields, MD | Washington University School of Medicine

William E. Fisher, MD | Baylor College of Medicine

Jennifer A. Flood, ANP-NC | Memorial Sloan Kettering Cancer Center

Yuman Fong, MD | City of Hope

Asmund A. Fretland, MD | Oslo University Hospital

Steven Gallinger, MD | University Health Network, University of Toronto

T. Clark Gamblin, MD | Medical College of Wisconsin

Jose P. Garbanzo, MD | Centro de Enfermedades del Higado

David Geller, MD | University of Pittsburgh

Mariano Gimenez, MD | University of Buenos Aires

Gabriel E. Gondolesi, MD | Fundacion Favaloro

Vijaya Gottumukkala, MD | MD Anderson Cancer Center

Paul D. Greig, MD | University of Toronto

James V. Guarrera, MD | Rutgers New Jersey Medical School

Juan Francisco Guerra, MD | Pontificia Universidad Católica de Chile

Oscar A. Guevara, MD, MSc | Universidad Nacional de Colombia / Instituto

Nacional de Cancerologia

Rajesh Gupta, Professor | Postgraduate Institute of Medical Education and Research

Ellen Hagopian, MD | Hackensack Meridian

Julie H. Hallet, MD, MSc | Sunnybrook Health Sciences Centre, University of Toronto

Chet Hammill, MD | Washington University, St. Louis

William G. Hawkins, MD | Washington University School of Medicine

Julie K. Heimbach, MD | Mayo Clinic

W. Scott Helton, MD | Virginia Mason Medical Center

Mary Beth Henry, RN, MS, CS, APNP | University of Wisconsin


126


Paulo Herman, MD | University of São Paulo

Joseph M. Herman, MD | University of Texas MD Anderson Cancer Center

Roberto Hernandez-Alejandro, MD | University of Rochester

Melissa Hogg, MD MS | University of Pittsburgh Medical Center

Michael G. House, MD | Indiana University School of Medicine

David Iannitti, MD | Carolinas HealthCare System

Oscar C. Imventarza, MD | Hospital Argerich- Hospital Garrahan

William R. Jarnagin, MD | Memorial Sloan Kettering Cancer Center

Jenna L. Jeganathan, PA-C | Cleveland Clinic

D. Rohan Jeyarajah , MD | Trinity Care Surgical

Lynt B. Johnson, MD | Medstar Georgetown University Hospital

Matthew Katz, MD | UT MD Anderson Cancer Center

Kaitlyn J. Kelly, MD | University of California San Diego

Tara S. Kent, MD | Beth Israel Deaconess Medical Center, Harvard Medical School

T. Peter Kingham, MD | Memorial Sloan Kettering Cancer Center

Tanya Kintz, DNP, FNP-BC, HNB-BC, AOCNP | Henry Ford Hospital

Clifford Y. Ko, MD, MS, MSHS | University of California-Los Angeles/

American College of Surgeons

David Kooby, MD | Emory University

Major Lee, MD, PhD | University of Pennsylvania

Jeffrey E. Lee, MD | UTMD Anderson Cancer Center

Javier C. Lendoire, MD, PhD | Hospital Dr C Argerich

Keith D. Lillemoe, MD | Massachusetts General Hospital

David C. Linehan, MD | University of Rochester Medical Center

Cherese Lofton, RN | Cleveland Clinic

Quan Ly, MD | University of Nebraska Medical Center

Marcel Machado, MD | University of São Paulo

Shishir K. Maithel, MD | Emory University

Ajay Maker, MD | University of Illinois at Chicago

Giuseppe Malleo, MD, PhD | The Pancreas Institute, University of Verona

Lindsey Manos, DHSc, PA-C | Johns Hopkins Hospital

John Mansour, MD | University of Texas Southwestern Medical Center

Robert CG Martin, MD, PhD | University of Louisville

Jeffrey B. Matthews, MD | University of Chicago

Miguel Angel Mercado, MD | Instituto Nacional de Ciencias Medicas Y Nutricion

Salvador Zubiran

Nipun B. Merchant, MD | University of Miami Hospital




Charles Miller, MD | Cleveland Clinic

Rebecca M. Minter, MD | University of Wisconsin

Andre Montagnini, MD | Universidade de Sao Paulo, Brazil

Katy Morgan, MD | Medical University of South Carolina

Carol-anne Moulton, MD | University Health Network, University of Toronto

Satish N. Nadig, MD, PhD | Medical University of South Carolina

Hari Nathan, MD, PhD | University of Michigan

Nathan Ogilvie, PA-C | Wake Forest Baptist Medical Center

Susan L. Orloff, MD | Oregon Health & Science University

Nicholas A. O’Rourke, MBBS | Royal Brisbane Hospital

Houssam G. Osman, MD | Methodist Richardson Medical Center

Scott E. Page, | University of Michigan

Martin Palavecino, MD | Hospital Italiano de Buenos Aires

Ann Parker, CRNP | George Washington University Hospital

Timothy M. Pawlik, MD, MPH, PhD | The Ohio State University Medical Center

Charles Wright Pinson, MD, MBA | Vanderbilt University Medical Center

Patricia A. Rebolledo, MD | Hospital San Borja Arriaran

Sarah Reed, MHS, PA-C | Duke University

Flavio G. Rocha, MD | Virginia Mason Medical Center

Juan C. Sabogal, MD, MSc | Mederi Hospital and San Ignacio Hospital

Riad Salem, MD, MBA | Northwestern University

Benjamin Samstein, MD | Weill Cornell Medicine

Juan M. Sarmiento, MD | Emory University

Courtney L. Scaife, MD | University of Utah

Richard Schulick, MD, MBA | University of Colorado School of Medicine

Charles R. Scoggins, MD MBA | University of Louisville

Ashley H. Seawright, DNP, ACNP-BC | University of Mississippi Medical Center

Dorry Segev, MD PhD | Johns Hopkins University

Frans I. Serpa, MD | Hospital Carlos Andrade Marin

Jason K. Sicklick, MD | University of California San Diego

Robert Simon, MD | Cleveland Clinic Foundation

Davendra Sohal, MD | Cleveland Clinic

Christopher J. Sonnenday, MD, MHS | University of Michigan

Charles St. Hill, MD | UNLV School of Medicine

Charles A. Staley, MD | Emory University

Mark S. Talamonti, MD | NorthShore University HealthSystem

Alfred J. Tector, MD, PhD | University of Alabama at Birmingham


128


Mark J. Truty, MD, MS | Mayo Clinic

Jennifer F. Tseng, MD, MPH | Boston University School of Medicine

Nicholas Vauthey, MD | MD Anderson Cancer Center

Mario Vilatoba, MD | Instituto Nacional de Ciencias Medicas y Nutricion

Charles M. Vollmer, MD | University of Pennsylvania

Dennis Vrochides, MD | Carolinas HealthCare System

Dionisios Vrochides, MD, PhD | Carolinas Medical Center

Lan P. Vu, PA-C | UT Southwestern Medical Center

Susanne Warner, MD | City of Hope

Sharon Weber, MD | University of Wisconsin - Madison

Alice C. Wei, MD | University Health Network, University of Toronto

Rebekah R. White, MD | University of California San Diego

Emily R. Winslow, MD, MS | University of Wisconsin

Christopher L. Wolfgang, MD, PhD | Johns Hopkins

Herbert J. Zeh, MD | University of Pittsburgh Medical Center

Gazi B. Zibari, MD | Willis-Knighton Health System

Nicholas J. Zyromski, MD | Indiana University School of Medicine



FLOORPLANS &

EXHIBIT INFORMATION


130

HOTEL FLOORPLANS



HOTEL FLOORPLANS CONTINUED


132

EXHIBIT HALL DIAGRAM

Inventory

Dimension8'x10'8'x30'

Size80

240

Totals:

Qty251

26

SqFt2,000

240

2,240

Sky HookPatch Room

AMERICANA 3

FIREEXIT

FIREEXIT

FIREEXIT

SHOWENTRANCE

BO

NE

YA

RD

7'

7'

12'

42'

F & B AREA

1920

11

10

9

18

17

16

15

8

7

6

5

4

3

2

1

21

22

23

24

25

26

27

28

10'

12'-4

" 12 30'

9'-7"

JLFN.T.S.

11-8-173

AMERICANA BALLROOMLOEWS MIAMI BEACH HOTEL

1601 COLLINS AVEMIAMI BEACH, FL 33139 All concepts, designs and arrangements represented by this drawing were created by Expo Convention

Contractors Inc, and remain the property of said company. None of such ideas shall be used or disclosed toany person, firm or company for any purpose without prior written permission from ExpoCCI.

CONVENTION CONTRACTORS INC

www.expocci.com15959 NW 15th AVE.

MIAMI, FL 33169PHONE: (305) 751-1234FAX: (305) 754-9402

DRAWING NO.:

DATE:

SCALE:

DRAWN BY:

REVISIONS:

AHPBA ANNUAL MEETINGMARCH 7-11, 2018

1-31-18



EXHIBITOR SHOWCASE

Location: Americana 4 EXHIBIT HOURS

Thursday 5:15pm – 7:00pm

Friday 7:00am – 7:30pm

Saturday 7:00am – 1:00pm EVENTS HELD IN EXHIBIT HALL

Thursday

5:30pm – 7:00pm Welcome Reception

Friday

7:00am – 8:00am Continental Breakfast

10:30am – 11:00am Morning Beverage Break

12:30pm – 1:00pm Lunch

3:30pm – 4:00pm Afternoon Beverage Break

6:30pm – 7:30pm Cocktail Reception

Saturday

6:45am – 8:00am Continental Breakfast

10:00am – 10:30am Morning Break

12:00pm – 12:30pm Lunch EXHIBITOR PASSPORT Visit the exhibitors, complete your passport and enter a chance to win the raffle. Passport cards must be turned in to the AHPBA registration desk by Saturday afternoon.

/AHPBA

#ahpba18

/AHPBA


134

AHPBA EXHIBITORS AND SPONSORS

EXHIBITORSBOOTH

NUMBER

AbbVie, Inc. 24

Aesculap, Inc. 8

AngioDynamics 16

Bayer 9

BK Ultrasound 15

Boston Scientific 22

BTG 7

ChiRhoClin, Inc. 10

Cine-Med, Inc. 23

Erbe USA 17

Ethicon 12-14

Hitachi Healthcare 21

Integra Life Sciences 18

Medistim 11

Medtronic 1-3

Mission Healthcare 20

Novartis 28

Olympus 6

Sirtex Medical 4

Stryker 27

Thompson Surgical Instruments, Inc. 26

IHPBA 25

Vital Therapies 19

Zero Gravity Skin 5



Just a few highlights of the many benefits of Fellowship in the Americas Hepato-Pancreato-Biliary Association!

The Americas Heptao-Pancreato-Biliary Association (AHPBA),an incorporated, nonprofit organization, was created with a vision of devoting itself to relieving the human suffering caused by HPB disorders throughout the world, by improving education, training, innovation, research and patient care. The AHPBA serves as the American Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA). Today, more than 1,000 multidisciplinary active members create the energy of our society. Together with surgeons, residents and fellows, allied health, interventional/diagnostic radiologists, gastroenterologists, medical and radiation oncologists, pathologists, transplantation physicians and scientists we meet, have fun and learn and collaborate. The AHPBA fosters an atmosphere of alliance among clinicians and scientists to advance both learning and patient care.

BENEFITS OF MEMBERSHIPMembership in the AHPBA will provide you with an opportunity to belong to one of the most recognized organizations in the HPB field. Active member benefits include:

• Automatic joint membership in IHPBA (International Hepato-Pacreato- Biliary Association) • Discounted registration rates at the annual meeting.

• E-access to subscriptions to the premier journal of our specialty, HPB.

• State-of-the-art consensus conferences and chapter meetings that keep you on the cutting edge of clinical care and research.

• Eligibility to apply for research grants, travel fellowships and awards.

• Opportunities to develop professional and social relationships with leaders in the field of gastrointestinal and HPB surgery.

AHPBA Membership Benefits

For more information on application guidelines or to apply, please visit www.ahpba.org/membership


136

Americas Hepato-Pancreato- Biliary Association 2625 West 51st Terrace Westwood, KS 66205 t: [email protected]/AHPBA/AHPBA

Join today!The AHPBA is a great place for HPB enthusiasts

to meet, learn and collaborate!



2017 - 2018 NEW MEMBERS*New Members as of 12/31/2017

Raafat Abdel-Misih | Christiana Care Health System, USA

Emilio Alonso | University of California Riverside, USA

Ilan Avin | Novant Heath Carolina Surgical, USA

Sabrina Aziz | The Mount Sinai Hospital, USA

Kanthi Rekha Badipatla | Bronx Lebanon Hospital Center, USA

George Baison | Tufts Medical Center, USA

Joseph Bennett | Christiana Care Health System, USA

Rushin Brahmbhatt | UPMC, USA

John Bynon | Memorial Hermann/University of Texas Houston, USA

Gonzalez De Pedro Carlos | Servicio Andaluz de Salud. Hospital Universitario

Virgen Del Rocio, Spain

andre carpenter | Willis Knighton Medical Center, USA

Pamela Cassidy | Hospital of the University of Pennsylvania, USA

Rohit Chandwani | Weill Cornell Medicine, USA

Tammy Chang | University of California, San Francisco, USA

Sicong Chen | Shenzhen Nanshan hospial, China

Jose Roberto Contreras Ramirez | Instituto Guatemalteco de Seguridad Social,

Guatemala

Harvey Cramer | Indiana University Health Pathology Laboratory, USA

Carlos Derosas | Clinica Santa María, Chile

Alexandra Dili | CHU UCL Namur, Belgium

Juan Echeverri | Toronto General Hospital, Canada

Bijan Eghtesad | Cleveland Clinic, USA

Irami Araujo Filho | Hospital Universitário Onofre Lopes, Brazil

Shani Fruchter | Florida Hospital, USA

Natasha Goins | Methodist LeBonheur Healthcare, USA

Jason Gold | VA Boston Healthcare System, USA

Lisha Ho | Emory Winship Cancer Institute, USA

Caroline Jadlowiec | Mayo Clinic, USA

Sean Judge | University of California, Davis, USA

Navpreet Kaur | Keck School of Medicine of USC, USA

Anna Lakoma | Loyola University Medical Center, USA

Russell Langan | Rutgers Cancer Institute of New Jersey, RWJBarnabas Health, USA

Congratulations and Welcome to our Newest Members


138

2017 - 2018 NEW MEMBERS*New Members as of 12/31/2017

Tingbo Liang | The Second Affiliated Hospital, School of Medicine, Zhejiang

Univesity, China

Heather Lillemoe | Vanderbilt University Medical Center, USA

Mokenge Malafa | Moffitt Cancer Center, USA

James Marsh | West Virginia University, USA

Mariano Massa | Hospital Español, Argentina

Roy Jason Montecillo | The Health Centrum Hospital, Phillipines

Yutaka Mushiake | Iwakuni clinical center, Japan

Christian Eugen Oberkofler | University Hospital Zürich, Switzerland

Anita Pabani | St John Providence, USA

Fabrizio Panaro | Montpellier UNiversity Hospital-School of Medicine, France

Bradley Reames | Johns Hopkins Medicine, USA

Manas Roy | Tata Medical Center, India

Maria Liz Sánchez Rivas | Hospital de Clinicas, Paraguay

Hector Saucedo Crespo | Avera Medical Group, USA

Darryl Schuitevoerder | Oregon Health & Science University, USA

Debbie Sebring | University of Michigan Hospital, USA

Ana Senent Boza | SAS, Spain

Francisco Antonio Sergi Filho | Grupo Hepato, Brazil

Anton Skaro | London Health Sciences Center- University Hospital, Canada

Kerrington Smith | Dartmouth-Hitchcock, USA

Fodil Taleb | HOPITAUX DU LEMAN, France

Juliane Theurer | Hospital of the Johannes-Gutenberg-University Mainz, Germany

Kiara Tulla | University of Illinois at Chicago, USA

Constantinos Zambirinis | Memorial Sloan Kettering Cancer Center, USA

Konstantinos Zorbas | Temple University Hospital, USA

Impact Factor 3.290

Home of the HPB Journal

Well established as an international forum for clinical, scientific and educational communication, HPB is the major journal in which the latest advances in our specialty are published. HPB recently achieved a further increase in impact factor to 3.290.

The Editorial Team will not be complacent with this accomplishment and intend to drive further the quality of the Journal’s content. In twelve issues over the year HPB encompasses all aspects of benign and malignant hepatobiliary disease and its management through:-

• the manuscripts of key presentations at regional and international congresses

• leading articles

• expert reviews

• original articles

• editorials

• virtual journal clubs

• reader correspondence

• and more . . .

Home of myHPBmyHPB is an innovative e-learning platform providing IHPBA members with up-to-date, quality-assured content, including master class videos and key educational resources as well as a meeting space to discuss the latest developments in our speciality field. This platform has been developed to facilitate access to the highest quality learning resources and to enable interaction with like-minded individuals.

New to myHPB - Pre-operative Planning ModulesWe are pleased to announce our new pre-operative planning modules, the latest exciting addition to the educational content on myHPB. These modules focus on recognizing procedure - and patient-specific key decision-making points during preoperative planning and feature expert surgeons describing their slowing down moments in standard procedures. “Slowing down when you should” moments are characteristic of expert surgical judgment and may be anticipated and proactively planned for, or triggered by unanticipated situations that arise during the operation. Please check out these modules on www.myhpb.org.

Membership Renewal

IHPBA and AHPBA offer a single

membership package, making paying your dues

more convenient and cost effective.

To enjoy the benefits of membership of both

associations, don’t forget to renew your

membership or join as a new member.

All of our membership options are detailed

on the website.

Please visit

www.ihpba.org

As well as in hard copy, HPB can be accessed on-line by members via the IHPBA website, with improved readability and functionality, and can be viewed on your computer, tablet or mobile device.

International Hepato-Pancreato-Biliary Association

Miami IHPBA myHPB iii.indd 1 29/12/2017 13:03AHPBA_2018_FinalProgram.indd 138 2/22/18 9:13 PM

Impact Factor 3.290

Home of the HPB Journal

Well established as an international forum for clinical, scientific and educational communication, HPB is the major journal in which the latest advances in our specialty are published. HPB recently achieved a further increase in impact factor to 3.290.

The Editorial Team will not be complacent with this accomplishment and intend to drive further the quality of the Journal’s content. In twelve issues over the year HPB encompasses all aspects of benign and malignant hepatobiliary disease and its management through:-

• the manuscripts of key presentations at regional and international congresses

• leading articles

• expert reviews

• original articles

• editorials

• virtual journal clubs

• reader correspondence

• and more . . .

Home of myHPBmyHPB is an innovative e-learning platform providing IHPBA members with up-to-date, quality-assured content, including master class videos and key educational resources as well as a meeting space to discuss the latest developments in our speciality field. This platform has been developed to facilitate access to the highest quality learning resources and to enable interaction with like-minded individuals.

New to myHPB - Pre-operative Planning ModulesWe are pleased to announce our new pre-operative planning modules, the latest exciting addition to the educational content on myHPB. These modules focus on recognizing procedure - and patient-specific key decision-making points during preoperative planning and feature expert surgeons describing their slowing down moments in standard procedures. “Slowing down when you should” moments are characteristic of expert surgical judgment and may be anticipated and proactively planned for, or triggered by unanticipated situations that arise during the operation. Please check out these modules on www.myhpb.org.

Membership Renewal

IHPBA and AHPBA offer a single

membership package, making paying your dues

more convenient and cost effective.

To enjoy the benefits of membership of both

associations, don’t forget to renew your

membership or join as a new member.

All of our membership options are detailed

on the website.

Please visit

www.ihpba.org

As well as in hard copy, HPB can be accessed on-line by members via the IHPBA website, with improved readability and functionality, and can be viewed on your computer, tablet or mobile device.

International Hepato-Pancreato-Biliary Association

Miami IHPBA myHPB iii.indd 1 29/12/2017 13:03AHPBA_2018_FinalProgram.indd 139 2/22/18 9:13 PM

Our GoalsIHPBA is a non-profit organisation devoted to relieving world-wide human suffering caused by HPB disorders by improving education, training, innovation, research and patient care.

Our goals are to:-

1. Promote understanding of the causes, investigation and treatment of disorders of the liver, pancreas and biliary tree.

2. Encourage the interchange of clinical and scientific knowledge among surgeons and members of related disciplines working in this field.

3. Study any relevant problems that affect the liver, pancreas and biliary tract.

4. Facilitate collaborative research into the factors that lead to disease of these organs and their prevention.

5. Foster friendship among clinicians and scientists involved in hepatic, pancreatic and biliary disciplines.

6. Strive towards the highest ethical standards in the Association’s fields of endeavour.

7. Foster education and career development in the field through an identifiable funding mechanism.

Membership BenefitsJoin or renew your membership and continue to enjoy the many benefits of being a member of IHPBA. We currently have more than 2,400 members from over 92 countries. IHPBA fosters close relations with its three Regional Associations: Americas, Asian/Pacific and Europe/Africa/Middle East, extending to joint membership, shared journal and collaborative projects and meetings. Membership benefits include:-

• being part of a growing professional and global network of your peers

• Interaction with other HPB specialists and leaders

• Access to myHPB thriving online community with access to videos and discussions contributed by leaders in the field, including the Pre-Op Planning Modules which is an exciting new development on myHPB

• Networking and career opportunities

• Annual subscription for online access to the official journal, HPB, one of the world’s top 50 surgical journals with an impact factor of 3.210

• The opportunity to order a printed copy of HPB to be sent to you monthly at a discounted cost

• Discounted registration to the biennial IHPBA World Congress, visit www.ihpba2018.com for more information

• Discounted registration fees for all Regional Congresses

• Regular IHPBA electronic newsletters to keep you up to date

• Access to technical and training guidelines

• Eligibility to apply for the Warren Research Fellowship

• Access to the IHPBA Fellowship Registry

• And much more . . .

IHPBA Fellowship RegistryIHPBA membership gives you access to the HPB Fellowship Registry, one of the most popular areas of the IHPBA website. Updated weekly, IHPBA seeks to ensure that this registry is an essential resource tool for general surgery trainees seeking further training in HPB surgery. It contains details of fellowships offered in all three regions, categorised by country. Newly added: reports by recently-trained fellows.

Join or Renew your MembershipPlease visit: www.ihpba.org

Please DonateThe IHPBA Foundation relies on support from our members.

For more information please visit: www.ihpba.org.

IHPBA FoundationThe IHPBA Foundation co-ordinates IHPBA’s charitable work in four areas:

• Education • Research

• Kenneth Warren Fellowship • Outreach

To volunteer, donate or find our more about the the IHPBA Foundation’s important work, please see our separate advert or the IHPBA website.

Miami IHPBA myHPB iii.indd 2 29/12/2017 13:03

IHPBA Foundation: Education, Research & Training

Global ReachIHPBA FoundationThe IHPBA Foundation co-ordinates IHPBA’s charitable work in three key areas:

• EducationThis includes international education, training and evaluation, e-learning and tele-mentoring.

• ResearchThe new home for the IHPBA Kenneth Warren Fellowship.

• OutreachWe are delighted to be collaborating with the World Health Organization on a series of global outreach missions to assist in the care of patients with HPB diseases in developing countries by fostering, mentoring and supporting local surgeons and institutions. A number of international projects have been carried out and more are planned. You can find further information about this important aspect of our work or volunteer to take part in an outreach mission on our website.

Please visit www.ihpba.org > Outreach Projects for more information.

IHPBA Kenneth Warren FellowshipEach year the Warren Fellowship is awarded to an outstanding young investigator to promote collaborative scientific discovery in HPB diseases through clinical or laboratory research. $25,000 is awarded to support the investigator’s own salary over 12 months in a host department outside the applicant’s own department and country. We were delighted to be able to award two Kenneth Warren Fellowships in 2017. You can read about experiences of past fellows on the website.

Find out more about the fellowship at: www.ihpba.org > Fellowship

Miami Foundation iv Greyscale.indd 1 29/12/2017 15:23AHPBA_2018_FinalProgram.indd 140 2/22/18 9:13 PM

Our GoalsIHPBA is a non-profit organisation devoted to relieving world-wide human suffering caused by HPB disorders by improving education, training, innovation, research and patient care.

Our goals are to:-

1. Promote understanding of the causes, investigation and treatment of disorders of the liver, pancreas and biliary tree.

2. Encourage the interchange of clinical and scientific knowledge among surgeons and members of related disciplines working in this field.

3. Study any relevant problems that affect the liver, pancreas and biliary tract.

4. Facilitate collaborative research into the factors that lead to disease of these organs and their prevention.

5. Foster friendship among clinicians and scientists involved in hepatic, pancreatic and biliary disciplines.

6. Strive towards the highest ethical standards in the Association’s fields of endeavour.

7. Foster education and career development in the field through an identifiable funding mechanism.

Membership BenefitsJoin or renew your membership and continue to enjoy the many benefits of being a member of IHPBA. We currently have more than 2,400 members from over 92 countries. IHPBA fosters close relations with its three Regional Associations: Americas, Asian/Pacific and Europe/Africa/Middle East, extending to joint membership, shared journal and collaborative projects and meetings. Membership benefits include:-

• being part of a growing professional and global network of your peers

• Interaction with other HPB specialists and leaders

• Access to myHPB thriving online community with access to videos and discussions contributed by leaders in the field, including the Pre-Op Planning Modules which is an exciting new development on myHPB

• Networking and career opportunities

• Annual subscription for online access to the official journal, HPB, one of the world’s top 50 surgical journals with an impact factor of 3.210

• The opportunity to order a printed copy of HPB to be sent to you monthly at a discounted cost

• Discounted registration to the biennial IHPBA World Congress, visit www.ihpba2018.com for more information

• Discounted registration fees for all Regional Congresses

• Regular IHPBA electronic newsletters to keep you up to date

• Access to technical and training guidelines

• Eligibility to apply for the Warren Research Fellowship

• Access to the IHPBA Fellowship Registry

• And much more . . .

IHPBA Fellowship RegistryIHPBA membership gives you access to the HPB Fellowship Registry, one of the most popular areas of the IHPBA website. Updated weekly, IHPBA seeks to ensure that this registry is an essential resource tool for general surgery trainees seeking further training in HPB surgery. It contains details of fellowships offered in all three regions, categorised by country. Newly added: reports by recently-trained fellows.

Join or Renew your MembershipPlease visit: www.ihpba.org

Please DonateThe IHPBA Foundation relies on support from our members.

For more information please visit: www.ihpba.org.

IHPBA FoundationThe IHPBA Foundation co-ordinates IHPBA’s charitable work in four areas:

• Education • Research

• Kenneth Warren Fellowship • Outreach

To volunteer, donate or find our more about the the IHPBA Foundation’s important work, please see our separate advert or the IHPBA website.

Miami IHPBA myHPB iii.indd 2 29/12/2017 13:03

IHPBA Foundation: Education, Research & Training

Global ReachIHPBA FoundationThe IHPBA Foundation co-ordinates IHPBA’s charitable work in three key areas:

• EducationThis includes international education, training and evaluation, e-learning and tele-mentoring.

• ResearchThe new home for the IHPBA Kenneth Warren Fellowship.

• OutreachWe are delighted to be collaborating with the World Health Organization on a series of global outreach missions to assist in the care of patients with HPB diseases in developing countries by fostering, mentoring and supporting local surgeons and institutions. A number of international projects have been carried out and more are planned. You can find further information about this important aspect of our work or volunteer to take part in an outreach mission on our website.

Please visit www.ihpba.org > Outreach Projects for more information.

IHPBA Kenneth Warren FellowshipEach year the Warren Fellowship is awarded to an outstanding young investigator to promote collaborative scientific discovery in HPB diseases through clinical or laboratory research. $25,000 is awarded to support the investigator’s own salary over 12 months in a host department outside the applicant’s own department and country. We were delighted to be able to award two Kenneth Warren Fellowships in 2017. You can read about experiences of past fellows on the website.

Find out more about the fellowship at: www.ihpba.org > Fellowship

Miami Foundation iv Greyscale.indd 1 29/12/2017 15:23AHPBA_2018_FinalProgram.indd 141 2/22/18 9:13 PM

IHPBA Foundation DonorsThe Foundation promotes collaborative scientific discovery in hepatic, biliary, or pancreatic diseases through support of clinical or laboratory research by a young investigator in a laboratory outside the applicant’s own department and country. Fellowships, funded by the Foundation, support the recipient’s own salary. Further details of the history and goals of the Foundation are detailed on the IHPBA website: http://www.ihpba.org/157_IHPBA-Foundation.html.We are proud to recognise our donors and would like to thank all of the organisations and individual supporters whose continued generosity allows us to continue this important work.

Warren Family Circle$100,000 and upKenneth WarrenThomas WarrenInternational Hepato-Pancreato-Biliary Association (IHPBA)

International Life Circle$50,000 - $99,999Americas Hepato-Pancreato-Biliary Association (AHPBA)Wiley Blackwell

Sustainers$10,000 - $24,999Australia and New Zealand Hepatic, Pancreatic and Biliary Association (ANZHPBA)European-African Hepato-Pancreato-Biliary Association (E-AHPBA)O. James GardenC. Wright PinsonHenry A. PittSally Warren

Christoph AuschMark CalleryJohn W. ChenCharles ChengMarcelo EnneDaniel Figueroa-Tentori

Ellen HagopianHo-seong HanClem ImrieYoshifumi KawaradaBasil P. KekisKi-Hun Kim

Norihiro KokudoSatoshi KondoDavid KoobyKeith LillemoeMichelle MolinariAttila Nakeeb

lgin ÖzdenMaris PavarsKaya SaribeyogluHarjit SinghKarl SondenaaTianqiang Song

Steven StrasbergCheng-hsi SuMiguel Angel S. Munoz

Eduardo AkaishiMohammed AlsaghierTaku AokiGerard AranhaTakehide AsanoOffei Kwaku AsareTelesforo BacchellaMohammed BallalJose Bartilotti FernandezDarlene BarrGiulio BelliNeil Anthony BerryMarc BesselinkAndrew BiankinChristoph BroelschMatteo CesconMariana Chavez

Julian ChoiMichael ChotiSean ClearyEduardo de SantibanesHoracio D’AgostinoAdalberto de AraujoJeroen de JongeMikhail EfanovChristos GalanopoulosGeorgios GlantzounisTakeshi GochoMehmet HaberalChoi HanlimNezor HouliThomas HowardShuji IsajiDhiresh Rohan Jeyarajah

Timoleon KakavoulisSanteev KanoriaIgor E KhatkovWolfram Trudo KnoefelJaime KrugerNobuaki KurauchiRoberto LauroSer Yee LeeSung-gyu LeeMichael Ka Wah LiSameer MihrshahiKohji MiyazakiGareth Morris-StiffSatvinder MudanAkimasa NakaoLeslie NathansonOvergaard Nielson

Ryuta NishitaiGregory NolanLilia Osorio-MolinaCriostoir O’SuilleabhainPurvi Yogesh ParikhIl Young ParkStefano PuleoGuntars PupelisRenyi QinMohammed Saeed QuraishyDaltro RosaKerrington SmithEduardo Sanez CorralesJon Arne SøreideGandham SrinivasRoger Rangel

Norbert SenningerChristopher SonnendayShin TakasakiClara Tan-TamMark TaylorJorge H. Tobar de LeonGuido TorzilliEvangelos C. TsimoyiannisSimon TurcotteTjarda van HeekAndrew WarshawRobin WilliamsonKrzysztof Zieniewicz

Sponsors $250 - $499

Friends $100 - $249

To make a donation, please go to the IHPBA website http://www.ihpba.org/48_Charitable-Donations.html, or do so when renewing your IHPBA dues. Donor wall updated 20 December 2017

Leaders$1,000 - $9,999Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA)IHPBA China National ChapterMarkus BüchlerJohn L. CameronXiao-Ping ChenChris DiamondisElijah DixonItaru EndoCarlos Fernandez-del CastilloDirk Joan GoumaW. Scott HeltonOscar ImventarzaPalepu JagannathWilliam R JarnaginJoan E. KolliganJoseph W.Y. LauSean MulvihillYuji Nimura

James ToouliThomas van GulikGeorge Warren

Benefactors$500 - $999Jacques BelghitiRoland Montenegro CostaMichael D’AngelicaCarlos Florez-ZorillaMahesh GoelMichael J JacobsChen-guo KerMickael LesurtelSusan OrloffSamuel Ramos LinajeAlvarao RiartShailesh V ShrikhandeGlenn D SteeleMiguel Angel Suarez MunozAtushi Sugioka

Miami Foundation iv Greyscale.indd 2 29/12/2017 15:23

Now seeking applications for the 2018/2019 IHPBA Kenneth Warren Fellowship

BackgroundDr Kenneth W. Warren, of Boston, USA, was recognised internationally as an authority on diseases of the liver, pancreas and biliary tract. Committed to advancement of the surgical science in his field, Dr Warren enjoyed an illustrious career spanning over 60 years. He established the IHPBA Kenneth Warren Foundation (now part of the IHPBA Foundation) in 2000 and passed away the following year at the age of 90.

PurposeThe goal of the fellowship is to promote collaborative scientific discovery in HPB diseases through support of clinical or laboratory research for a young investigator in a laboratory outside the applicant’s own department and country.

Conditions of AwardThe applicant should be a person seeking additional training in the laboratory with a mentor. Applicants will normally travel to the host institution to begin the fellowship and should confirm their intention to return to their home country after completion of their research. The award will be made on 1st July 2018 and the fellowship may commence at any time up to six months after this date. The awardee will notify the Chairperson of the IHPBA Research Committee of acceptance or refusal of the award by 14th July 2018. The applicant and the host sponsor must be members of the IHPBA at the time of the application. An applicant may apply for IHPBA membership at the time of the application, but the host sponsor must have been an active IHPBA member for one year immediately prior to the application.

Fellowship StipendA stipend of USD 25,000 will be granted to support the recipient’s salary in the conduct of clinical or laboratory research over 12 months in a host department.

Fellowship Application ProcessTo be eligible for consideration, the following items should be submitted to the IHPBA in electronic format at the email address below:-

• Cover letter

• The applicant’s curriculum vitae

• The mentor’s curriculum vitae from the host institution

• A summary of the research project, including title, background, aims, methodology and timeframe of the research (not to exceed one A4 or letter size page)

• An acknowledgment from the host institution of support for the applicant’s research

• Letter of reference from the mentor at the host institution

• Letter of reference from the applicant’s home institution

Closing Date: 30th April 2018Please send applications to:

IHPBA Kenneth Warren Fellowship • Email: [email protected]

Miami Warren Fellowship Grey.indd 1 29/12/2017 15:30AHPBA_2018_FinalProgram.indd 142 2/22/18 9:13 PM

IHPBA Foundation DonorsThe Foundation promotes collaborative scientific discovery in hepatic, biliary, or pancreatic diseases through support of clinical or laboratory research by a young investigator in a laboratory outside the applicant’s own department and country. Fellowships, funded by the Foundation, support the recipient’s own salary. Further details of the history and goals of the Foundation are detailed on the IHPBA website: http://www.ihpba.org/157_IHPBA-Foundation.html.We are proud to recognise our donors and would like to thank all of the organisations and individual supporters whose continued generosity allows us to continue this important work.

Warren Family Circle$100,000 and upKenneth WarrenThomas WarrenInternational Hepato-Pancreato-Biliary Association (IHPBA)

International Life Circle$50,000 - $99,999Americas Hepato-Pancreato-Biliary Association (AHPBA)Wiley Blackwell

Sustainers$10,000 - $24,999Australia and New Zealand Hepatic, Pancreatic and Biliary Association (ANZHPBA)European-African Hepato-Pancreato-Biliary Association (E-AHPBA)O. James GardenC. Wright PinsonHenry A. PittSally Warren

Christoph AuschMark CalleryJohn W. ChenCharles ChengMarcelo EnneDaniel Figueroa-Tentori

Ellen HagopianHo-seong HanClem ImrieYoshifumi KawaradaBasil P. KekisKi-Hun Kim

Norihiro KokudoSatoshi KondoDavid KoobyKeith LillemoeMichelle MolinariAttila Nakeeb

lgin ÖzdenMaris PavarsKaya SaribeyogluHarjit SinghKarl SondenaaTianqiang Song

Steven StrasbergCheng-hsi SuMiguel Angel S. Munoz

Eduardo AkaishiMohammed AlsaghierTaku AokiGerard AranhaTakehide AsanoOffei Kwaku AsareTelesforo BacchellaMohammed BallalJose Bartilotti FernandezDarlene BarrGiulio BelliNeil Anthony BerryMarc BesselinkAndrew BiankinChristoph BroelschMatteo CesconMariana Chavez

Julian ChoiMichael ChotiSean ClearyEduardo de SantibanesHoracio D’AgostinoAdalberto de AraujoJeroen de JongeMikhail EfanovChristos GalanopoulosGeorgios GlantzounisTakeshi GochoMehmet HaberalChoi HanlimNezor HouliThomas HowardShuji IsajiDhiresh Rohan Jeyarajah

Timoleon KakavoulisSanteev KanoriaIgor E KhatkovWolfram Trudo KnoefelJaime KrugerNobuaki KurauchiRoberto LauroSer Yee LeeSung-gyu LeeMichael Ka Wah LiSameer MihrshahiKohji MiyazakiGareth Morris-StiffSatvinder MudanAkimasa NakaoLeslie NathansonOvergaard Nielson

Ryuta NishitaiGregory NolanLilia Osorio-MolinaCriostoir O’SuilleabhainPurvi Yogesh ParikhIl Young ParkStefano PuleoGuntars PupelisRenyi QinMohammed Saeed QuraishyDaltro RosaKerrington SmithEduardo Sanez CorralesJon Arne SøreideGandham SrinivasRoger Rangel

Norbert SenningerChristopher SonnendayShin TakasakiClara Tan-TamMark TaylorJorge H. Tobar de LeonGuido TorzilliEvangelos C. TsimoyiannisSimon TurcotteTjarda van HeekAndrew WarshawRobin WilliamsonKrzysztof Zieniewicz

Sponsors $250 - $499

Friends $100 - $249

To make a donation, please go to the IHPBA website http://www.ihpba.org/48_Charitable-Donations.html, or do so when renewing your IHPBA dues. Donor wall updated 20 December 2017

Leaders$1,000 - $9,999Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA)IHPBA China National ChapterMarkus BüchlerJohn L. CameronXiao-Ping ChenChris DiamondisElijah DixonItaru EndoCarlos Fernandez-del CastilloDirk Joan GoumaW. Scott HeltonOscar ImventarzaPalepu JagannathWilliam R JarnaginJoan E. KolliganJoseph W.Y. LauSean MulvihillYuji Nimura

James ToouliThomas van GulikGeorge Warren

Benefactors$500 - $999Jacques BelghitiRoland Montenegro CostaMichael D’AngelicaCarlos Florez-ZorillaMahesh GoelMichael J JacobsChen-guo KerMickael LesurtelSusan OrloffSamuel Ramos LinajeAlvarao RiartShailesh V ShrikhandeGlenn D SteeleMiguel Angel Suarez MunozAtushi Sugioka

Miami Foundation iv Greyscale.indd 2 29/12/2017 15:23

Now seeking applications for the 2018/2019 IHPBA Kenneth Warren Fellowship

BackgroundDr Kenneth W. Warren, of Boston, USA, was recognised internationally as an authority on diseases of the liver, pancreas and biliary tract. Committed to advancement of the surgical science in his field, Dr Warren enjoyed an illustrious career spanning over 60 years. He established the IHPBA Kenneth Warren Foundation (now part of the IHPBA Foundation) in 2000 and passed away the following year at the age of 90.

PurposeThe goal of the fellowship is to promote collaborative scientific discovery in HPB diseases through support of clinical or laboratory research for a young investigator in a laboratory outside the applicant’s own department and country.

Conditions of AwardThe applicant should be a person seeking additional training in the laboratory with a mentor. Applicants will normally travel to the host institution to begin the fellowship and should confirm their intention to return to their home country after completion of their research. The award will be made on 1st July 2018 and the fellowship may commence at any time up to six months after this date. The awardee will notify the Chairperson of the IHPBA Research Committee of acceptance or refusal of the award by 14th July 2018. The applicant and the host sponsor must be members of the IHPBA at the time of the application. An applicant may apply for IHPBA membership at the time of the application, but the host sponsor must have been an active IHPBA member for one year immediately prior to the application.

Fellowship StipendA stipend of USD 25,000 will be granted to support the recipient’s salary in the conduct of clinical or laboratory research over 12 months in a host department.

Fellowship Application ProcessTo be eligible for consideration, the following items should be submitted to the IHPBA in electronic format at the email address below:-

• Cover letter

• The applicant’s curriculum vitae

• The mentor’s curriculum vitae from the host institution

• A summary of the research project, including title, background, aims, methodology and timeframe of the research (not to exceed one A4 or letter size page)

• An acknowledgment from the host institution of support for the applicant’s research

• Letter of reference from the mentor at the host institution

• Letter of reference from the applicant’s home institution

Closing Date: 30th April 2018Please send applications to:

IHPBA Kenneth Warren Fellowship • Email: [email protected]

Miami Warren Fellowship Grey.indd 1 29/12/2017 15:30AHPBA_2018_FinalProgram.indd 143 2/22/18 9:13 PM

144

Geneva IHPBA 2018Early

Registration

Deadline:

2nd May 2018

13th WORLD CONGRESS GENEVA

SWITZERLAND

4 - 7 September 2018

President: Pierre-Alain ClavienVice Presidents: G. Mentha (†) , C.Toso www.ihpba2018.orgE-AHPBA

Follow us on

Twitter

https://www.

twitter.com/ihpba2018

and Facebook

https://www.

facebook.com/

ihpba2018

We are delighted to receive a record number of abstracts. Don’t forget to register by the early registration deadline 2nd May



Geneva IHPBA 2018Early

Registration

Deadline:

2nd May 2018

13th WORLD CONGRESS GENEVA

SWITZERLAND

4 - 7 September 2018

President: Pierre-Alain ClavienVice Presidents: G. Mentha (†) , C.Toso www.ihpba2018.orgE-AHPBA

Follow us on

Twitter

https://www.

twitter.com/ihpba2018

and Facebook

https://www.

facebook.com/

ihpba2018

We are delighted to receive a record number of abstracts. Don’t forget to register by the early registration deadline 2nd May

IN MEMORIAM

Michael Rawls Moore Sr., MD Shreveport, LA - Dr. Michael Rawls Moore, Sr., 69, passed away on November 23, 2017. Michael was born on September 11, 1948 in Honolulu, Hawaii. After graduating from the University of Tennessee in Knoxville, TN, he went on to study medicine at the University of Tennessee in Memphis and was awarded his Doctor of Medicine in 1973. He completed a Fellowship in Hematology and Medical Oncology in 1980. Michael and his family moved to Shreveport, Louisiana in 1980, where he practiced Hematology and Oncology at Willis-Knighton. He later worked as a Clinical Associate Professor at Louisiana State University Health from 1996 until the present. He was

a Senior member of the American Federation of Medical Research (AFMR), a member of the American Society of Hematology, a Regular Member of the International Society on Thrombosis and Hemostasis, and a Medical Advisor, ACOS-compliant Tumor Registry, at the Willis-Knighton Cancer Center in Shreveport, Louisiana. Michael loved his children and grandchildren. He found deep joy in serving others through international medical missions in Kurdistan and Honduras. His many hobbies included studying languages, gardening, sailing, playing the guitar, reading, traveling, and discussing complex issues with his friends. Michael was preceded in death by his first wife, Laura Stegbauer Moore. He is survived by his wife Penny Frantom Moore, his sister, Julie Rawls Moore, his son and daughter-in-law, Michael Rawls Moore, Jr., and Kate LaRiche Moore, son and son-in-law, Frank Newland Moore and Mick Alan Lewis; daughter Laura Elizabeth Moore; granddaughters Etta and Iris Moore. Michael is also survived by Christy and Brandon Story and their children Penn and Sam, Erin and Carlos Andica, Jenny and Joe Blaznek and their children Carson and Teagan, and Stephanie and Ryan Bielli. Michael was beloved by his family, friends, and patients and will be dearly missed. Visitation will be held on Sunday. November 26 from 4-6 p.m. at Rose-Neath Funeral Home on Marshall Street. A memorial service will be held on Monday, November 27 at 10:00 a.m. at King’s Highway Christian Church. In lieu of flowers, please make donations to CellCycle to support blood cancer patients. Checks are payable to CellCycle, 3750 Vine Street, Denver, CO 80205 or online at www.cellcycleride.org. Donations may also be made to the Caddo-Bossier Cancer Foundation League, 3300 Albert L. Bicknell Dr. #3, Shreveport, LA 71103.

Published in Shreveport Times from Nov. 25 to Nov. 27, 2017

Michael Rawls Moore Sr., MD


146 MARCH 7 – 11, 2018 | MIAMI BEACH, FLORIDANovartis Pharmaceuticals CorporationEast Hanover, New Jersey 07936–1080 © 2015 Novartis 5/15 T–TPF–1317633

OVER

30YEARSOF WORKING TOGETHER TO

HELP ADDRESSPATIENT NEEDS

T–TPF–1317633_30 Years Ad_4x6_FINAL.indd 1 9/5/17 11:56 AM



Thank you to our Silver Meeting Sponsor

Novartis Pharmaceuticals CorporationEast Hanover, New Jersey 07936–1080 © 2015 Novartis 5/15 T–TPF–1317633

OVER

30YEARSOF WORKING TOGETHER TO

HELP ADDRESSPATIENT NEEDS

T–TPF–1317633_30 Years Ad_4x6_FINAL.indd 1 9/5/17 11:56 AM



Humanitarian Device.TheraSphere® is authorized by Federal Law for use in radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable hepatocellular carcinoma (HCC) who can have placement of appropriately positioned hepatic arterial catheters. The device is also indicated for HCC patients with partial or branch portal vein thrombosis/occlusion, when clinical evaluation warrants the treatment. The effectiveness of this device for this use has not been demonstrated.1 Common adverse effects include fatigue, pain, and nausea. The majority of adverse effects are mild to moderate in severity and are manageable or resolved over time. For details on rare or more severe adverse effects, please refer to the TheraSphere® Package Insert at www.therasphere.com.1,2,3

1. Package Insert – TheraSphere® Yttrium-90 Glass Microspheres – Rev. 14. Biocompatibles UK Ltd, a BTG International group company. Available at: www.therasphere.com 2. Hilgard P, Hamami M, Fouly AE, et al. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 2010;52(5):1741–9. 3. Mazzaferro V, Sposito C, Bhoori S, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology 2013;57(5):1826–37.

TheraSphere® is manufactured for Biocompatibles UK Ltd, a BTG International group company. TheraSphere and the TheraSphere logo are trademarks of Theragenics Corporation, used under license by Biocompatibles UK Ltd. TheraSphere is a registered trademark in the US, EU and certain other territories. ‘Power Within’ is a trademark of Biocompatibles UK Ltd. ‘Imagine where we can go’, BTG and the BTG roundel logo are trademarks of BTG International Ltd. BTG and the BTG roundel logo are registered trademarks of BTG International Ltd. All rights reserved. NA-THS-2018-0260

AHPBA 2018

Date: Saturday, March 10, 2018 Time: 12:00 – 12:30 PM

Can Adjuvant Y90 Convert Unresectable HCC to Resectable by Increasing the Future Liver Remnant in Cirrhotic Livers?

Riad Salem MD, MBA, FSIR Professor of Radiology, Medicine and SurgeryVice-Chair, Image-Guided Therapy Chief, Vascular and Interventional Radiology Robert H Lurie Comprehensive Cancer Center Northwestern University, Chicago, Illinois

Join us for a thought-provoking discussion led by Dr. Riad Salem, as he describes the expanding and evolving applications of Y90, particularly in the areas of curative intent. He will discuss innovative techniques such as radiation segmentectomy and radiation lobectomy, and will also present new clinical evidence from the recent publication in Hepatology – “Institutional Decision to Adopt Y90 as Primary Treatment for HCC Informed by a 1,000-patient 15-year Experience.”

Drop by the BTG booth #7 to Learn More!

SPEAKER:

Thank you to our Bronze Sponsor



Humanitarian Device.TheraSphere® is authorized by Federal Law for use in radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable hepatocellular carcinoma (HCC) who can have placement of appropriately positioned hepatic arterial catheters. The device is also indicated for HCC patients with partial or branch portal vein thrombosis/occlusion, when clinical evaluation warrants the treatment. The effectiveness of this device for this use has not been demonstrated.1 Common adverse effects include fatigue, pain, and nausea. The majority of adverse effects are mild to moderate in severity and are manageable or resolved over time. For details on rare or more severe adverse effects, please refer to the TheraSphere® Package Insert at www.therasphere.com.1,2,3

1. Package Insert – TheraSphere® Yttrium-90 Glass Microspheres – Rev. 14. Biocompatibles UK Ltd, a BTG International group company. Available at: www.therasphere.com 2. Hilgard P, Hamami M, Fouly AE, et al. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 2010;52(5):1741–9. 3. Mazzaferro V, Sposito C, Bhoori S, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology 2013;57(5):1826–37.

TheraSphere® is manufactured for Biocompatibles UK Ltd, a BTG International group company. TheraSphere and the TheraSphere logo are trademarks of Theragenics Corporation, used under license by Biocompatibles UK Ltd. TheraSphere is a registered trademark in the US, EU and certain other territories. ‘Power Within’ is a trademark of Biocompatibles UK Ltd. ‘Imagine where we can go’, BTG and the BTG roundel logo are trademarks of BTG International Ltd. BTG and the BTG roundel logo are registered trademarks of BTG International Ltd. All rights reserved. NA-THS-2018-0260

AHPBA 2018

Date: Saturday, March 10, 2018 Time: 12:00 – 12:30 PM

Can Adjuvant Y90 Convert Unresectable HCC to Resectable by Increasing the Future Liver Remnant in Cirrhotic Livers?

Riad Salem MD, MBA, FSIR Professor of Radiology, Medicine and SurgeryVice-Chair, Image-Guided Therapy Chief, Vascular and Interventional Radiology Robert H Lurie Comprehensive Cancer Center Northwestern University, Chicago, Illinois

Join us for a thought-provoking discussion led by Dr. Riad Salem, as he describes the expanding and evolving applications of Y90, particularly in the areas of curative intent. He will discuss innovative techniques such as radiation segmentectomy and radiation lobectomy, and will also present new clinical evidence from the recent publication in Hepatology – “Institutional Decision to Adopt Y90 as Primary Treatment for HCC Informed by a 1,000-patient 15-year Experience.”

Drop by the BTG booth #7 to Learn More!

SPEAKER:


U L T R A S O U N D

D E S I G N E D F O R

S U R G E R Y

Superb images instantly - no adjustments needed

Wide range of specialized and steril izable transducers See us at AHPBA

AD0241-B AHPBA 2018.indd 1 08/02/2018 20.22.13


2625 West 51st Terrace Westwood, KS 66205 t: [email protected]


SAVE THE DATE

March 20–24, 2019 Loews Miami Beach Hotel, Miami Beach, FL

Watch the website for updates www.ahpba.org

“Get Better”


2018 MEETING ANNUAL - ahpba.org · 6:30pm - 9:30pm Executive Council Meeting | Poinciana 1/2...

Documents

Transcript of 2018 MEETING ANNUAL - ahpba.org · 6:30pm - 9:30pm Executive Council Meeting | Poinciana 1/2...